XM_040193533.1	chrI	11609314	11609314	chrI	11588752	11610155	+	XM_040193533.1	path1	Q6GPD0	Rho GTPase-activating protein 32	Rho-type GTPase-activating protein 32;Rho/Cdc42/Rac GTPase-activating protein RICS;	 PF00620;PF07653;	 GO:0005737;GO:0005886;GO:0014069;GO:0005096;GO:1901981;GO:0043547;GO:0007165;	  C:cytoplasm; C:plasma membrane; C:postsynaptic density;	  F:GTPase activator activity; F:phosphatidylinositol phosphate binding;	  P:positive regulation of GTPase activity; P:signal transduction;
XM_040182742.1	chrI	11695959	11695959	chrI	11623256	11721071	-	XM_040182742.1	path1	Q9BY67 A4FVB5 F5H0J4 H0YGA7 H1ZZV9 H1ZZW1 H1ZZW2 Q86WB8 Q8N2F4 X5D2C8	Cell adhesion molecule 1	Immunoglobulin superfamily member 4;Nectin-like protein 2;Spermatogenic immunoglobulin superfamily;Synaptic cell adhesion molecule;Tumor suppressor in lung cancer 1;	 PF08205;PF07686;	 GO:0016323;GO:0005911;GO:0016021;GO:0005886;GO:0045202;GO:0030165;GO:0042803;GO:0005102;GO:0034332;GO:0006915;GO:0030154;GO:0008037;GO:0051606;GO:0007157;GO:0007156;GO:0002376;GO:0007275;GO:0001819;GO:0045954;GO:0007283;GO:0042271;GO:0016032;	  C:basolateral plasma membrane; C:cell-cell junction; C:integral component of membrane; C:plasma membrane; C:synapse;	  F:PDZ domain binding; F:protein homodimerization activity; F:signaling receptor binding;	  P:adherens junction organization; P:apoptotic process; P:cell differentiation; P:cell recognition; P:detection of stimulus; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:immune system process; P:multicellular organism development; P:positive regulation of cytokine production; P:positive regulation of natural killer cell mediated cytotoxicity; P:spermatogenesis; P:susceptibility to natural killer cell mediated cytotoxicity; P:viral process;
XM_040173325.1	chrI	11752484	11752484	chrI	11745530	11803004	+	XM_040173325.1	path1	P31836	Neural cell adhesion molecule 1		 PF00041;PF07679;	 GO:0030424;GO:0016021;GO:0005886;GO:0098632;GO:0007411;GO:0070593;GO:0007156;	  C:axon; C:integral component of membrane; C:plasma membrane;	  F:cell-cell adhesion mediator activity;	  P:axon guidance; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules;
XM_040183888.1	chrI	11801582	11801582	chrI	11805392	11824598	+	XM_040183888.1	path1	Q802Y8	Zinc finger and BTB domain-containing protein 16-A {ECO:0000312|EMBL:AAH46887.1}	Promyelocytic leukemia zinc finger protein-A;Zinc finger protein PLZF-A {ECO:0000303|PubMed:20080956};	 PF00651;PF00096;	 GO:0005737;GO:0005654;GO:0005634;GO:0001227;GO:0046872;GO:0000978;GO:0032481;GO:0016567;GO:0050767;GO:0006357;	  C:cytoplasm; C:nucleoplasm; C:nucleus;	  F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;	  P:positive regulation of type I interferon production; P:protein ubiquitination; P:regulation of neurogenesis; P:regulation of transcription by RNA polymerase II;
XM_040193381.1	chrI	11820309	11820309	chrI	11829342	11835526	+	XM_040193381.1	path1	Q9H3S3	Transmembrane protease serine 5	Spinesin;	 PF15494;PF00089;	 GO:0016021;GO:0043025;GO:0005886;GO:0008233;GO:0005044;GO:0004252;GO:0006508;	  C:integral component of membrane; C:neuronal cell body; C:plasma membrane;	  F:peptidase activity; F:scavenger receptor activity; F:serine-type endopeptidase activity;	  P:proteolysis;
XM_040183769.1	chrI	11820309	11820309	chrI	11835628	11837754	+	XM_040183769.1	path1	Q5PRB3	PIH1 domain-containing protein 2		 PF08190;PF18201;	 GO:0005737;GO:0097255;GO:1990904;GO:0070286;GO:0000492;GO:0006364;	  C:cytoplasm; C:R2TP complex; C:ribonucleoprotein complex;	 	  P:axonemal dynein complex assembly; P:box C/D snoRNP assembly; P:rRNA processing;
XM_040183791.1	chrI	11820309	11820309	chrI	11838170	11846235	-	XM_040183791.1	path1	Q804T6	Dixin-A	Coiled-coil protein DIX1-A;DIX domain-containing protein 1-A;	 PF00778;	 GO:0005829;GO:0005925;GO:0042802;GO:0043010;GO:0060070;GO:0030900;	  C:cytosol; C:focal adhesion;	  F:identical protein binding;	  P:camera-type eye development; P:canonical Wnt signaling pathway; P:forebrain development;
XM_040194087.1	chrI	20496298	20496298	chrI	20449404	20524081	+	XM_040194087.1	path1	Q8BNA6 Q08ED4	Protocadherin Fat 3	FAT tumor suppressor homolog 3;	 PF00028;PF02210;	 GO:0030425;GO:0016021;GO:0005886;GO:0005509;GO:0000904;GO:0098609;GO:0007156;GO:2000171;GO:0001764;GO:0010842;	  C:dendrite; C:integral component of membrane; C:plasma membrane;	  F:calcium ion binding;	  P:cell morphogenesis involved in differentiation; P:cell-cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:negative regulation of dendrite development; P:neuron migration; P:retina layer formation;
XM_040194242.1	chrI	20496298	20496298	chrI	20506711	20511273	-	XM_040194242.1	path1	Q5F4A1	G2/M phase-specific E3 ubiquitin-protein ligase	G2/M phase-specific HECT-type E3 ubiquitin transferase;	 PF00632;	 GO:0005737;GO:0005730;GO:0005634;GO:0046872;GO:0004842;GO:0006915;GO:0007275;	  C:cytoplasm; C:nucleolus; C:nucleus;	  F:metal ion binding; F:ubiquitin-protein transferase activity;	  P:apoptotic process; P:multicellular organism development;
XM_040194325.1	chrI	20551435	20551435	chrI	20586461	20603904	-	XM_040194325.1	path1	Q14119	Vascular endothelial zinc finger 1	Putative transcription factor DB1;Zinc finger protein 161;	 PF00096;	 GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0046872;GO:0000977;GO:0001525;GO:0006968;GO:0001885;GO:0045603;GO:0045944;GO:0006357;	  C:nucleoplasm; C:nucleus;	  F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;	  P:angiogenesis; P:cellular defense response; P:endothelial cell development; P:positive regulation of endothelial cell differentiation; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II;
XM_040194501.1	chrI	20565140	20565140	chrI	20610083	20612048	+	XM_040194501.1	path1	Q2HJ66	Gap junction gamma-1 protein	Gap junction alpha-7 protein;	 PF00029;	 GO:0005922;GO:0016021;GO:0005243;GO:0007267;	  C:connexin complex; C:integral component of membrane;	  F:gap junction channel activity;	  P:cell-cell signaling;
XM_040175727.1	chrI	20638786	20638786	chrI	20630130	20633908	-	XM_040175727.1	path1	Q8VE22 Q9CXH1	28S ribosomal protein S23, mitochondrial		 PF10484;	 GO:0005763;GO:0005739;GO:0031965;GO:0003735;GO:0006412;	  C:mitochondrial small ribosomal subunit; C:mitochondrion; C:nuclear membrane;	  F:structural constituent of ribosome;	  P:translation;
XM_040175715.1	chrI	20638786	20638786	chrI	20633849	20658177	+	XM_040175715.1	path1	Q8CHT1 Q8R204 Q923H2 Q9JHT9	Ephexin-1	Eph-interacting exchange protein;Neuronal guanine nucleotide exchange factor;	 PF00169;PF00621;PF00018;	 GO:0005829;GO:0098978;GO:0030426;GO:0016020;GO:0046875;GO:0005085;GO:0090630;GO:0030154;GO:0009987;GO:0048013;GO:0061002;GO:0007399;GO:0043087;GO:0098883;	  C:cytosol; C:glutamatergic synapse; C:growth cone; C:membrane;	  F:ephrin receptor binding; F:guanyl-nucleotide exchange factor activity;	  P:activation of GTPase activity; P:cell differentiation; P:cellular process; P:ephrin receptor signaling pathway; P:negative regulation of dendritic spine morphogenesis; P:nervous system development; P:regulation of GTPase activity; P:synapse pruning;
XM_040178053.1	chrI	20638786	20638786	chrI	20685538	20686504	-	XM_040178053.1	path1	Q5QNP2	Trace amine-associated receptor 13c {ECO:0000312|ZFIN:ZDB-GENE-041014-60}		 PF00001;	 GO:0016021;GO:0005886;GO:0008227;GO:0004984;GO:0019808;GO:0019810;GO:0001594;GO:0007610;GO:0050911;GO:1990834;GO:0007606;GO:0009995;	  C:integral component of membrane; C:plasma membrane;	  F:G protein-coupled amine receptor activity; F:olfactory receptor activity; F:polyamine binding; F:putrescine binding; F:trace-amine receptor activity;	  P:behavior; P:detection of chemical stimulus involved in sensory perception of smell; P:response to odorant; P:sensory perception of chemical stimulus; P:soluble molecule recognition;
XR_005712686.1	chrI	20667517	20667517	chrI	20710484	20732081	+	XR_005712686.1	path1	Q9QX47 E3WC91 E9PXW2 E9Q3H8 E9Q3I0 E9Q6M4 E9Q7G2 E9QAR8 E9QMT0 Q811G3 Q9CQ12 Q9CQK6 Q9QXP5	Protein SON	Negative regulatory element-binding protein;	 PF01585;	 GO:0016607;GO:0003677;GO:0003723;GO:0050733;GO:0000226;GO:0000281;GO:0006397;GO:0043066;GO:0051726;GO:0048024;GO:0043484;GO:0008380;	  C:nuclear speck;	  F:DNA binding; F:RNA binding; F:RS domain binding;	  P:microtubule cytoskeleton organization; P:mitotic cytokinesis; P:mRNA processing; P:negative regulation of apoptotic process; P:regulation of cell cycle; P:regulation of mRNA splicing, via spliceosome; P:regulation of RNA splicing; P:RNA splicing;
XM_040167321.1	chrII	8245408	8245408	chrII	8240052	8325974	+	XM_040167321.1	path1	P78333 B2R726 O60436 Q9BX27	Glypican-5		 PF01153;	 GO:0046658;GO:0009986;GO:0062023;GO:0005576;GO:0005615;GO:0005796;GO:0016021;GO:0043202;GO:0005886;GO:0016477;GO:0006024;GO:0006027;GO:0090263;GO:1905475;GO:0001523;	  C:anchored component of plasma membrane; C:cell surface; C:collagen-containing extracellular matrix; C:extracellular region; C:extracellular space; C:Golgi lumen; C:integral component of membrane; C:lysosomal lumen; C:plasma membrane;	 	  P:cell migration; P:glycosaminoglycan biosynthetic process; P:glycosaminoglycan catabolic process; P:positive regulation of canonical Wnt signaling pathway; P:regulation of protein localization to membrane; P:retinoid metabolic process;
XM_040164547.1	chrII	8355240	8355240	chrII	8335561	8432963	-	XM_040164547.1	path1	Q5RE54	Glypican-6		 PF01153;	 GO:0046658;GO:0062023;GO:0005615;GO:0016477;GO:0009966;	  C:anchored component of plasma membrane; C:collagen-containing extracellular matrix; C:extracellular space;	 	  P:cell migration; P:regulation of signal transduction;
XM_040166369.1	chrII	8473336	8473336	chrII	8490444	8512551	+	XM_040166369.1	path1	Q8WWI1 E9PLH4 O15462 O95346 Q5TBK6 Q9UKC1 Q9UQM5 Q9Y6A7	LIM domain only protein 7	F-box only protein 20;LOMP;	 PF00307;PF15949;PF00412;PF00595;	 GO:0016324;GO:0009986;GO:0005737;GO:0005829;GO:0005925;GO:0005635;GO:0005634;GO:0000151;GO:0046872;GO:0004842;GO:0045944;GO:0043687;GO:0000209;GO:0016567;GO:0030155;GO:0023051;	  C:apical plasma membrane; C:cell surface; C:cytoplasm; C:cytosol; C:focal adhesion; C:nuclear envelope; C:nucleus; C:ubiquitin ligase complex;	  F:metal ion binding; F:ubiquitin-protein transferase activity;	  P:positive regulation of transcription by RNA polymerase II; P:post-translational protein modification; P:protein polyubiquitination; P:protein ubiquitination; P:regulation of cell adhesion; P:regulation of signaling;
XM_040202818.1	chrII	8488486	8488486	chrII	8516798	8521225	-	XM_040202818.1	path1	Q96CX2	BTB/POZ domain-containing protein KCTD12	Pfetin;Predominantly fetal expressed T1 domain;	 PF02214;	 GO:0042995;GO:0045211;GO:0042734;GO:0042802;GO:0003723;GO:0051260;	  C:cell projection; C:postsynaptic membrane; C:presynaptic membrane;	  F:identical protein binding; F:RNA binding;	  P:protein homooligomerization;
XM_040168314.1	chrII	8540162	8540162	chrII	8530126	8536135	-	XM_040168314.1	path1	Q8UWF0	High-affinity choline transporter 1		 PF00474;	 GO:0016021;GO:0015220;GO:0015293;GO:0008292;GO:0006814;	  C:integral component of membrane;	  F:choline transmembrane transporter activity; F:symporter activity;	  P:acetylcholine biosynthetic process; P:sodium ion transport;
XM_040204268.1	chrII	8540162	8540162	chrII	8537776	8543185	-	XM_040204268.1	path1	Q5M9P8	ADP-ribosylation factor-like protein 6		 PF00025;	 GO:0005930;GO:0060170;GO:0005525;GO:0003924;GO:0046872;GO:0060271;GO:0007368;GO:0007369;GO:0006886;GO:0070121;GO:0032402;GO:0033339;GO:0061512;GO:0008593;GO:0050896;GO:0016192;GO:0007601;	  C:axoneme; C:ciliary membrane;	  F:GTP binding; F:GTPase activity; F:metal ion binding;	  P:cilium assembly; P:determination of left/right symmetry; P:gastrulation; P:intracellular protein transport; P:Kupffer's vesicle development; P:melanosome transport; P:pectoral fin development; P:protein localization to cilium; P:regulation of Notch signaling pathway; P:response to stimulus; P:vesicle-mediated transport; P:visual perception;
XM_040204255.1	chrII	8540162	8540162	chrII	8543717	8580703	-	XM_040204255.1	path1	Q62413 B9EIV2 Q8CCN2	Ephrin type-A receptor 6	EPH homology kinase 2;	 PF14575;PF01404;PF00041;PF07714;PF00536;	 GO:0005887;GO:0043005;GO:0005654;GO:0043235;GO:0005524;GO:0004714;GO:0005005;GO:0007411;GO:0007275;GO:0033674;GO:0007169;	  C:integral component of plasma membrane; C:neuron projection; C:nucleoplasm; C:receptor complex;	  F:ATP binding; F:transmembrane receptor protein tyrosine kinase activity; F:transmembrane-ephrin receptor activity;	  P:axon guidance; P:multicellular organism development; P:positive regulation of kinase activity; P:transmembrane receptor protein tyrosine kinase signaling pathway;
XM_040163422.1	chrII	10950517	10950517	chrII	10909896	10927882	+	XM_040163422.1	path1	Q7Z442 Q6UEE1 Q6ZN46 Q6ZSP2 Q8N1H9 Q96CL2 Q96Q08	Polycystic kidney disease protein 1-like 2	PC1-like 2 protein;Polycystin-1L2;	 PF02140;PF01825;PF00059;PF08016;PF01477;PF02010;	 GO:0016021;GO:0016020;GO:0005262;GO:0005509;GO:0030246;GO:0050982;	  C:integral component of membrane; C:membrane;	  F:calcium channel activity; F:calcium ion binding; F:carbohydrate binding;	  P:detection of mechanical stimulus;
XM_040203845.1	chrII	10950517	10950517	chrII	10928330	10954458	+	XM_040203845.1	path1	Q9WV30 E9Q0P3 E9Q6U2 G5E8N9 Q91WY0 Q9JLA1	Nuclear factor of activated T-cells 5	Rel domain-containing transcription factor NFAT5;T-cell transcription factor NFAT5;	 PF16179;PF00554;	 GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005667;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0000978;GO:1990837;GO:0008134;GO:0033173;GO:0071345;GO:0010628;GO:1904996;GO:1901224;GO:0045944;GO:0070884;GO:0006357;GO:0006970;GO:0006366;GO:0006351;	  C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus; C:transcription regulator complex;	  F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding;	  P:calcineurin-NFAT signaling cascade; P:cellular response to cytokine stimulus; P:positive regulation of gene expression; P:positive regulation of leukocyte adhesion to vascular endothelial cell; P:positive regulation of NIK/NF-kappaB signaling; P:positive regulation of transcription by RNA polymerase II; P:regulation of calcineurin-NFAT signaling cascade; P:regulation of transcription by RNA polymerase II; P:response to osmotic stress; P:transcription by RNA polymerase II; P:transcription, DNA-templated;
XM_040201715.1	chrII	10950517	10950517	chrII	10955766	10962627	+	XM_040201715.1	path1	Q99MN1	Lysine--tRNA ligase	Lysyl-tRNA synthetase;	 PF00152;PF01336;	 GO:0017101;GO:0005737;GO:0005829;GO:0005615;GO:0005739;GO:0005634;GO:0005886;GO:0016597;GO:0003877;GO:0005524;GO:0042802;GO:0004824;GO:0042803;GO:0097110;GO:0000049;GO:0002276;GO:0015966;GO:0070371;GO:0006430;GO:0002863;GO:0043032;GO:0045893;GO:0010165;	  C:aminoacyl-tRNA synthetase multienzyme complex; C:cytoplasm; C:cytosol; C:extracellular space; C:mitochondrion; C:nucleus; C:plasma membrane;	  F:amino acid binding; F:ATP adenylyltransferase activity; F:ATP binding; F:identical protein binding; F:lysine-tRNA ligase activity; F:protein homodimerization activity; F:scaffold protein binding; F:tRNA binding;	  P:basophil activation involved in immune response; P:diadenosine tetraphosphate biosynthetic process; P:ERK1 and ERK2 cascade; P:lysyl-tRNA aminoacylation; P:positive regulation of inflammatory response to antigenic stimulus; P:positive regulation of macrophage activation; P:positive regulation of transcription, DNA-templated; P:response to X-ray;
XM_040201753.1	chrII	10950517	10950517	chrII	10963794	10968614	+	XM_040201753.1	path1	P11183	Glycine cleavage system H protein, mitochondrial {ECO:0000303|PubMed:1993703}	Lipoic acid-containing protein;	 PF01597;	 GO:0005737;GO:0005960;GO:0005739;GO:0019464;GO:0009249;	  C:cytoplasm; C:glycine cleavage complex; C:mitochondrion;	 	  P:glycine decarboxylation via glycine cleavage system; P:protein lipoylation;
XM_040201729.1	chrII	10950517	10950517	chrII	10970247	10973256	+	XM_040201729.1	path1	Q90Z10	60S ribosomal protein L13		 PF01294;	 GO:0022625;GO:0003723;GO:0003735;GO:0051726;GO:0006412;	  C:cytosolic large ribosomal subunit;	  F:RNA binding; F:structural constituent of ribosome;	  P:regulation of cell cycle; P:translation;
XM_040160346.1	chrII	10950517	10950517	chrII	10976951	11000375	+	XM_040160346.1	path1	H1UBN0	Copine-7 {ECO:0000305}	Copine VII {ECO:0000250|UniProtKB:Q99829, ECO:0000312|RGD:1307466};	 PF00168;PF07002;	 GO:0005737;GO:0005634;GO:0005886;GO:0005544;GO:0046872;GO:0071277;	  C:cytoplasm; C:nucleus; C:plasma membrane;	  F:calcium-dependent phospholipid binding; F:metal ion binding;	  P:cellular response to calcium ion;
XM_040169283.1	chrII	10985254	10985254	chrII	11023236	11026886	+	XM_040169283.1	path1	P97292 Q9D282	Histamine H2 receptor	Gastric receptor I;	 PF00001;	 GO:0030425;GO:0005887;GO:0016020;GO:0045202;GO:0004993;GO:1901363;GO:0004969;GO:0030594;GO:0007268;GO:0048565;GO:0003382;GO:0007187;GO:0001696;GO:0001698;GO:0048732;GO:0001697;GO:0007613;GO:1900139;GO:0045907;GO:0048167;GO:1901998;GO:0008542;	  C:dendrite; C:integral component of plasma membrane; C:membrane; C:synapse;	  F:G protein-coupled serotonin receptor activity; F:heterocyclic compound binding; F:histamine receptor activity; F:neurotransmitter receptor activity;	  P:chemical synaptic transmission; P:digestive tract development; P:epithelial cell morphogenesis; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:gastric acid secretion; P:gastrin-induced gastric acid secretion; P:gland development; P:histamine-induced gastric acid secretion; P:memory; P:negative regulation of arachidonic acid secretion; P:positive regulation of vasoconstriction; P:regulation of synaptic plasticity; P:toxin transport; P:visual learning;
XM_040164604.1	chrII	10988507	10988507	chrII	11029439	11033334	-	XM_040164604.1	path1	P56395	Cytochrome b5		 PF00173;	 GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0043231;GO:0016020;GO:0005739;GO:0009055;GO:0019899;GO:0020037;GO:0046872;GO:0004768;GO:0006631;GO:0046686;	  C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:membrane; C:mitochondrion;	  F:electron transfer activity; F:enzyme binding; F:heme binding; F:metal ion binding; F:stearoyl-CoA 9-desaturase activity;	  P:fatty acid metabolic process; P:response to cadmium ion;
XM_040196163.1	chrII	10995608	10995608	chrII	11034603	11049674	+	XM_040196163.1	path1	Q17R09	Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16	ATP-dependent RNA helicase DHX38;DEAH box protein 38;	 PF00270;PF04408;PF00271;PF07717;	 GO:0071013;GO:0005681;GO:0005524;GO:0016787;GO:0003723;GO:0003724;GO:0000398;	  C:catalytic step 2 spliceosome; C:spliceosomal complex;	  F:ATP binding; F:hydrolase activity; F:RNA binding; F:RNA helicase activity;	  P:mRNA splicing, via spliceosome;
XM_040201775.1	chrII	12000352	12000352	chrII	11942926	11969290	+	XM_040201775.1	path1	Q2EY14	Protogenin A		 PF00041;PF07679;	 GO:0016021;GO:0050768;	  C:integral component of membrane;	 	  P:negative regulation of neurogenesis;
XM_040201786.1	chrII	12000352	12000352	chrII	11969691	11977469	+	XM_040201786.1	path1	Q5R6R3	Cell cycle progression protein 1		 	 GO:0016021;GO:0007049;GO:2001106;	  C:integral component of membrane;	 	  P:cell cycle; P:regulation of Rho guanyl-nucleotide exchange factor activity;
XM_040201817.1	chrII	12000352	12000352	chrII	11977486	11981200	-	XM_040201817.1	path1	Q7SXZ1	GPI mannosyltransferase 3	GPI mannosyltransferase III;Phosphatidylinositol-glycan biosynthesis class B protein;	 PF03901;	 GO:0005789;GO:0016021;GO:0000026;GO:0004376;GO:0000030;GO:0006506;	  C:endoplasmic reticulum membrane; C:integral component of membrane;	  F:alpha-1,2-mannosyltransferase activity; F:glycolipid mannosyltransferase activity; F:mannosyltransferase activity;	  P:GPI anchor biosynthetic process;
XM_040197318.1	chrII	12000352	12000352	chrII	11982140	11983214	+	XM_040197318.1	path1	A0A0B4J2F0	Protein PIGBOS1 {ECO:0000305}	PIGB opposite strand protein 1 {ECO:0000312|HGNC:HGNC:50696};	 	 GO:0031307;GO:1900101;GO:0006986;	  C:integral component of mitochondrial outer membrane;	 	  P:regulation of endoplasmic reticulum unfolded protein response; P:response to unfolded protein;
XM_040197296.1	chrII	12000352	12000352	chrII	11983956	11991706	+	XM_040197296.1	path1	P51159 O00195 Q6FI40 Q9UIR9 Q9Y5U3	Ras-related protein Rab-27A	GTP-binding protein Ram;	 PF00071;	 GO:0016324;GO:0005829;GO:0030425;GO:0070382;GO:0070062;GO:0005576;GO:0005794;GO:0005770;GO:0005764;GO:0042470;GO:0033162;GO:0032585;GO:0001750;GO:0030141;GO:0030667;GO:0035580;GO:0033093;GO:0003925;GO:0019003;GO:0005525;GO:0003924;GO:0031489;GO:0019904;GO:0019882;GO:0007596;GO:0097278;GO:0043316;GO:0006887;GO:1990182;GO:0030318;GO:0032400;GO:0032402;GO:0036257;GO:0071985;GO:0043320;GO:0043312;GO:1903435;GO:0045921;GO:0010628;GO:0050766;GO:1903428;GO:1903307;GO:0006605;GO:0048489;	  C:apical plasma membrane; C:cytosol; C:dendrite; C:exocytic vesicle; C:extracellular exosome; C:extracellular region; C:Golgi apparatus; C:late endosome; C:lysosome; C:melanosome; C:melanosome membrane; C:multivesicular body membrane; C:photoreceptor outer segment; C:secretory granule; C:secretory granule membrane; C:specific granule lumen; C:Weibel-Palade body;	  F:G protein activity; F:GDP binding; F:GTP binding; F:GTPase activity; F:myosin V binding; F:protein domain specific binding;	  P:antigen processing and presentation; P:blood coagulation; P:complement-dependent cytotoxicity; P:cytotoxic T cell degranulation; P:exocytosis; P:exosomal secretion; P:melanocyte differentiation; P:melanosome localization; P:melanosome transport; P:multivesicular body organization; P:multivesicular body sorting pathway; P:natural killer cell degranulation; P:neutrophil degranulation; P:positive regulation of constitutive secretory pathway; P:positive regulation of exocytosis; P:positive regulation of gene expression; P:positive regulation of phagocytosis; P:positive regulation of reactive oxygen species biosynthetic process; P:positive regulation of regulated secretory pathway; P:protein targeting; P:synaptic vesicle transport;
XM_040161248.1	chrII	12000352	12000352	chrII	11992769	11999340	+	XM_040161248.1	path1	Q8K3G5 Q921W6	Inactive serine/threonine-protein kinase VRK3	Serine/threonine-protein pseudokinase VRK3;Vaccinia-related kinase 3;	 PF00069;PF13240;	 GO:0005737;GO:0043231;GO:0005730;GO:0005654;GO:0005634;GO:0005524;GO:0019903;GO:0004674;GO:0070373;GO:0018105;GO:0032516;	  C:cytoplasm; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleoplasm; C:nucleus;	  F:ATP binding; F:protein phosphatase binding; F:protein serine/threonine kinase activity;	  P:negative regulation of ERK1 and ERK2 cascade; P:peptidyl-serine phosphorylation; P:positive regulation of phosphoprotein phosphatase activity;
XM_040197285.1	chrII	12000352	12000352	chrII	11998744	12007760	-	XM_040197285.1	path1	Q6ZS17 B4DEQ9 B4DIM2 E9PBS3 Q4G0A4 Q7Z5R7 Q8NDA4 Q96J39 Q96PV8 Q9H8D9	Rho family-interacting cell polarization regulator 1		 PF15903;	 GO:0031252;GO:0005737;GO:0070062;GO:0005794;GO:0016020;GO:0012506;GO:0071889;GO:1990869;GO:0009267;GO:0051683;GO:2001107;GO:0035024;GO:0030335;GO:0090316;GO:0034067;GO:0009611;GO:0007266;	  C:cell leading edge; C:cytoplasm; C:extracellular exosome; C:Golgi apparatus; C:membrane; C:vesicle membrane;	  F:14-3-3 protein binding;	  P:cellular response to chemokine; P:cellular response to starvation; P:establishment of Golgi localization; P:negative regulation of Rho guanyl-nucleotide exchange factor activity; P:negative regulation of Rho protein signal transduction; P:positive regulation of cell migration; P:positive regulation of intracellular protein transport; P:protein localization to Golgi apparatus; P:response to wounding; P:Rho protein signal transduction;
XM_040202598.1	chrII	12000352	12000352	chrII	12009492	12015319	-	XM_040202598.1	path1	Q08705	Transcriptional repressor CTCF	11-zinc finger protein;CCCTC-binding factor;CTCFL paralog;	 PF00096;	 GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0006357;	  C:nucleus;	  F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;	  P:regulation of transcription by RNA polymerase II;
XM_040198171.1	chrII	12000352	12000352	chrII	12017074	12021743	+	XM_040198171.1	path1	Q6F5E8 B8X2Z3	Capping protein, Arp2/3 and myosin-I linker protein 2 {ECO:0000303|PubMed:19846667}	Capping protein regulator and myosin 1 linker 2 {ECO:0000312|HGNC:HGNC:27089};F-actin-uncapping protein RLTPR {ECO:0000305};Leucine-rich repeat-containing protein 16C;RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein {ECO:0000303|PubMed:15588584};	 PF17888;PF16000;PF13516;	 GO:0015629;GO:0031252;GO:0005737;GO:0031234;GO:0045111;GO:0030027;GO:0044354;GO:0016020;GO:0005886;GO:0001726;GO:0005543;GO:0044877;GO:0051639;GO:0007163;GO:0061339;GO:0030011;GO:2000813;GO:0030335;GO:0090091;GO:0010592;GO:1902745;GO:1900029;GO:0044319;	  C:actin cytoskeleton; C:cell leading edge; C:cytoplasm; C:extrinsic component of cytoplasmic side of plasma membrane; C:intermediate filament cytoskeleton; C:lamellipodium; C:macropinosome; C:membrane; C:plasma membrane; C:ruffle;	  F:phospholipid binding; F:protein-containing complex binding;	  P:actin filament network formation; P:establishment or maintenance of cell polarity; P:establishment or maintenance of monopolar cell polarity; P:maintenance of cell polarity; P:negative regulation of barbed-end actin filament capping; P:positive regulation of cell migration; P:positive regulation of extracellular matrix disassembly; P:positive regulation of lamellipodium assembly; P:positive regulation of lamellipodium organization; P:positive regulation of ruffle assembly; P:wound healing, spreading of cells;
XM_040198227.1	chrII	12000352	12000352	chrII	12022728	12024999	+	XM_040198227.1	path1	Q7T3C6	Cleavage and polyadenylation specificity factor subunit 5 {ECO:0000250|UniProtKB:O43809}	Nudix hydrolase 21 {ECO:0000250|UniProtKB:O43809};	 PF13869;	 GO:0005737;GO:0005849;GO:0005634;GO:0042382;GO:0016787;GO:0042802;GO:0035925;GO:0003729;GO:0030154;GO:1990120;GO:0110104;GO:0006378;GO:0006397;GO:0031439;GO:1900365;GO:2000975;GO:2000738;GO:0010608;GO:0051290;	  C:cytoplasm; C:mRNA cleavage factor complex; C:nucleus; C:paraspeckles;	  F:hydrolase activity; F:identical protein binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA binding;	  P:cell differentiation; P:messenger ribonucleoprotein complex assembly; P:mRNA alternative polyadenylation; P:mRNA polyadenylation; P:mRNA processing; P:positive regulation of mRNA cleavage; P:positive regulation of mRNA polyadenylation; P:positive regulation of pro-B cell differentiation; P:positive regulation of stem cell differentiation; P:posttranscriptional regulation of gene expression; P:protein heterotetramerization;
XM_040198192.1	chrII	12000352	12000352	chrII	12027042	12031229	+	XM_040198192.1	path1	Q5R4R3	Prolyl 3-hydroxylase OGFOD1	2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1;uS12 prolyl 3-hydroxylase;	 PF13661;PF10637;	 GO:0010494;GO:0005634;GO:0005506;GO:0031418;GO:0031544;GO:0031543;GO:0008283;GO:0018126;GO:0006449;GO:0034063;	  C:cytoplasmic stress granule; C:nucleus;	  F:iron ion binding; F:L-ascorbic acid binding; F:peptidyl-proline 3-dioxygenase activity; F:peptidyl-proline dioxygenase activity;	  P:cell population proliferation; P:protein hydroxylation; P:regulation of translational termination; P:stress granule assembly;
XM_040198214.1	chrII	12000352	12000352	chrII	12031331	12038077	+	XM_040198214.1	path1	Q1M161	Tumor necrosis factor receptor type 1-associated DEATH domain protein	TNFRSF1A-associated via death domain protein;	 PF00531;PF09034;	 GO:0005737;GO:0005856;GO:0005634;GO:0060090;GO:0006915;GO:0043123;GO:0007165;	  C:cytoplasm; C:cytoskeleton; C:nucleus;	  F:molecular adaptor activity;	  P:apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:signal transduction;
XM_040198202.1	chrII	12000352	12000352	chrII	12039386	12045729	+	XM_040198202.1	path1	P09471 P29777 Q8TD72 Q9UMV4	Guanine nucleotide-binding protein G(o) subunit alpha		 PF00503;	 GO:0044297;GO:0030425;GO:0005834;GO:0043209;GO:0005886;GO:0051430;GO:0001664;GO:0031821;GO:0031683;GO:0005525;GO:0032794;GO:0003924;GO:0046872;GO:0031852;GO:0007188;GO:0007568;GO:0007212;GO:0030900;GO:0007626;GO:0006936;GO:0051926;GO:0031175;GO:0042475;GO:0043547;GO:0006457;GO:0008016;GO:0034097;GO:0042493;GO:0042542;GO:0043278;GO:0007223;	  C:cell body; C:dendrite; C:heterotrimeric G-protein complex; C:myelin sheath; C:plasma membrane;	  F:corticotropin-releasing hormone receptor 1 binding; F:G protein-coupled receptor binding; F:G protein-coupled serotonin receptor binding; F:G-protein beta/gamma-subunit complex binding; F:GTP binding; F:GTPase activating protein binding; F:GTPase activity; F:metal ion binding; F:mu-type opioid receptor binding;	  P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; P:aging; P:dopamine receptor signaling pathway; P:forebrain development; P:locomotory behavior; P:muscle contraction; P:negative regulation of calcium ion transport; P:neuron projection development; P:odontogenesis of dentin-containing tooth; P:positive regulation of GTPase activity; P:protein folding; P:regulation of heart contraction; P:response to cytokine; P:response to drug; P:response to hydrogen peroxide; P:response to morphine; P:Wnt signaling pathway, calcium modulating pathway;
XM_040204750.1	chrII	12000352	12000352	chrII	12045963	12051790	-	XM_040204750.1	path1	Q29RB1	Conserved oligomeric Golgi complex subunit 4	Component of oligomeric Golgi complex 4;	 PF08318;	 GO:0005829;GO:0000139;GO:0017119;GO:0007030;GO:0048213;GO:0015031;GO:0006029;GO:0006890;GO:0001501;	  C:cytosol; C:Golgi membrane; C:Golgi transport complex;	 	  P:Golgi organization; P:Golgi vesicle prefusion complex stabilization; P:protein transport; P:proteoglycan metabolic process; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; P:skeletal system development;
XM_040200603.1	chrII	12227158	12227158	chrII	12149675	12162461	+	XM_040200603.1	path1	Q7RTU9	Stereocilin		 	 GO:0009986;GO:0060091;GO:0032426;GO:0060088;GO:0007160;GO:0050910;	  C:cell surface; C:kinocilium; C:stereocilium tip;	 	  P:auditory receptor cell stereocilium organization; P:cell-matrix adhesion; P:detection of mechanical stimulus involved in sensory perception of sound;
XM_040200644.1	chrII	12224595	12224595	chrII	12163939	12220110	+	XM_040200644.1	path1	P23188 Q6GTN6	Furin	Dibasic-processing enzyme;Paired basic amino acid residue-cleaving enzyme;Prohormone convertase 3;	 PF01483;PF00082;PF16470;	 GO:0009986;GO:0005769;GO:0005783;GO:0005788;GO:0005789;GO:0010008;GO:0005576;GO:0031985;GO:0000139;GO:0030173;GO:0016021;GO:0016020;GO:0045121;GO:0005886;GO:0005802;GO:0030140;GO:0012510;GO:0004175;GO:0046872;GO:0048406;GO:0008233;GO:0042277;GO:0002020;GO:0004252;GO:0004867;GO:0001825;GO:0090472;GO:0032804;GO:0032911;GO:0032902;GO:0043043;GO:0016486;GO:0030335;GO:0030511;GO:1901394;GO:0016485;GO:0032374;GO:0052548;GO:0042176;GO:0009966;GO:0032940;GO:0006465;GO:0019058;GO:0031638;GO:0097341;	  C:cell surface; C:early endosome; C:endoplasmic reticulum; C:endoplasmic reticulum lumen; C:endoplasmic reticulum membrane; C:endosome membrane; C:extracellular region; C:Golgi cisterna; C:Golgi membrane; C:integral component of Golgi membrane; C:integral component of membrane; C:membrane; C:membrane raft; C:plasma membrane; C:trans-Golgi network; C:trans-Golgi network transport vesicle; C:trans-Golgi network transport vesicle membrane;	  F:endopeptidase activity; F:metal ion binding; F:nerve growth factor binding; F:peptidase activity; F:peptide binding; F:protease binding; F:serine-type endopeptidase activity; F:serine-type endopeptidase inhibitor activity;	  P:blastocyst formation; P:dibasic protein processing; P:negative regulation of low-density lipoprotein particle receptor catabolic process; P:negative regulation of transforming growth factor beta1 production; P:nerve growth factor production; P:peptide biosynthetic process; P:peptide hormone processing; P:positive regulation of cell migration; P:positive regulation of transforming growth factor beta receptor signaling pathway; P:positive regulation of transforming growth factor beta1 activation; P:protein processing; P:regulation of cholesterol transport; P:regulation of endopeptidase activity; P:regulation of protein catabolic process; P:regulation of signal transduction; P:secretion by cell; P:signal peptide processing; P:viral life cycle; P:zymogen activation; P:zymogen inhibition;
XM_040200672.1	chrII	12224595	12224595	chrII	12267273	12277383	-	XM_040200672.1	path1	Q58G59	Kinesin-like protein kif7	Kinesin-like protein costal2;	 PF00225;	 GO:0005929;GO:0005737;GO:0035301;GO:0005871;GO:0005874;GO:0005524;GO:1990939;GO:0016887;GO:0008017;GO:0003777;GO:0007368;GO:0007018;GO:0045879;GO:0035845;	  C:cilium; C:cytoplasm; C:Hedgehog signaling complex; C:kinesin complex; C:microtubule;	  F:ATP binding; F:ATP-dependent microtubule motor activity; F:ATPase activity; F:microtubule binding; F:microtubule motor activity;	  P:determination of left/right symmetry; P:microtubule-based movement; P:negative regulation of smoothened signaling pathway; P:photoreceptor cell outer segment organization;
XM_040169199.1	chrII	12227100	12227100	chrII	12286477	12291916	-	XM_040169199.1	path1	Q53RD9 A0JNV1 A0JNV2 Q5H9P5 Q8N9G0	Fibulin-7		 PF00008;PF07645;PF00084;	 GO:0031012;GO:0005615;GO:0005925;GO:0005509;GO:0043395;GO:0008201;GO:0007155;GO:0110151;	  C:extracellular matrix; C:extracellular space; C:focal adhesion;	  F:calcium ion binding; F:heparan sulfate proteoglycan binding; F:heparin binding;	  P:cell adhesion; P:positive regulation of biomineralization;
XM_040199442.1	chrII	12240132	12240132	chrII	12315576	12348893	+	XM_040199442.1	path1	P19600 Q6GR47	Heterogeneous nuclear ribonucleoprotein C	hnRNP core protein C;	 PF00076;	 GO:0005634;GO:1990247;GO:0000398;	  C:nucleus;	  F:N6-methyladenosine-containing RNA binding;	  P:mRNA splicing, via spliceosome;
XR_005714410.1	chrII	12379464	12379464	chrII	12338929	12340220	-	XR_005714410.1	path2	P04323	Retrovirus-related Pol polyprotein from transposon 17.6		 PF17921;PF17917;PF00078;	 GO:0004190;GO:0004519;GO:0003676;GO:0003964;GO:0015074;	 	  F:aspartic-type endopeptidase activity; F:endonuclease activity; F:nucleic acid binding; F:RNA-directed DNA polymerase activity;	  P:DNA integration;
XM_040199454.1	chrII	12379464	12379464	chrII	12349655	12351395	+	XM_040199454.1	path1	Q06S87 Q0P422	5-hydroxyisourate hydrolase	Transthyretin-related protein;	 PF00576;	 GO:0005777;GO:0016811;GO:0033971;GO:0006144;GO:0019628;	  C:peroxisome;	  F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:hydroxyisourate hydrolase activity;	  P:purine nucleobase metabolic process; P:urate catabolic process;
XM_040199475.1	chrII	12379464	12379464	chrII	12351592	12354161	+	XM_040199475.1	path1	Q06S87 Q0P422	5-hydroxyisourate hydrolase	Transthyretin-related protein;	 PF00576;	 GO:0005777;GO:0016811;GO:0033971;GO:0006144;GO:0019628;	  C:peroxisome;	  F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides; F:hydroxyisourate hydrolase activity;	  P:purine nucleobase metabolic process; P:urate catabolic process;
XM_040199488.1	chrII	12379464	12379464	chrII	12354289	12357894	+	XM_040199488.1	path1	P56812	Programmed cell death protein 5	TF-1 cell apoptosis-related protein 19;	 PF01984;	 GO:0005737;GO:0005829;GO:0005634;GO:0010698;GO:0048487;GO:0003677;GO:0008201;GO:0006915;GO:0071560;GO:0008285;GO:1903645;GO:0043065;GO:0043280;GO:0010628;GO:1903638;GO:0090200;	  C:cytoplasm; C:cytosol; C:nucleus;	  F:acetyltransferase activator activity; F:beta-tubulin binding; F:DNA binding; F:heparin binding;	  P:apoptotic process; P:cellular response to transforming growth factor beta stimulus; P:negative regulation of cell population proliferation; P:negative regulation of chaperone-mediated protein folding; P:positive regulation of apoptotic process; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of gene expression; P:positive regulation of protein insertion into mitochondrial outer membrane; P:positive regulation of release of cytochrome c from mitochondria;
XM_040199430.1	chrII	12379464	12379464	chrII	12358627	12362722	+	XM_040199430.1	path1	Q5U403	Diphosphomevalonate decarboxylase	Mevalonate (diphospho)decarboxylase;Mevalonate pyrophosphate decarboxylase;	 PF00288;PF18376;	 GO:0005829;GO:0005524;GO:0004163;GO:0006695;GO:0019287;	  C:cytosol;	  F:ATP binding; F:diphosphomevalonate decarboxylase activity;	  P:cholesterol biosynthetic process; P:isopentenyl diphosphate biosynthetic process, mevalonate pathway;
XM_040165734.1	chrII	12379464	12379464	chrII	12363156	12365663	+	XM_040165734.1	path1	Q95L73	Cytochrome b-245 light chain	Cytochrome b(558) alpha chain;Cytochrome b558 subunit alpha;Neutrophil cytochrome b 22 kDa polypeptide;Superoxide-generating NADPH oxidase light chain subunit;p22 phagocyte B-cytochrome;p22-phox;	 PF05038;	 GO:0043020;GO:0020037;GO:0046872;GO:0016491;GO:0045087;	  C:NADPH oxidase complex;	  F:heme binding; F:metal ion binding; F:oxidoreductase activity;	  P:innate immune response;
XM_040199277.1	chrII	12379464	12379464	chrII	12366362	12376637	+	XM_040199277.1	path1	Q8R3L2 Q3THR8 Q3UBI7 Q3UD64 Q3UG75 Q80ZX3 Q8BR80 Q8C200 Q8C2M3 Q8C6B4 Q9CUW0 Q9ER19	Transcription factor 25	Nuclear localized protein 1;	 PF04910;	 GO:0005634;GO:1990112;GO:0003677;GO:0003714;GO:0000122;	  C:nucleus; C:RQC complex;	  F:DNA binding; F:transcription corepressor activity;	  P:negative regulation of transcription by RNA polymerase II;
XM_040199339.1	chrII	12379464	12379464	chrII	12378017	12381555	+	XM_040199339.1	path1	P55167	Melanocyte-stimulating hormone receptor	Melanocortin receptor 1;	 PF00001;	 GO:0005737;GO:0016021;GO:0005886;GO:0004930;GO:0004980;GO:0007189;GO:0019222;	  C:cytoplasm; C:integral component of membrane; C:plasma membrane;	  F:G protein-coupled receptor activity; F:melanocyte-stimulating hormone receptor activity;	  P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:regulation of metabolic process;
XM_040199316.1	chrII	12379464	12379464	chrII	12384553	12392974	+	XM_040199316.1	path1	Q6ZN54 B3KT65 B4DK62 B4E0S9 B7Z3H6 H3BUG7 Q8N8N3 Q9NXL0	Differentially expressed in FDCP 8 homolog		 PF00130;PF13901;	 GO:0046872;GO:0035556;GO:0032418;GO:0045780;GO:1900029;	 	  F:metal ion binding;	  P:intracellular signal transduction; P:lysosome localization; P:positive regulation of bone resorption; P:positive regulation of ruffle assembly;
XM_040203892.1	chrII	12379464	12379464	chrII	12415034	12419125	-	XM_040203892.1	path1	A1L1S5	Forkhead box protein F1		 PF00250;	 GO:0005634;GO:0000981;GO:0000978;GO:0009887;GO:0006357;GO:0002040;	  C:nucleus;	  F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;	  P:animal organ morphogenesis; P:regulation of transcription by RNA polymerase II; P:sprouting angiogenesis;
XM_040164950.1	chrII	12414256	12414256	chrII	12493963	12497600	-	XM_040164950.1	path1	Q90871	Interferon regulatory factor 8 {ECO:0000305}	Interferon consensus sequence-binding protein {ECO:0000303|PubMed:7536924};	 PF00605;PF10401;	 GO:0005737;GO:0005654;GO:0005634;GO:0000981;GO:0001227;GO:0000978;GO:0071346;GO:0071222;GO:0042742;GO:0042832;GO:0097028;GO:0002316;GO:0002314;GO:0006955;GO:0002376;GO:0030099;GO:0000122;GO:0006909;GO:0002273;GO:0032729;GO:0032735;GO:0045944;GO:0006357;GO:0032479;	  C:cytoplasm; C:nucleoplasm; C:nucleus;	  F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;	  P:cellular response to interferon-gamma; P:cellular response to lipopolysaccharide; P:defense response to bacterium; P:defense response to protozoan; P:dendritic cell differentiation; P:follicular B cell differentiation; P:germinal center B cell differentiation; P:immune response; P:immune system process; P:myeloid cell differentiation; P:negative regulation of transcription by RNA polymerase II; P:phagocytosis; P:plasmacytoid dendritic cell differentiation; P:positive regulation of interferon-gamma production; P:positive regulation of interleukin-12 production; P:positive regulation of transcription by RNA polymerase II; P:regulation of transcription by RNA polymerase II; P:regulation of type I interferon production;
XM_040164689.1	chrII	12429618	12429618	chrII	12498952	12507190	-	XM_040164689.1	path1	Q1LWL2 Q6DGQ6	Dual specificity protein phosphatase 22-A		 	 GO:0005829;GO:0005634;GO:0106306;GO:0106307;GO:0004725;GO:0008138;GO:0046330;GO:0042127;GO:0007179;	  C:cytosol; C:nucleus;	  F:protein serine phosphatase activity; F:protein threonine phosphatase activity; F:protein tyrosine phosphatase activity; F:protein tyrosine/serine/threonine phosphatase activity;	  P:positive regulation of JNK cascade; P:regulation of cell population proliferation; P:transforming growth factor beta receptor signaling pathway;
XM_040164722.1	chrII	12429618	12429618	chrII	12507642	12510045	-	XM_040164722.1	path1	Q9I8U0	Cytochrome c oxidase subunit 4 isoform 1, mitochondrial	Cytochrome c oxidase subunit IV isoform 1;	 PF02936;	 GO:0016021;GO:0005743;GO:0004129;GO:0006119;	  C:integral component of membrane; C:mitochondrial inner membrane;	  F:cytochrome-c oxidase activity;	  P:oxidative phosphorylation;
XM_040164675.1	chrII	12429618	12429618	chrII	12510112	12513228	+	XM_040164675.1	path1	Q32KL5	ER membrane protein complex subunit 8	Neighbor of COX4;	 PF03665;	 GO:0005737;GO:0072546;GO:0045050;GO:0071816;	  C:cytoplasm; C:EMC complex;	 	  P:protein insertion into ER membrane by stop-transfer membrane-anchor sequence; P:tail-anchored membrane protein insertion into ER membrane;
XM_040164699.1	chrII	12429618	12429618	chrII	12514121	12516787	+	XM_040164699.1	path1	Q9Y248 D3DUM5 Q6IAG9	DNA replication complex GINS protein PSF2	GINS complex subunit 2;	 PF05916;	 GO:0071162;GO:0000811;GO:0005654;GO:0006271;GO:0000727;	  C:CMG complex; C:GINS complex; C:nucleoplasm;	 	  P:DNA strand elongation involved in DNA replication; P:double-strand break repair via break-induced replication;
XM_040171021.1	chrIII	3108803	3108803	chrIII	3007497	3121393	+	XM_040171021.1	path1	Q6PFX6	Cadherin-24		 PF00028;PF01049;	 GO:0005912;GO:0016342;GO:0005911;GO:0016021;GO:0045294;GO:0008013;GO:0045296;GO:0005509;GO:0070097;GO:0034332;GO:0016339;GO:0000902;GO:0098609;GO:0098742;GO:0007043;GO:0007156;GO:0007275;	  C:adherens junction; C:catenin complex; C:cell-cell junction; C:integral component of membrane;	  F:alpha-catenin binding; F:beta-catenin binding; F:cadherin binding; F:calcium ion binding; F:delta-catenin binding;	  P:adherens junction organization; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; P:cell morphogenesis; P:cell-cell adhesion; P:cell-cell adhesion via plasma-membrane adhesion molecules; P:cell-cell junction assembly; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:multicellular organism development;
XM_040170934.1	chrIII	3799826	3799826	chrIII	3507088	3809329	+	XM_040170934.1	path1	O14525 A5PL12 B4DHI9 E9PFR8 O60799 Q5W0V7 Q5W0V8	Astrotactin-1		 PF18411;	 GO:0030136;GO:0005768;GO:0009897;GO:0016021;GO:0043204;GO:0007626;GO:0007158;GO:0001764;	  C:clathrin-coated vesicle; C:endosome; C:external side of plasma membrane; C:integral component of membrane; C:perikaryon;	 	  P:locomotory behavior; P:neuron cell-cell adhesion; P:neuron migration;
XM_040171057.1	chrIII	3799826	3799826	chrIII	3809703	3861859	-	XM_040171057.1	path1	Q9BXP8 A9Z1Y8 Q96PH7 Q96PH8 Q9H4C9	Pappalysin-2	Pregnancy-associated plasma protein A2;Pregnancy-associated plasma protein E1;	 PF00066;PF05572;PF00084;	 GO:0016324;GO:0005829;GO:0070062;GO:0005576;GO:0008237;GO:0008270;GO:0060349;GO:0044267;GO:0006508;GO:0001558;GO:0009651;	  C:apical plasma membrane; C:cytosol; C:extracellular exosome; C:extracellular region;	  F:metallopeptidase activity; F:zinc ion binding;	  P:bone morphogenesis; P:cellular protein metabolic process; P:proteolysis; P:regulation of cell growth; P:response to salt stress;
XM_040171060.1	chrIII	3866554	3866554	chrIII	3865318	3875697	+	XM_040171060.1	path1	Q8NHY2 E9PKI0 Q504W6 Q6H103 Q9H6L7 X5D9B4	E3 ubiquitin-protein ligase COP1 {ECO:0000305}	Constitutive photomorphogenesis protein 1 homolog {ECO:0000303|PubMed:12466024};RING finger and WD repeat domain protein 2 {ECO:0000305};RING finger protein 200;RING-type E3 ubiquitin transferase RFWD2 {ECO:0000305};	 PF00400;	 GO:0031464;GO:0005829;GO:0000139;GO:0016607;GO:0005654;GO:0046872;GO:0061630;GO:0032436;GO:0043687;GO:0043161;GO:0010212;	  C:Cul4A-RING E3 ubiquitin ligase complex; C:cytosol; C:Golgi membrane; C:nuclear speck; C:nucleoplasm;	  F:metal ion binding; F:ubiquitin protein ligase activity;	  P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:post-translational protein modification; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:response to ionizing radiation;
XM_040170778.1	chrIII	3866554	3866554	chrIII	3877126	3898512	+	XM_040170778.1	path1	P97789 O35651 P97790 Q3TE44 Q3TRE9 Q3UQL5	5'-3' exoribonuclease 1	Protein Dhm2;Strand-exchange protein 1 homolog;	 PF18129;PF18332;PF17846;PF03159;	 GO:0005737;GO:0005829;GO:0030425;GO:0043025;GO:0005634;GO:0000932;GO:0005886;GO:0045202;GO:0004534;GO:0051880;GO:0002151;GO:0003723;GO:0007569;GO:0071044;GO:0051321;GO:0017148;GO:0071028;GO:0000956;GO:0090503;GO:0006396;GO:0016075;GO:0000723;	  C:cytoplasm; C:cytosol; C:dendrite; C:neuronal cell body; C:nucleus; C:P-body; C:plasma membrane; C:synapse;	  F:5'-3' exoribonuclease activity; F:G-quadruplex DNA binding; F:G-quadruplex RNA binding; F:RNA binding;	  P:cell aging; P:histone mRNA catabolic process; P:meiotic cell cycle; P:negative regulation of translation; P:nuclear mRNA surveillance; P:nuclear-transcribed mRNA catabolic process; P:RNA phosphodiester bond hydrolysis, exonucleolytic; P:RNA processing; P:rRNA catabolic process; P:telomere maintenance;
XM_040170776.1	chrIII	3910478	3910478	chrIII	3899525	3903932	-	XM_040170776.1	path1	Q17QN2	Target of EGR1 protein 1		 PF04857;PF00642;	 GO:0015030;GO:0005737;GO:0016607;GO:0005730;GO:0000175;GO:0046872;GO:0004535;GO:0003723;GO:0017069;GO:0034472;	  C:Cajal body; C:cytoplasm; C:nuclear speck; C:nucleolus;	  F:3'-5'-exoribonuclease activity; F:metal ion binding; F:poly(A)-specific ribonuclease activity; F:RNA binding; F:snRNA binding;	  P:snRNA 3'-end processing;
XM_040172030.1	chrIII	3910478	3910478	chrIII	3907565	3911124	+	XM_040172030.1	path1	Q98SV0	Selenoprotein Pb		 PF04592;	 GO:0005576;GO:0008430;GO:0001887;	  C:extracellular region;	  F:selenium binding;	  P:selenium compound metabolic process;
XM_040172029.1	chrIII	3910478	3910478	chrIII	3911740	3917261	+	XM_040172029.1	path1	Q3S8M4	Elongation of very long chain fatty acids protein 4 {ECO:0000255|HAMAP-Rule:MF_03204, ECO:0000305}	3-keto acyl-CoA synthase ELOVL4 {ECO:0000255|HAMAP-Rule:MF_03204};ELOVL fatty acid elongase 4 {ECO:0000255|HAMAP-Rule:MF_03204};Very long chain 3-ketoacyl-CoA synthase 4 {ECO:0000255|HAMAP-Rule:MF_03204};Very long chain 3-oxoacyl-CoA synthase 4 {ECO:0000255|HAMAP-Rule:MF_03204};	 PF01151;	 GO:0005783;GO:0030176;GO:0102336;GO:0102337;GO:0102338;GO:0009922;GO:0102756;GO:0034625;GO:0034626;GO:0019367;GO:0035338;GO:0030148;GO:0006636;GO:0042761;	  C:endoplasmic reticulum; C:integral component of endoplasmic reticulum membrane;	  F:3-oxo-arachidoyl-CoA synthase activity; F:3-oxo-cerotoyl-CoA synthase activity; F:3-oxo-lignoceronyl-CoA synthase activity; F:fatty acid elongase activity; F:very-long-chain 3-ketoacyl-CoA synthase activity;	  P:fatty acid elongation, monounsaturated fatty acid; P:fatty acid elongation, polyunsaturated fatty acid; P:fatty acid elongation, saturated fatty acid; P:long-chain fatty-acyl-CoA biosynthetic process; P:sphingolipid biosynthetic process; P:unsaturated fatty acid biosynthetic process; P:very long-chain fatty acid biosynthetic process;
XM_040169835.1	chrIII	3939780	3939780	chrIII	3927883	3929106	+	XM_040169835.1	path1	P10289	Gastrotropin	Fatty acid-binding protein 6;Ileal lipid-binding protein;Porcine ileal peptide;	 	 GO:0005737;GO:0016020;GO:0008289;GO:0006869;	  C:cytoplasm; C:membrane;	  F:lipid binding;	  P:lipid transport;
XM_040171054.1	chrIII	3943593	3943593	chrIII	3963173	4010131	+	XM_040171054.1	path1	Q80TC6	Zinc finger SWIM domain-containing protein 5		 	 GO:0031462;GO:0008270;GO:1902667;	  C:Cul2-RING ubiquitin ligase complex;	  F:zinc ion binding;	  P:regulation of axon guidance;
XM_040171763.1	chrIII	3983795	3983795	chrIII	4015764	4021445	-	XM_040171763.1	path1	Q9PTS2	Uroporphyrinogen decarboxylase		 PF01208;	 GO:0005829;GO:0004853;GO:0006783;GO:0006778;GO:0006782;	  C:cytosol;	  F:uroporphyrinogen decarboxylase activity;	  P:heme biosynthetic process; P:porphyrin-containing compound metabolic process; P:protoporphyrinogen IX biosynthetic process;
XM_040170406.1	chrIII	3989857	3989857	chrIII	4023607	4035664	-	XM_040170406.1	path1	Q07014 Q63320	Tyrosine-protein kinase Lyn	V-yes-1 Yamaguchi sarcoma viral related oncogene homolog;p53Lyn;p56Lyn;	 PF07714;PF00017;PF00018;	 GO:0005912;GO:0005737;GO:0031234;GO:0098978;GO:0005794;GO:0034666;GO:0016020;GO:0045121;GO:0030061;GO:0005758;GO:0031966;GO:0005634;GO:0048471;GO:0005886;GO:0014069;GO:0099091;GO:0032991;GO:0005524;GO:0019899;GO:0046875;GO:0043015;GO:0043208;GO:0005178;GO:0044325;GO:0016301;GO:0004715;GO:0051219;GO:0140031;GO:0005161;GO:0004672;GO:0004713;GO:0044877;GO:0017124;GO:0005102;GO:0004714;GO:0031625;GO:0002250;GO:0001782;GO:0050853;GO:0030154;GO:0006974;GO:0031668;GO:0034605;GO:0071300;GO:0097028;GO:0030218;GO:0002774;GO:0002431;GO:0030097;GO:0002553;GO:0002768;GO:0045087;GO:0035556;GO:0031663;GO:0030889;GO:0008285;GO:0070373;GO:1902532;GO:0043407;GO:0070667;GO:0002762;GO:0001933;GO:0034136;GO:0034144;GO:0031175;GO:0014003;GO:0018108;GO:0002576;GO:1902961;GO:0030335;GO:0008284;GO:0051272;GO:2000670;GO:0060369;GO:0060252;GO:0070668;GO:0010976;GO:0070447;GO:0043552;GO:0042327;GO:0001934;GO:0070304;GO:0042531;GO:0046777;GO:0006468;GO:0002902;GO:0050855;GO:0033628;GO:0001817;GO:0070372;GO:0045646;GO:0050727;GO:0033003;GO:0043304;GO:0090025;GO:0090330;GO:0051279;GO:0043200;GO:0048678;GO:0009743;GO:0042493;GO:0009725;GO:0032868;GO:0014070;GO:0043434;GO:0006991;GO:0009636;GO:0002513;GO:0034142;GO:0007169;	  C:adherens junction; C:cytoplasm; C:extrinsic component of cytoplasmic side of plasma membrane; C:glutamatergic synapse; C:Golgi apparatus; C:integrin alpha2-beta1 complex; C:membrane; C:membrane raft; C:mitochondrial crista; C:mitochondrial intermembrane space; C:mitochondrial membrane; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:postsynaptic density; C:postsynaptic specialization, intracellular component; C:protein-containing complex;	  F:ATP binding; F:enzyme binding; F:ephrin receptor binding; F:gamma-tubulin binding; F:glycosphingolipid binding; F:integrin binding; F:ion channel binding; F:kinase activity; F:non-membrane spanning protein tyrosine kinase activity; F:phosphoprotein binding; F:phosphorylation-dependent protein binding; F:platelet-derived growth factor receptor binding; F:protein kinase activity; F:protein tyrosine kinase activity; F:protein-containing complex binding; F:SH3 domain binding; F:signaling receptor binding; F:transmembrane receptor protein tyrosine kinase activity; F:ubiquitin protein ligase binding;	  P:adaptive immune response; P:B cell homeostasis; P:B cell receptor signaling pathway; P:cell differentiation; P:cellular response to DNA damage stimulus; P:cellular response to extracellular stimulus; P:cellular response to heat; P:cellular response to retinoic acid; P:dendritic cell differentiation; P:erythrocyte differentiation; P:Fc receptor mediated inhibitory signaling pathway; P:Fc receptor mediated stimulatory signaling pathway; P:hemopoiesis; P:histamine secretion by mast cell; P:immune response-regulating cell surface receptor signaling pathway; P:innate immune response; P:intracellular signal transduction; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of B cell proliferation; P:negative regulation of cell population proliferation; P:negative regulation of ERK1 and ERK2 cascade; P:negative regulation of intracellular signal transduction; P:negative regulation of MAP kinase activity; P:negative regulation of mast cell proliferation; P:negative regulation of myeloid leukocyte differentiation; P:negative regulation of protein phosphorylation; P:negative regulation of toll-like receptor 2 signaling pathway; P:negative regulation of toll-like receptor 4 signaling pathway; P:neuron projection development; P:oligodendrocyte development; P:peptidyl-tyrosine phosphorylation; P:platelet degranulation; P:positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process; P:positive regulation of cell migration; P:positive regulation of cell population proliferation; P:positive regulation of cellular component movement; P:positive regulation of dendritic cell apoptotic process; P:positive regulation of Fc receptor mediated stimulatory signaling pathway; P:positive regulation of glial cell proliferation; P:positive regulation of mast cell proliferation; P:positive regulation of neuron projection development; P:positive regulation of oligodendrocyte progenitor proliferation; P:positive regulation of phosphatidylinositol 3-kinase activity; P:positive regulation of phosphorylation; P:positive regulation of protein phosphorylation; P:positive regulation of stress-activated protein kinase signaling cascade; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of B cell apoptotic process; P:regulation of B cell receptor signaling pathway; P:regulation of cell adhesion mediated by integrin; P:regulation of cytokine production; P:regulation of ERK1 and ERK2 cascade; P:regulation of erythrocyte differentiation; P:regulation of inflammatory response; P:regulation of mast cell activation; P:regulation of mast cell degranulation; P:regulation of monocyte chemotaxis; P:regulation of platelet aggregation; P:regulation of release of sequestered calcium ion into cytosol; P:response to amino acid; P:response to axon injury; P:response to carbohydrate; P:response to drug; P:response to hormone; P:response to insulin; P:response to organic cyclic compound; P:response to peptide hormone; P:response to sterol depletion; P:response to toxic substance; P:tolerance induction to self antigen; P:toll-like receptor 4 signaling pathway; P:transmembrane receptor protein tyrosine kinase signaling pathway;
XM_040171436.1	chrIII	7293902	7293902	chrIII	7246756	7251038	+	XM_040171436.1	path1	Q91YL2	E3 ubiquitin-protein ligase RNF126 {ECO:0000305}	RING finger protein 126 {ECO:0000312|MGI:MGI:1917544};	 PF13639;PF14369;	 GO:0005737;GO:0005829;GO:0005654;GO:0005634;GO:0005154;GO:0046872;GO:0061630;GO:0071629;GO:0042059;GO:0043161;GO:0070936;GO:0070534;GO:0006513;GO:0042127;GO:0042147;GO:0006511;GO:0043162;	  C:cytoplasm; C:cytosol; C:nucleoplasm; C:nucleus;	  F:epidermal growth factor receptor binding; F:metal ion binding; F:ubiquitin protein ligase activity;	  P:cytoplasm protein quality control by the ubiquitin-proteasome system; P:negative regulation of epidermal growth factor receptor signaling pathway; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein K63-linked ubiquitination; P:protein monoubiquitination; P:regulation of cell population proliferation; P:retrograde transport, endosome to Golgi; P:ubiquitin-dependent protein catabolic process; P:ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;
XM_040171435.1	chrIII	7288474	7288474	chrIII	7252694	7277964	+	XM_040171435.1	path1	Q9UL51 O60742 O60743 O75267 Q9UBS2	Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2	Brain cyclic nucleotide-gated channel 2;	 PF00027;PF00520;PF08412;	 GO:0098855;GO:0005887;GO:0005886;GO:0008076;GO:0030552;GO:0042802;GO:0005222;GO:0005249;GO:0005248;GO:0007267;GO:0071320;GO:0071321;GO:0086012;GO:1990573;GO:0071805;GO:0034765;GO:0042391;GO:0098719;GO:0035725;	  C:HCN channel complex; C:integral component of plasma membrane; C:plasma membrane; C:voltage-gated potassium channel complex;	  F:cAMP binding; F:identical protein binding; F:intracellular cAMP-activated cation channel activity; F:voltage-gated potassium channel activity; F:voltage-gated sodium channel activity;	  P:cell-cell signaling; P:cellular response to cAMP; P:cellular response to cGMP; P:membrane depolarization during cardiac muscle cell action potential; P:potassium ion import across plasma membrane; P:potassium ion transmembrane transport; P:regulation of ion transmembrane transport; P:regulation of membrane potential; P:sodium ion import across plasma membrane; P:sodium ion transmembrane transport;
XM_040171547.1	chrIII	7288474	7288474	chrIII	7291648	7296093	+	XM_040171547.1	path1	Q90WG1	Spindlin-Z		 PF02513;	 GO:0005634;GO:0007049;GO:0007276;	  C:nucleus;	 	  P:cell cycle; P:gamete generation;
XM_040171546.1	chrIII	7288474	7288474	chrIII	7291652	7296093	+	XM_040171546.1	path1	Q4V8J7	Spindlin-1	Spindlin1;	 PF02513;	 GO:0005829;GO:0005730;GO:0005654;GO:0005634;GO:0005819;GO:0003677;GO:0035064;GO:0006325;GO:0007276;GO:0051321;GO:0007275;GO:0045893;GO:0030177;GO:0006355;GO:0009303;GO:0016055;	  C:cytosol; C:nucleolus; C:nucleoplasm; C:nucleus; C:spindle;	  F:DNA binding; F:methylated histone binding;	  P:chromatin organization; P:gamete generation; P:meiotic cell cycle; P:multicellular organism development; P:positive regulation of transcription, DNA-templated; P:positive regulation of Wnt signaling pathway; P:regulation of transcription, DNA-templated; P:rRNA transcription; P:Wnt signaling pathway;
XM_040171795.1	chrIII	7288474	7288474	chrIII	7305422	7311711	-	XM_040171795.1	path1	Q9R1K5	Fizzy-related protein homolog	Cdh1/Hct1 homolog;	 PF12894;PF00400;	 GO:0005680;GO:0031965;GO:0005654;GO:0010997;GO:1990757;GO:0031145;GO:0007049;GO:0051301;GO:0006281;GO:0070306;GO:0090344;GO:1905786;GO:0008284;GO:0045732;GO:1904668;GO:0016567;GO:0051603;GO:0040020;GO:0072425;	  C:anaphase-promoting complex; C:nuclear membrane; C:nucleoplasm;	  F:anaphase-promoting complex binding; F:ubiquitin ligase activator activity;	  P:anaphase-promoting complex-dependent catabolic process; P:cell cycle; P:cell division; P:DNA repair; P:lens fiber cell differentiation; P:negative regulation of cell aging; P:positive regulation of anaphase-promoting complex-dependent catabolic process; P:positive regulation of cell population proliferation; P:positive regulation of protein catabolic process; P:positive regulation of ubiquitin protein ligase activity; P:protein ubiquitination; P:proteolysis involved in cellular protein catabolic process; P:regulation of meiotic nuclear division; P:signal transduction involved in G2 DNA damage checkpoint;
XM_040171184.1	chrIII	7288474	7288474	chrIII	7312068	7315636	-	XM_040171184.1	path1	Q6P0G8	Pleckstrin homology domain-containing family J member 1		 PF00169;	 GO:0005829;GO:0005769;GO:0055037;GO:0005802;GO:0007032;GO:0001881;GO:0042147;	  C:cytosol; C:early endosome; C:recycling endosome; C:trans-Golgi network;	 	  P:endosome organization; P:receptor recycling; P:retrograde transport, endosome to Golgi;
XM_040171181.1	chrIII	7288474	7288474	chrIII	7316221	7319238	+	XM_040171181.1	path1	Q15428 B2RBU1 D6W605 O75245	Splicing factor 3A subunit 2	SF3a66 {ECO:0000303|PubMed:11533230, ECO:0000303|PubMed:21349847};Spliceosome-associated protein 62;	 PF16835;	 GO:0071013;GO:0016607;GO:0005654;GO:0005634;GO:0005681;GO:0005686;GO:0071005;GO:0071004;GO:0003723;GO:0008270;GO:0000389;GO:0006397;GO:0000398;GO:0010976;GO:0000245;GO:1903241;	  C:catalytic step 2 spliceosome; C:nuclear speck; C:nucleoplasm; C:nucleus; C:spliceosomal complex; C:U2 snRNP; C:U2-type precatalytic spliceosome; C:U2-type prespliceosome;	  F:RNA binding; F:zinc ion binding;	  P:mRNA 3'-splice site recognition; P:mRNA processing; P:mRNA splicing, via spliceosome; P:positive regulation of neuron projection development; P:spliceosomal complex assembly; P:U2-type prespliceosome assembly;
XM_040172357.1	chrIII	7293901	7293901	chrIII	7335415	7343138	+	XM_040172357.1	path1	P79762 Q4VU46 Q4VU49 Q4VU50 Q4VU53 Q4VU54 Q4VU57 Q4VU62 Q4VU63 Q4VU66 Q9PWF8	Zona pellucida sperm-binding protein 3	Sperm receptor;Zona pellucida C protein;Zona pellucida glycoprotein 3;	 PF00100;	 GO:0045177;GO:0031012;GO:0005615;GO:0016021;GO:0005886;GO:0032190;GO:0042802;GO:0035804;GO:0007339;GO:0035803;GO:2000344;GO:0032570;GO:0033574;	  C:apical part of cell; C:extracellular matrix; C:extracellular space; C:integral component of membrane; C:plasma membrane;	  F:acrosin binding; F:identical protein binding; F:structural constituent of egg coat;	  P:binding of sperm to zona pellucida; P:egg coat formation; P:positive regulation of acrosome reaction; P:response to progesterone; P:response to testosterone;
XM_040171019.1	chrIII	7346671	7346671	chrIII	7378655	7391994	-	XM_040171019.1	path1	O95948	One cut domain family member 2	Hepatocyte nuclear factor 6-beta;One cut homeobox 2;Transcription factor ONECUT-2;	 PF02376;PF00046;	 GO:0015629;GO:0000785;GO:0005654;GO:0005634;GO:0001228;GO:0000981;GO:0000978;GO:1990837;GO:0009887;GO:0045165;GO:0060271;GO:0031018;GO:0002064;GO:0001889;GO:0030512;GO:0048935;GO:0030335;GO:0045944;GO:0001952;GO:0006357;	  C:actin cytoskeleton; C:chromatin; C:nucleoplasm; C:nucleus;	  F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;	  P:animal organ morphogenesis; P:cell fate commitment; P:cilium assembly; P:endocrine pancreas development; P:epithelial cell development; P:liver development; P:negative regulation of transforming growth factor beta receptor signaling pathway; P:peripheral nervous system neuron development; P:positive regulation of cell migration; P:positive regulation of transcription by RNA polymerase II; P:regulation of cell-matrix adhesion; P:regulation of transcription by RNA polymerase II;
XM_040170668.1	chrIII	7397661	7397661	chrIII	7410835	7433212	+	XM_040170668.1	path1	Q01978 Q5D0A6	Transcription factor E2-alpha	Transcription factor 3;Transcription factor XE12/XE47;	 PF00010;	 GO:0005634;GO:0043425;GO:0003700;GO:0000981;GO:0070888;GO:0046982;GO:0030154;GO:0007399;GO:0045666;GO:0045944;	  C:nucleus;	  F:bHLH transcription factor binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:E-box binding; F:protein heterodimerization activity;	  P:cell differentiation; P:nervous system development; P:positive regulation of neuron differentiation; P:positive regulation of transcription by RNA polymerase II;
XM_040170674.1	chrIII	7397661	7397661	chrIII	7441171	7444932	+	XM_040170674.1	path1	O95983 A8K4B7 D6W5Z2 Q6PIL9 Q6PJZ9 Q86XF4	Methyl-CpG-binding domain protein 3	Methyl-CpG-binding protein MBD3;	 PF01429;PF14048;PF16564;	 GO:0000785;GO:0005737;GO:0000792;GO:0005654;GO:0016581;GO:0032991;GO:0003682;GO:0003677;GO:0008327;GO:0007568;GO:0043044;GO:0007420;GO:0006346;GO:0048568;GO:0007507;GO:0016573;GO:0001701;GO:0000122;GO:0044030;GO:1901796;GO:0032355;GO:0031667;GO:0009888;	  C:chromatin; C:cytoplasm; C:heterochromatin; C:nucleoplasm; C:NuRD complex; C:protein-containing complex;	  F:chromatin binding; F:DNA binding; F:methyl-CpG binding;	  P:aging; P:ATP-dependent chromatin remodeling; P:brain development; P:DNA methylation-dependent heterochromatin assembly; P:embryonic organ development; P:heart development; P:histone acetylation; P:in utero embryonic development; P:negative regulation of transcription by RNA polymerase II; P:regulation of DNA methylation; P:regulation of signal transduction by p53 class mediator; P:response to estradiol; P:response to nutrient levels; P:tissue development;
XM_040170659.1	chrIII	7397661	7397661	chrIII	7446061	7453940	+	XM_040170659.1	path1	Q3UE17	RNA-binding protein MEX3D	RING finger and KH domain-containing protein 1;	 PF00013;	 GO:0005634;GO:0048471;GO:0046872;GO:0035925;GO:0003730;GO:0006402;GO:0061157;GO:0050779;	  C:nucleus; C:perinuclear region of cytoplasm;	  F:metal ion binding; F:mRNA 3'-UTR AU-rich region binding; F:mRNA 3'-UTR binding;	  P:mRNA catabolic process; P:mRNA destabilization; P:RNA destabilization;
XM_040170656.1	chrIII	7398663	7398663	chrIII	7454915	7479729	-	XM_040170656.1	path1	Q62768	Protein unc-13 homolog A {ECO:0000305}	Munc13-1;	 PF00130;PF00168;PF06292;PF10540;	 GO:0030424;GO:0044305;GO:0060076;GO:0098978;GO:0005798;GO:0031594;GO:0043005;GO:0005886;GO:0098793;GO:0048786;GO:0098831;GO:0042734;GO:0032991;GO:0045202;GO:0097060;GO:0030672;GO:0043195;GO:0005509;GO:0005516;GO:0019992;GO:0042802;GO:0005543;GO:0019904;GO:0047485;GO:0044877;GO:0000149;GO:0030507;GO:0019905;GO:0017075;GO:0050435;GO:0030154;GO:0061789;GO:0060384;GO:0035556;GO:0060291;GO:0007528;GO:0099011;GO:0007269;GO:1903861;GO:1900451;GO:0001956;GO:0031915;GO:0099525;GO:1902991;GO:0048172;GO:0010807;GO:0035249;GO:0016081;GO:0016079;GO:0016188;GO:0016082;	  C:axon; C:calyx of Held; C:excitatory synapse; C:glutamatergic synapse; C:Golgi-associated vesicle; C:neuromuscular junction; C:neuron projection; C:plasma membrane; C:presynapse; C:presynaptic active zone; C:presynaptic active zone cytoplasmic component; C:presynaptic membrane; C:protein-containing complex; C:synapse; C:synaptic membrane; C:synaptic vesicle membrane; C:terminal bouton;	  F:calcium ion binding; F:calmodulin binding; F:diacylglycerol binding; F:identical protein binding; F:phospholipid binding; F:protein domain specific binding; F:protein N-terminus binding; F:protein-containing complex binding; F:SNARE binding; F:spectrin binding; F:syntaxin binding; F:syntaxin-1 binding;	  P:amyloid-beta metabolic process; P:cell differentiation; P:dense core granule priming; P:innervation; P:intracellular signal transduction; P:long-term synaptic potentiation; P:neuromuscular junction development; P:neuronal dense core vesicle exocytosis; P:neurotransmitter secretion; P:positive regulation of dendrite extension; P:positive regulation of glutamate receptor signaling pathway; P:positive regulation of neurotransmitter secretion; P:positive regulation of synaptic plasticity; P:presynaptic dense core vesicle exocytosis; P:regulation of amyloid precursor protein catabolic process; P:regulation of short-term neuronal synaptic plasticity; P:regulation of synaptic vesicle priming; P:synaptic transmission, glutamatergic; P:synaptic vesicle docking; P:synaptic vesicle exocytosis; P:synaptic vesicle maturation; P:synaptic vesicle priming;
XM_040170669.1	chrIII	7469458	7469458	chrIII	7481063	7484980	+	XM_040170669.1	path1	Q9BX70 O60418 O75248 Q4VBZ1 Q6IAC5 Q7Z5W0 Q96SX8 Q9NPS1 Q9NX81	BTB/POZ domain-containing protein 2		 PF07707;PF00651;PF08005;	 GO:0005829;GO:0000932;GO:0022008;	  C:cytosol; C:P-body;	 	  P:neurogenesis;
XM_040170658.1	chrIII	7469458	7469458	chrIII	7485338	7491861	-	XM_040170658.1	path1	Q90705	Elongation factor 2		 PF00679;PF14492;PF03764;PF00009;PF03144;	 GO:0005737;GO:1990904;GO:0005525;GO:0003924;GO:0043022;GO:0003746;GO:0006414;	  C:cytoplasm; C:ribonucleoprotein complex;	  F:GTP binding; F:GTPase activity; F:ribosome binding; F:translation elongation factor activity;	  P:translational elongation;
XM_040170673.1	chrIII	7469458	7469458	chrIII	7494488	7499547	+	XM_040170673.1	path1	Q91XE9 Q8BWS0	Cyclic AMP-responsive element-binding protein 3-like protein 3	Transcription factor CREB-H;	 PF00170;	 GO:0005829;GO:0005783;GO:0005789;GO:0016021;GO:0016020;GO:0005654;GO:0005634;GO:0035497;GO:0001228;GO:0000981;GO:0046982;GO:0042803;GO:0000978;GO:0000977;GO:0000976;GO:0030968;GO:0045944;GO:1990440;GO:0006357;	  C:cytosol; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:membrane; C:nucleoplasm; C:nucleus;	  F:cAMP response element binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;	  P:endoplasmic reticulum unfolded protein response; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; P:regulation of transcription by RNA polymerase II;
XM_040172046.1	chrIII	7469458	7469458	chrIII	7502262	7504787	+	XM_040172046.1	path1	Q9NSD7 Q14DA5	Relaxin-3 receptor 1	G protein-coupled receptor SALPR;G-protein coupled receptor GPCR135;Relaxin family peptide receptor 3;Somatostatin- and angiotensin-like peptide receptor;	 PF00001;	 GO:0005887;GO:0005886;GO:0008528;GO:0004930;GO:0007186;GO:0007218;GO:0032467;	  C:integral component of plasma membrane; C:plasma membrane;	  F:G protein-coupled peptide receptor activity; F:G protein-coupled receptor activity;	  P:G protein-coupled receptor signaling pathway; P:neuropeptide signaling pathway; P:positive regulation of cytokinesis;
XM_040172047.1	chrIII	7469458	7469458	chrIII	7506046	7512245	-	XM_040172047.1	path1	Q8N6T7 B2RCD0 O75291 Q6IAF5 Q6PK99 Q8NCD2 Q9BSI5 Q9BWP3 Q9NRC7 Q9UQD1	NAD-dependent protein deacetylase sirtuin-6	Regulatory protein SIR2 homolog 6;SIR2-like protein 6;	 PF02146;	 GO:0099115;GO:0005737;GO:0005654;GO:0005634;GO:0019213;GO:0004407;GO:0003956;GO:0003950;GO:0070403;GO:0017136;GO:0046969;GO:0003714;GO:0008270;GO:0070932;GO:0000122;GO:1905555;GO:1902732;GO:0031940;GO:0120162;GO:1905549;GO:0032206;GO:1901485;GO:1905564;GO:0003247;GO:0006471;GO:0006476;GO:0010569;GO:0031667;	  C:chromosome, subtelomeric region; C:cytoplasm; C:nucleoplasm; C:nucleus;	  F:deacetylase activity; F:histone deacetylase activity; F:NAD(P)+-protein-arginine ADP-ribosyltransferase activity; F:NAD+ ADP-ribosyltransferase activity; F:NAD+ binding; F:NAD-dependent histone deacetylase activity; F:NAD-dependent histone deacetylase activity (H3-K9 specific); F:transcription corepressor activity; F:zinc ion binding;	  P:histone H3 deacetylation; P:negative regulation of transcription by RNA polymerase II; P:positive regulation of blood vessel branching; P:positive regulation of chondrocyte proliferation; P:positive regulation of chromatin silencing at telomere; P:positive regulation of cold-induced thermogenesis; P:positive regulation of subtelomeric heterochromatin assembly; P:positive regulation of telomere maintenance; P:positive regulation of transcription factor catabolic process; P:positive regulation of vascular endothelial cell proliferation; P:post-embryonic cardiac muscle cell growth involved in heart morphogenesis; P:protein ADP-ribosylation; P:protein deacetylation; P:regulation of double-strand break repair via homologous recombination; P:response to nutrient levels;
XM_040172055.1	chrIII	7469458	7469458	chrIII	7513359	7517606	-	XM_040172055.1	path1	Q8CFI2 Q505K8	Ubiquitin-conjugating enzyme E2 R1	(E3-independent) E2 ubiquitin-conjugating enzyme R1;E2 ubiquitin-conjugating enzyme R1;Ubiquitin-conjugating enzyme E2-32 kDa complementing;Ubiquitin-conjugating enzyme E2-CDC34;Ubiquitin-protein ligase R1;	 PF00179;	 GO:0005829;GO:0016607;GO:0005524;GO:0061631;GO:0004842;GO:0007049;GO:0035458;GO:0043951;GO:0090261;GO:0043525;GO:0043161;GO:0070936;GO:0006513;GO:0000209;GO:0016567;GO:0006511;	  C:cytosol; C:nuclear speck;	  F:ATP binding; F:ubiquitin conjugating enzyme activity; F:ubiquitin-protein transferase activity;	  P:cell cycle; P:cellular response to interferon-beta; P:negative regulation of cAMP-mediated signaling; P:positive regulation of inclusion body assembly; P:positive regulation of neuron apoptotic process; P:proteasome-mediated ubiquitin-dependent protein catabolic process; P:protein K48-linked ubiquitination; P:protein monoubiquitination; P:protein polyubiquitination; P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;
XM_040172048.1	chrIII	7469458	7469458	chrIII	7518201	7522744	+	XM_040172048.1	path1	F1Q8W0 A1L232	Cactin		 PF10312;PF09732;	 GO:0005737;GO:0005681;GO:0008595;GO:0001654;GO:0045087;GO:0045292;GO:0045824;GO:0007399;GO:0003407;GO:0040019;GO:0010468;	  C:cytoplasm; C:spliceosomal complex;	 	  P:anterior/posterior axis specification, embryo; P:eye development; P:innate immune response; P:mRNA cis splicing, via spliceosome; P:negative regulation of innate immune response; P:nervous system development; P:neural retina development; P:positive regulation of embryonic development; P:regulation of gene expression;
XM_040172049.1	chrIII	7469458	7469458	chrIII	7522944	7529342	-	XM_040172049.1	path1	Q9YHX4	Semaphorin-4E	Semaphorin-7;Semaphorin-Z7;	 PF01437;PF01403;	 GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0050919;GO:0010693;GO:0048843;GO:0000122;GO:0001755;GO:0043931;GO:0030335;GO:0043547;GO:0071526;	  C:extracellular space; C:integral component of plasma membrane;	  F:chemorepellent activity; F:semaphorin receptor binding;	  P:axon guidance; P:negative chemotaxis; P:negative regulation of alkaline phosphatase activity; P:negative regulation of axon extension involved in axon guidance; P:negative regulation of transcription by RNA polymerase II; P:neural crest cell migration; P:ossification involved in bone maturation; P:positive regulation of cell migration; P:positive regulation of GTPase activity; P:semaphorin-plexin signaling pathway;
XM_040172054.1	chrIII	7469458	7469458	chrIII	7529646	7534343	-	XM_040172054.1	path1	Q9UGK3 A6NKK3 Q9NXI2	Signal-transducing adaptor protein 2	Breast tumor kinase substrate;	 	 GO:0005829;GO:0005886;GO:0035591;GO:0042531;	  C:cytosol; C:plasma membrane;	  F:signaling adaptor activity;	  P:positive regulation of tyrosine phosphorylation of STAT protein;
XM_040172051.1	chrIII	7469458	7469458	chrIII	7534649	7543634	-	XM_040172051.1	path1	Q8AXV0	Endophilin-A2	Endophilin-2;SH3 domain-containing GRB2-like protein 2;SH3p8;	 PF03114;PF00018;	 GO:0030054;GO:0042995;GO:0031901;GO:0002102;GO:0008289;GO:0006897;	  C:cell junction; C:cell projection; C:early endosome membrane; C:podosome;	  F:lipid binding;	  P:endocytosis;
XM_040172180.1	chrIII	7474578	7474578	chrIII	7544336	7556424	-	XM_040172180.1	path1	Q92753 Q8WX73	Nuclear receptor ROR-beta	Nuclear receptor RZR-beta;Nuclear receptor subfamily 1 group F member 2;Retinoid-related orphan receptor-beta;	 PF00104;PF00105;	 GO:0000785;GO:0005654;GO:0005634;GO:0001228;GO:0003700;GO:0000981;GO:0008502;GO:0004879;GO:0000978;GO:1990837;GO:0008134;GO:0008270;GO:0035881;GO:0071300;GO:0042462;GO:0045668;GO:0045892;GO:0045944;GO:0045893;GO:0042752;GO:0006357;GO:0006355;GO:0060041;GO:0046549;GO:0046548;GO:0048511;GO:0006367;GO:0007601;	  C:chromatin; C:nucleoplasm; C:nucleus;	  F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:melatonin receptor activity; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription factor binding; F:zinc ion binding;	  P:amacrine cell differentiation; P:cellular response to retinoic acid; P:eye photoreceptor cell development; P:negative regulation of osteoblast differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:regulation of circadian rhythm; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:retina development in camera-type eye; P:retinal cone cell development; P:retinal rod cell development; P:rhythmic process; P:transcription initiation from RNA polymerase II promoter; P:visual perception;
XM_040172186.1	chrIII	7499887	7499887	chrIII	7564006	7565723	+	XM_040172186.1	path1	Q9HC97 J3KR30 O43495 Q17R58 Q4VBN5 Q4ZFV2 Q6FHI8 Q86UH4	G-protein coupled receptor 35	Kynurenic acid receptor;	 PF00001;	 GO:0005887;GO:0005886;GO:0016494;GO:0004930;GO:0070098;GO:0007010;GO:0007186;GO:1904456;GO:1901386;GO:0007204;GO:0051482;GO:0035025;	  C:integral component of plasma membrane; C:plasma membrane;	  F:C-X-C chemokine receptor activity; F:G protein-coupled receptor activity;	  P:chemokine-mediated signaling pathway; P:cytoskeleton organization; P:G protein-coupled receptor signaling pathway; P:negative regulation of neuronal action potential; P:negative regulation of voltage-gated calcium channel activity; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; P:positive regulation of Rho protein signal transduction;
XM_040172177.1	chrIII	7499887	7499887	chrIII	7574165	7596301	-	XM_040172177.1	path1	O70141	Semaphorin-6B	Semaphorin-Z;	 PF01403;	 GO:0005615;GO:0005887;GO:0045499;GO:0030215;GO:0007411;GO:0007417;GO:0021766;GO:0050919;GO:0048843;GO:0001755;GO:0030335;GO:0071526;	  C:extracellular space; C:integral component of plasma membrane;	  F:chemorepellent activity; F:semaphorin receptor binding;	  P:axon guidance; P:central nervous system development; P:hippocampus development; P:negative chemotaxis; P:negative regulation of axon extension involved in axon guidance; P:neural crest cell migration; P:positive regulation of cell migration; P:semaphorin-plexin signaling pathway;
XM_040170278.1	chrIII	7534491	7534491	chrIII	7614100	7670001	-	XM_040170278.1	path1	F1NWE3 Q90815	Receptor-type tyrosine-protein phosphatase S	Chick receptor tyrosine phosphatase alpha {ECO:0000303|PubMed:7918104};	 PF00041;PF07679;PF00102;	 GO:0030424;GO:0030426;GO:0005887;GO:0099061;GO:0030285;GO:0043204;GO:0005886;GO:0043395;GO:0008201;GO:0042803;GO:0004725;GO:0030517;GO:0048681;GO:0048671;GO:0061000;GO:0035335;GO:0006470;GO:0099560;	  C:axon; C:growth cone; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:integral component of synaptic vesicle membrane; C:perikaryon; C:plasma membrane;	  F:heparan sulfate proteoglycan binding; F:heparin binding; F:protein homodimerization activity; F:protein tyrosine phosphatase activity;	  P:negative regulation of axon extension; P:negative regulation of axon regeneration; P:negative regulation of collateral sprouting; P:negative regulation of dendritic spine development; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; P:synaptic membrane adhesion;
XM_040170293.1	chrIII	7588491	7588491	chrIII	7672640	7675986	-	XM_040170293.1	path1	Q6P9Z4	Protein fem-1 homolog A	FEM1-alpha;	 PF12796;PF13606;	 GO:0005737;GO:0000151;GO:0050728;GO:0016567;GO:0051438;GO:0006511;	  C:cytoplasm; C:ubiquitin ligase complex;	 	  P:negative regulation of inflammatory response; P:protein ubiquitination; P:regulation of ubiquitin-protein transferase activity; P:ubiquitin-dependent protein catabolic process;
XM_040174970.1	chrIV	9946595	9946595	chrIV	9807861	9980493	-	XM_040174970.1	path1	Q91XY4 Q80Y31	Protocadherin gamma-A4 {ECO:0000312|EMBL:AAK26087.1}		 PF00028;PF08266;PF16492;PF15974;	 GO:0005887;GO:0016020;GO:0005509;GO:0007155;GO:0007156;GO:0007283;	  C:integral component of plasma membrane; C:membrane;	  F:calcium ion binding;	  P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:spermatogenesis;
XM_040174997.1	chrIV	9947509	9947509	chrIV	9936511	9939116	-	XM_040174997.1	path1	Q5DRC1	Protocadherin gamma-A10		 PF00028;PF08266;PF16492;PF15974;	 GO:0005887;GO:0005509;GO:0007155;GO:0007156;	  C:integral component of plasma membrane;	  F:calcium ion binding;	  P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;
XM_040174995.1	chrIV	9946646	9946646	chrIV	9941451	9945219	-	XM_040174995.1	path1	Q9Y5H1 Q52LL6 Q9Y5D5	Protocadherin gamma-A2		 PF00028;PF08266;PF16492;PF15974;	 GO:0005887;GO:0005509;GO:0007155;GO:0007156;	  C:integral component of plasma membrane;	  F:calcium ion binding;	  P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;
XM_040174987.1	chrIV	9966032	9966032	chrIV	9968073	9970647	-	XM_040174987.1	path1	Q91XY4 Q80Y31	Protocadherin gamma-A4 {ECO:0000312|EMBL:AAK26087.1}		 PF00028;PF08266;PF16492;PF15974;	 GO:0005887;GO:0016020;GO:0005509;GO:0007155;GO:0007156;GO:0007283;	  C:integral component of plasma membrane; C:membrane;	  F:calcium ion binding;	  P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:spermatogenesis;
XM_040174564.1	chrIV	9971697	9971697	chrIV	9989645	9996285	-	XM_040174564.1	path1	Q91XY4 Q80Y31	Protocadherin gamma-A4 {ECO:0000312|EMBL:AAK26087.1}		 PF00028;PF08266;PF16492;PF15974;	 GO:0005887;GO:0016020;GO:0005509;GO:0007155;GO:0007156;GO:0007283;	  C:integral component of plasma membrane; C:membrane;	  F:calcium ion binding;	  P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:spermatogenesis;
XM_040172909.1	chrIV	10064385	10064385	chrIV	10030249	10047830	-	XM_040172909.1	path1	Q9Y5I4 Q2M3V1 Q9Y5F4	Protocadherin alpha-C2		 PF00028;PF08266;PF16492;PF15974;	 GO:0005887;GO:0005509;GO:0007155;GO:0007156;GO:0007399;	  C:integral component of plasma membrane;	  F:calcium ion binding;	  P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:nervous system development;
XM_040172913.1	chrIV	10064385	10064385	chrIV	10030249	10070067	-	XM_040172913.1	path1	Q9Y5I0 O75277	Protocadherin alpha-13		 PF00028;PF08266;PF15974;	 GO:0005887;GO:0005509;GO:0007155;GO:0007156;	  C:integral component of plasma membrane;	  F:calcium ion binding;	  P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;
XM_040172915.1	chrIV	10064385	10064385	chrIV	10030249	10072677	-	XM_040172915.1	path1	Q9Y5H9 O75287 Q9BTV3	Protocadherin alpha-2		 PF00028;PF08266;PF15974;	 GO:0005783;GO:0005887;GO:0005634;GO:0005509;GO:0007155;GO:0007156;GO:0007399;	  C:endoplasmic reticulum; C:integral component of plasma membrane; C:nucleus;	  F:calcium ion binding;	  P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:nervous system development;
XM_040172925.1	chrIV	10064385	10064385	chrIV	10030249	10133359	-	XM_040172925.1	path1	Q9Y5H6 B9EGT7 O75281	Protocadherin alpha-8		 PF00028;PF08266;PF15974;	 GO:0005887;GO:0005509;GO:0007155;GO:0007156;GO:0007399;	  C:integral component of plasma membrane;	  F:calcium ion binding;	  P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:nervous system development;
XM_040172923.1	chrIV	10064385	10064385	chrIV	10030249	10191115	-	XM_040172923.1	path1	Q5DRE5	Protocadherin alpha-7 {ECO:0000305}		 PF00028;PF08266;PF15974;	 GO:0005887;GO:0005509;GO:0042802;GO:0007155;GO:0009988;GO:0007156;	  C:integral component of plasma membrane;	  F:calcium ion binding; F:identical protein binding;	  P:cell adhesion; P:cell-cell recognition; P:homophilic cell adhesion via plasma membrane adhesion molecules;
XM_040172934.1	chrIV	10064385	10064385	chrIV	10064540	10066215	-	XM_040172934.1	path1	Q5DRA4	Protocadherin gamma-C3		 PF00028;PF08266;PF16492;PF15974;	 GO:0016021;GO:0005886;GO:0005509;GO:0007156;	  C:integral component of membrane; C:plasma membrane;	  F:calcium ion binding;	  P:homophilic cell adhesion via plasma membrane adhesion molecules;
XM_040172935.1	chrIV	10066297	10066297	chrIV	10093439	10094522	-	XM_040172935.1	path1	Q9Y5I2 A1L493 O75280 Q9NRU2	Protocadherin alpha-10		 PF00028;PF08266;PF15974;	 GO:0005576;GO:0005887;GO:0005509;GO:0007155;GO:0007156;GO:0007399;	  C:extracellular region; C:integral component of plasma membrane;	  F:calcium ion binding;	  P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:nervous system development;
XM_040172666.1	chrIV	10092353	10092353	chrIV	10102455	10116122	-	XM_040172666.1	path1	Q9Y5H8 O75286	Protocadherin alpha-3		 PF00028;PF08266;PF15974;	 GO:0005887;GO:0005509;GO:0007155;GO:0007156;GO:0007399;	  C:integral component of plasma membrane;	  F:calcium ion binding;	  P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:nervous system development;
XM_040174167.1	chrIV	18621989	18621989	chrIV	18583181	18590507	+	XM_040174167.1	path1	Q9JHC9 Q6NST2 Q8BTX8 Q9JHC7 Q9JHC8 Q9JHD0	ETS-related transcription factor Elf-2	E74-like factor 2;New ETS-related factor;	 PF12310;PF00178;	 GO:0005829;GO:0016604;GO:0005654;GO:0005634;GO:0003700;GO:0000981;GO:0043565;GO:1990837;GO:0030154;GO:0045892;GO:0045893;GO:0006357;	  C:cytosol; C:nuclear body; C:nucleoplasm; C:nucleus;	  F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;	  P:cell differentiation; P:negative regulation of transcription, DNA-templated; P:positive regulation of transcription, DNA-templated; P:regulation of transcription by RNA polymerase II;
XM_040174618.1	chrIV	18621989	18621989	chrIV	18591661	18597267	-	XM_040174618.1	path1	P79942	Nocturnin {ECO:0000303|PubMed:8962150}	Carbon catabolite repression 4-like protein;Rhythmic message 1;	 PF03372;	 GO:0005739;GO:0005634;GO:0048471;GO:0046872;GO:0019178;GO:0102757;GO:0004535;GO:0032922;GO:0006739;	  C:mitochondrion; C:nucleus; C:perinuclear region of cytoplasm;	  F:metal ion binding; F:NADP phosphatase activity; F:NADPH phosphatase activity; F:poly(A)-specific ribonuclease activity;	  P:circadian regulation of gene expression; P:NADP metabolic process;
XM_040174395.1	chrIV	18834089	18834089	chrIV	18818311	18835306	+	XM_040174395.1	path1	Q9P2E7 Q4W5F6 Q96SF0	Protocadherin-10		 PF00028;PF08266;PF16492;	 GO:0005887;GO:0005509;GO:0007155;GO:0007156;	  C:integral component of plasma membrane;	  F:calcium ion binding;	  P:cell adhesion; P:homophilic cell adhesion via plasma membrane adhesion molecules;
XM_040172872.1	chrIV	18834089	18834089	chrIV	18843660	18853682	+	XM_040172872.1	path1	P04323	Retrovirus-related Pol polyprotein from transposon 17.6		 PF17921;PF17917;PF00078;	 GO:0004190;GO:0004519;GO:0003676;GO:0003964;GO:0015074;	 	  F:aspartic-type endopeptidase activity; F:endonuclease activity; F:nucleic acid binding; F:RNA-directed DNA polymerase activity;	  P:DNA integration;
XM_040183008.1	chrIV	18834089	18834089	chrIV	18845228	18847795	+	XM_040183008.1	path2	Q7LHG5 D6VVK4 Q04717 Q04722 Q05350	Transposon Ty3-I Gag-Pol polyprotein	Gag3-Pol3;Transposon Ty3-2 TYA-TYB polyprotein;	 PF17921;PF12384;PF17919;PF00665;PF00078;	 GO:0005737;GO:0005634;GO:0000943;GO:0004190;GO:0005524;GO:0003677;GO:0003887;GO:0008233;GO:0004540;GO:0003723;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;GO:0032197;	  C:cytoplasm; C:nucleus; C:retrotransposon nucleocapsid;	  F:aspartic-type endopeptidase activity; F:ATP binding; F:DNA binding; F:DNA-directed DNA polymerase activity; F:peptidase activity; F:ribonuclease activity; F:RNA binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;	  P:DNA integration; P:DNA recombination; P:transposition, RNA-mediated;
XM_040173106.1	chrIV	20557842	20557842	chrIV	20523626	20526320	+	XM_040173106.1	path1	Q7SVK7	Gag-pol polyprotein		 PF01140;PF01141;PF02093;PF18697;PF00075;PF17919;PF00665;PF00077;PF00078;PF00098;PF16721;	 GO:0044185;GO:0020002;GO:0072494;GO:0016020;GO:0019013;GO:0004190;GO:0003677;GO:0003887;GO:0003723;GO:0003964;GO:0004523;GO:0039660;GO:0008270;GO:0015074;GO:0006310;GO:0075713;GO:0039657;GO:0046718;GO:0044826;GO:0019068;	  C:host cell late endosome membrane; C:host cell plasma membrane; C:host multivesicular body; C:membrane; C:viral nucleocapsid;	  F:aspartic-type endopeptidase activity; F:DNA binding; F:DNA-directed DNA polymerase activity; F:RNA binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:structural constituent of virion; F:zinc ion binding;	  P:DNA integration; P:DNA recombination; P:establishment of integrated proviral latency; P:suppression by virus of host gene expression; P:viral entry into host cell; P:viral genome integration into host DNA; P:virion assembly;
XM_040173584.1	chrIV	20557842	20557842	chrIV	20544067	20576426	+	XM_040173584.1	path1	Q8C5H1 Q8CA37	Anoctamin-4 {ECO:0000250|UniProtKB:Q32M45}	Transmembrane protein 16D {ECO:0000250|UniProtKB:Q32M45};	 PF16178;PF04547;	 GO:0016021;GO:0005886;GO:0005254;GO:0017128;GO:0046983;GO:0061591;GO:0061590;GO:0061589;GO:1902476;GO:0006821;GO:0055085;	  C:integral component of membrane; C:plasma membrane;	  F:chloride channel activity; F:phospholipid scramblase activity; F:protein dimerization activity;	  P:calcium activated galactosylceramide scrambling; P:calcium activated phosphatidylcholine scrambling; P:calcium activated phosphatidylserine scrambling; P:chloride transmembrane transport; P:chloride transport; P:transmembrane transport;
XM_040173392.1	chrIV	20622923	20622923	chrIV	20643669	20649227	+	XM_040173392.1	path1	A8MQ14	Zinc finger protein 850		 PF01352;PF00096;	 GO:0005634;GO:0001228;GO:0046872;GO:0000978;GO:0006357;	  C:nucleus;	  F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;	  P:regulation of transcription by RNA polymerase II;
XM_040173393.1	chrIV	20622923	20622923	chrIV	20649287	20652366	-	XM_040173393.1	path1	A0MTA1 Q4V955 Q5RHZ7 Q7SXL6	DNA-(apurinic or apyrimidinic site) endonuclease	APEX nuclease;Apurinic-apyrimidinic endonuclease 1;	 PF03372;	 GO:0005783;GO:0005739;GO:0016607;GO:0005730;GO:0005634;GO:0003677;GO:0003906;GO:0008311;GO:0004519;GO:0046872;GO:0004528;GO:0003723;GO:0006284;GO:0080111;GO:0060047;GO:0001947;GO:0043066;GO:0010628;	  C:endoplasmic reticulum; C:mitochondrion; C:nuclear speck; C:nucleolus; C:nucleus;	  F:DNA binding; F:DNA-(apurinic or apyrimidinic site) endonuclease activity; F:double-stranded DNA 3'-5' exodeoxyribonuclease activity; F:endonuclease activity; F:metal ion binding; F:phosphodiesterase I activity; F:RNA binding;	  P:base-excision repair; P:DNA demethylation; P:heart contraction; P:heart looping; P:negative regulation of apoptotic process; P:positive regulation of gene expression;
XM_040173395.1	chrIV	20622923	20622923	chrIV	20652520	20662726	+	XM_040173395.1	path1	Q5RHZ6 Q561S3	Probable tRNA N6-adenosine threonylcarbamoyltransferase {ECO:0000255|HAMAP-Rule:MF_03180}	O-sialoglycoprotein endopeptidase {ECO:0000255|HAMAP-Rule:MF_03180};t(6)A37 threonylcarbamoyladenosine biosynthesis protein osgep {ECO:0000255|HAMAP-Rule:MF_03180};tRNA threonylcarbamoyladenosine biosynthesis protein osgep {ECO:0000255|HAMAP-Rule:MF_03180};	 PF00814;	 GO:0005737;GO:0000408;GO:0005634;GO:0046872;GO:0061711;GO:0002949;	  C:cytoplasm; C:EKC/KEOPS complex; C:nucleus;	  F:metal ion binding; F:N(6)-L-threonylcarbamoyladenine synthase activity;	  P:tRNA threonylcarbamoyladenosine modification;
XM_040170130.1	chrIV	20627226	20627226	chrIV	20677214	20678734	+	XM_040170130.1	path2	P0CT34 Q05654 Q96TJ6	Transposon Tf2-1 polyprotein	Retrotransposable element Tf2 155 kDa protein;	 PF17921;PF12382;PF17919;PF00665;PF00078;	 GO:0005634;GO:0004190;GO:0003677;GO:0003887;GO:0004519;GO:0046872;GO:0003723;GO:0003964;GO:0015074;GO:0006310;	  C:nucleus;	  F:aspartic-type endopeptidase activity; F:DNA binding; F:DNA-directed DNA polymerase activity; F:endonuclease activity; F:metal ion binding; F:RNA binding; F:RNA-directed DNA polymerase activity;	  P:DNA integration; P:DNA recombination;
XM_040174633.1	chrIV	20643150	20643150	chrIV	20682787	20688055	-	XM_040174633.1	path1	Q6GML1	Cytidine monophosphate-N-acetylneuraminic acid hydroxylase	CMP-N-acetylneuraminate monooxygenase;CMP-Neu5Ac hydroxylase;CMP-NeuAc hydroxylase;	 PF00355;	 GO:0005737;GO:0051537;GO:0030338;GO:0046872;GO:0006054;	  C:cytoplasm;	  F:2 iron, 2 sulfur cluster binding; F:CMP-N-acetylneuraminate monooxygenase activity; F:metal ion binding;	  P:N-acetylneuraminate metabolic process;
XM_040174234.1	chrIV	25131015	25131015	chrIV	25059006	25084453	-	XM_040174234.1	path1	Q5RHB5 J9WMP5	Inositol 1,4,5-triphosphate receptor associated 2	Lymphoid-restricted membrane protein;	 PF14658;PF14662;PF05781;	 GO:0005813;GO:0000785;GO:0005789;GO:0016021;GO:0072686;GO:0097431;GO:0031965;GO:0007052;GO:0051028;GO:0051984;GO:0007344;GO:0035046;	  C:centrosome; C:chromatin; C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitotic spindle; C:mitotic spindle pole; C:nuclear membrane;	 	  P:mitotic spindle organization; P:mRNA transport; P:positive regulation of chromosome segregation; P:pronuclear fusion; P:pronuclear migration;
XM_040172981.1	chrIV	25131015	25131015	chrIV	25086369	25100512	+	XM_040172981.1	path1	P54687 B3KY27 B7Z2M5 B7Z5L0 F5H5E4 Q68DQ7 Q96MY9	Branched-chain-amino-acid aminotransferase, cytosolic	Protein ECA39;	 PF01063;	 GO:0005829;GO:0005739;GO:0004084;GO:0042802;GO:0052656;GO:0052654;GO:0050048;GO:0052655;GO:0009082;GO:0009083;GO:0000082;GO:0009098;GO:0009099;	  C:cytosol; C:mitochondrion;	  F:branched-chain-amino-acid transaminase activity; F:identical protein binding; F:L-isoleucine transaminase activity; F:L-leucine transaminase activity; F:L-leucine:2-oxoglutarate aminotransferase activity; F:L-valine transaminase activity;	  P:branched-chain amino acid biosynthetic process; P:branched-chain amino acid catabolic process; P:G1/S transition of mitotic cell cycle; P:leucine biosynthetic process; P:valine biosynthetic process;
XM_040174021.1	chrIV	25178655	25178655	chrIV	25202237	25273029	+	XM_040174021.1	path1	P35711 B7Z8V0 F5H5B0 Q86UK8 Q8J017 Q8J018 Q8J019 Q8J020 Q8N1D9 Q8N7E0 Q8TEA4	Transcription factor SOX-5 {ECO:0000305}		 PF00505;	 GO:0000785;GO:0005634;GO:0003700;GO:0000981;GO:0000978;GO:0000976;GO:0055059;GO:0001502;GO:0051216;GO:0045165;GO:0071560;GO:0002062;GO:0061036;GO:0032332;GO:2000741;GO:0006357;GO:0006366;	  C:chromatin; C:nucleus;	  F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:transcription regulatory region sequence-specific DNA binding;	  P:asymmetric neuroblast division; P:cartilage condensation; P:cartilage development; P:cell fate commitment; P:cellular response to transforming growth factor beta stimulus; P:chondrocyte differentiation; P:positive regulation of cartilage development; P:positive regulation of chondrocyte differentiation; P:positive regulation of mesenchymal stem cell differentiation; P:regulation of transcription by RNA polymerase II; P:transcription by RNA polymerase II;
XM_040174639.1	chrIV	25274633	25274633	chrIV	25308735	25320125	-	XM_040174639.1	path1	Q9D4V0 F6Y9V2 Q8BXQ0	Ethanolamine kinase 1		 	 GO:0005737;GO:0005524;GO:0004305;GO:0006646;	  C:cytoplasm;	  F:ATP binding; F:ethanolamine kinase activity;	  P:phosphatidylethanolamine biosynthetic process;
XM_040172587.1	chrIV	25274633	25274633	chrIV	25330598	25333046	-	XM_040172587.1	path1	P17716	Islet amyloid polypeptide	Amylin;	 PF00214;	 GO:0005615;GO:0043025;GO:0005179;GO:0042802;GO:0045779;GO:0045596;GO:0019233;	  C:extracellular space; C:neuronal cell body;	  F:hormone activity; F:identical protein binding;	  P:negative regulation of bone resorption; P:negative regulation of cell differentiation; P:sensory perception of pain;
XM_040175249.1	chrIV	25274633	25274633	chrIV	25335477	25344522	-	XM_040175249.1	path1	Q9NYB5 B7Z251 B7Z3Q3 B7Z8P1 F5GZD6 Q5JPA4	Solute carrier organic anion transporter family member 1C1	Organic anion transporter F;Organic anion transporter polypeptide-related protein 5;Organic anion-transporting polypeptide 14;Solute carrier family 21 member 14;Thyroxine transporter;	 PF07648;PF03137;	 GO:0016323;GO:0005887;GO:0005886;GO:0015125;GO:0015347;GO:0015349;GO:0015721;GO:2000611;GO:0043252;GO:0070327;GO:0055085;GO:0150104;	  C:basolateral plasma membrane; C:integral component of plasma membrane; C:plasma membrane;	  F:bile acid transmembrane transporter activity; F:sodium-independent organic anion transmembrane transporter activity; F:thyroid hormone transmembrane transporter activity;	  P:bile acid and bile salt transport; P:positive regulation of thyroid hormone generation; P:sodium-independent organic anion transport; P:thyroid hormone transport; P:transmembrane transport; P:transport across blood-brain barrier;
XR_005712118.1	chrIV	25274633	25274633	chrIV	25337522	25340315	+	XR_005712118.1	path1	Q9NPD5 E7EMT8 Q5JAR4	Solute carrier organic anion transporter family member 1B3	Liver-specific organic anion transporter 2;Organic anion transporter 8;Organic anion-transporting polypeptide 8;Solute carrier family 21 member 8;	 PF07648;PF03137;	 GO:0016323;GO:0005887;GO:0005886;GO:0015125;GO:0008514;GO:0015347;GO:0015721;GO:0042167;GO:0015711;GO:0043252;	  C:basolateral plasma membrane; C:integral component of plasma membrane; C:plasma membrane;	  F:bile acid transmembrane transporter activity; F:organic anion transmembrane transporter activity; F:sodium-independent organic anion transmembrane transporter activity;	  P:bile acid and bile salt transport; P:heme catabolic process; P:organic anion transport; P:sodium-independent organic anion transport;
XM_040174810.1	chrIV	25277518	25277518	chrIV	25347489	25360810	-	XM_040174810.1	path1	Q9NYB5 B7Z251 B7Z3Q3 B7Z8P1 F5GZD6 Q5JPA4	Solute carrier organic anion transporter family member 1C1	Organic anion transporter F;Organic anion transporter polypeptide-related protein 5;Organic anion-transporting polypeptide 14;Solute carrier family 21 member 14;Thyroxine transporter;	 PF07648;PF03137;	 GO:0016323;GO:0005887;GO:0005886;GO:0015125;GO:0015347;GO:0015349;GO:0015721;GO:2000611;GO:0043252;GO:0070327;GO:0055085;GO:0150104;	  C:basolateral plasma membrane; C:integral component of plasma membrane; C:plasma membrane;	  F:bile acid transmembrane transporter activity; F:sodium-independent organic anion transmembrane transporter activity; F:thyroid hormone transmembrane transporter activity;	  P:bile acid and bile salt transport; P:positive regulation of thyroid hormone generation; P:sodium-independent organic anion transport; P:thyroid hormone transport; P:transmembrane transport; P:transport across blood-brain barrier;
NM_001267629.1	chrIV	25489505	25489505	chrIV	25382214	25472598	-	NM_001267629.1	path1	Q7Z5P9 G3CIG0 Q8NA85	Mucin-19		 PF08742;PF01826;PF00094;	 GO:0005576;GO:0005796;GO:0005886;GO:0016266;GO:0002223;	  C:extracellular region; C:Golgi lumen; C:plasma membrane;	 	  P:O-glycan processing; P:stimulatory C-type lectin receptor signaling pathway;
XR_005712000.1	chrIV	25489505	25489505	chrIV	25516628	25522888	-	XR_005712000.1	path1	Q7Z5P9 G3CIG0 Q8NA85	Mucin-19		 PF08742;PF01826;PF00094;	 GO:0005576;GO:0005796;GO:0005886;GO:0016266;GO:0002223;	  C:extracellular region; C:Golgi lumen; C:plasma membrane;	 	  P:O-glycan processing; P:stimulatory C-type lectin receptor signaling pathway;
XM_040172487.1	chrIV	25489505	25489505	chrIV	25548129	25564544	-	XM_040172487.1	path1	Q7Z5P9 G3CIG0 Q8NA85	Mucin-19		 PF08742;PF01826;PF00094;	 GO:0005576;GO:0005796;GO:0005886;GO:0016266;GO:0002223;	  C:extracellular region; C:Golgi lumen; C:plasma membrane;	 	  P:O-glycan processing; P:stimulatory C-type lectin receptor signaling pathway;
XM_040174217.1	chrIV	25497603	25497603	chrIV	25567905	25620819	+	XM_040174217.1	path1	Q96QE2 Q17S07	Proton myo-inositol cotransporter {ECO:0000305}	H(+)-myo-inositol symporter {ECO:0000303|PubMed:11500374};Solute carrier family 2 member 13;	 PF00083;	 GO:0097450;GO:0044297;GO:0071944;GO:0042995;GO:0005737;GO:0030426;GO:0005887;GO:0043231;GO:0016020;GO:0031090;GO:0005886;GO:0051117;GO:0005365;GO:0005366;GO:0002020;GO:0015798;GO:1902004;GO:0150104;	  C:astrocyte end-foot; C:cell body; C:cell periphery; C:cell projection; C:cytoplasm; C:growth cone; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:membrane; C:organelle membrane; C:plasma membrane;	  F:ATPase binding; F:myo-inositol transmembrane transporter activity; F:myo-inositol:proton symporter activity; F:protease binding;	  P:myo-inositol transport; P:positive regulation of amyloid-beta formation; P:transport across blood-brain barrier;
XM_040172881.1	chrIV	26891282	26891282	chrIV	26814584	26820478	-	XM_040172881.1	path1	P46527 Q16307 Q5U0H2 Q9BUS6	Cyclin-dependent kinase inhibitor 1B	Cyclin-dependent kinase inhibitor p27 {ECO:0000303|PubMed:28666995};p27Kip1 {ECO:0000303|PubMed:8033212};	 PF02234;	 GO:0031464;GO:0005737;GO:0005829;GO:0005768;GO:0043231;GO:0005654;GO:0005634;GO:0051087;GO:0030332;GO:0004861;GO:0019901;GO:0004860;GO:0019903;GO:0044877;GO:0048102;GO:0007050;GO:0071285;GO:0019221;GO:0006977;GO:0000082;GO:0007507;GO:0071850;GO:1905179;GO:0045786;GO:0030308;GO:0008285;GO:1904030;GO:0045736;GO:0033673;GO:0045930;GO:0042326;GO:0045892;GO:1904706;GO:0045787;GO:0010942;GO:0045732;GO:1902806;GO:0000079;	  C:Cul4A-RING E3 ubiquitin ligase complex; C:cytoplasm; C:cytosol; C:endosome; C:intracellular membrane-bounded organelle; C:nucleoplasm; C:nucleus;	  F:chaperone binding; F:cyclin binding; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; F:protein kinase binding; F:protein kinase inhibitor activity; F:protein phosphatase binding; F:protein-containing complex binding;	  P:autophagic cell death; P:cell cycle arrest; P:cellular response to lithium ion; P:cytokine-mediated signaling pathway; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; P:G1/S transition of mitotic cell cycle; P:heart development; P:mitotic cell cycle arrest; P:negative regulation of cardiac muscle tissue regeneration; P:negative regulation of cell cycle; P:negative regulation of cell growth; P:negative regulation of cell population proliferation; P:negative regulation of cyclin-dependent protein kinase activity; P:negative regulation of cyclin-dependent protein serine/threonine kinase activity; P:negative regulation of kinase activity; P:negative regulation of mitotic cell cycle; P:negative regulation of phosphorylation; P:negative regulation of transcription, DNA-templated; P:negative regulation of vascular associated smooth muscle cell proliferation; P:positive regulation of cell cycle; P:positive regulation of cell death; P:positive regulation of protein catabolic process; P:regulation of cell cycle G1/S phase transition; P:regulation of cyclin-dependent protein serine/threonine kinase activity;
XM_040175300.1	chrIV	26891282	26891282	chrIV	26833361	26834680	-	XM_040175300.1	path1	Q6XD76 Q7RTS2	Achaete-scute homolog 4	Achaete-scute-like protein 4;Class A basic helix-loop-helix protein 44;	 PF00010;	 GO:0000785;GO:0090575;GO:0000981;GO:0046983;GO:0000977;GO:0006357;GO:0043588;	  C:chromatin; C:RNA polymerase II transcription regulator complex;	  F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;	  P:regulation of transcription by RNA polymerase II; P:skin development;
XM_040173056.1	chrIV	26891282	26891282	chrIV	26835164	26841012	+	XM_040173056.1	path1	Q9UKN5 Q9UFA6	PR domain zinc finger protein 4	PR domain-containing protein 4;	 PF00096;PF18445;	 GO:0005737;GO:0035097;GO:0005634;GO:0001228;GO:0000981;GO:1990226;GO:0046872;GO:0008168;GO:0000978;GO:1990837;GO:0043985;GO:0045944;GO:0010468;GO:0006366;	  C:cytoplasm; C:histone methyltransferase complex; C:nucleus;	  F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone methyltransferase binding; F:metal ion binding; F:methyltransferase activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;	  P:histone H4-R3 methylation; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression; P:transcription by RNA polymerase II;
XM_040173057.1	chrIV	26891282	26891282	chrIV	26847680	26877405	+	XM_040173057.1	path1	Q96HN2 B4DIZ5 D9N155 O94917	Adenosylhomocysteinase 3	IP(3)Rs binding protein released with IP(3) 2;Long-IRBIT {ECO:0000303|PubMed:19220705};S-adenosyl-L-homocysteine hydrolase 3;S-adenosylhomocysteine hydrolase-like protein 2;	 PF05221;PF00670;	 GO:0005829;GO:0005783;GO:0043005;GO:0016787;GO:0006730;GO:0033353;	  C:cytosol; C:endoplasmic reticulum; C:neuron projection;	  F:hydrolase activity;	  P:one-carbon metabolic process; P:S-adenosylmethionine cycle;
XM_040174254.1	chrIV	26891282	26891282	chrIV	26879003	26898937	+	XM_040174254.1	path1	Q803T2	Striatin-interacting protein 1 homolog		 PF11882;PF07923;	 GO:0005829;GO:0030866;GO:0007010;GO:0060047;GO:0022604;	  C:cytosol;	 	  P:cortical actin cytoskeleton organization; P:cytoskeleton organization; P:heart contraction; P:regulation of cell morphogenesis;
XM_040174259.1	chrIV	26891282	26891282	chrIV	26899661	26900898	-	XM_040174259.1	path1	Q6UL01	MORN repeat-containing protein 2 {ECO:0000312|MGI:MGI:2674071}	MORN motif protein in testis {ECO:0000303|PubMed:19913896};	 PF02493;	 GO:0001669;GO:0005634;GO:0030154;GO:0007283;	  C:acrosomal vesicle; C:nucleus;	 	  P:cell differentiation; P:spermatogenesis;
XM_040174273.1	chrIV	26891282	26891282	chrIV	26912405	26913628	-	XM_040174273.1	path1	B3DFW5	Short transmembrane mitochondrial protein 1 {ECO:0000303|PubMed:23073385}		 PF15054;	 GO:0016021;GO:0005758;GO:0005741;GO:0005746;GO:0045087;GO:0032731;GO:1900227;	  C:integral component of membrane; C:mitochondrial intermembrane space; C:mitochondrial outer membrane; C:mitochondrial respirasome;	 	  P:innate immune response; P:positive regulation of interleukin-1 beta production; P:positive regulation of NLRP3 inflammasome complex assembly;
XM_040174263.1	chrIV	26891282	26891282	chrIV	26913756	26923998	+	XM_040174263.1	path1	Q7SXN5	Dynamin-1-like protein		 PF01031;PF00350;PF02212;	 GO:0005905;GO:0005737;GO:0005829;GO:0005794;GO:0016020;GO:0031966;GO:0005741;GO:0005739;GO:0005777;GO:0030672;GO:0005525;GO:0003924;GO:0008289;GO:0008017;GO:0042803;GO:0003374;GO:0048312;GO:0061025;GO:0000266;GO:0043653;GO:0016559;GO:0051259;GO:1903146;GO:0048511;	  C:clathrin-coated pit; C:cytoplasm; C:cytosol; C:Golgi apparatus; C:membrane; C:mitochondrial membrane; C:mitochondrial outer membrane; C:mitochondrion; C:peroxisome; C:synaptic vesicle membrane;	  F:GTP binding; F:GTPase activity; F:lipid binding; F:microtubule binding; F:protein homodimerization activity;	  P:dynamin family protein polymerization involved in mitochondrial fission; P:intracellular distribution of mitochondria; P:membrane fusion; P:mitochondrial fission; P:mitochondrial fragmentation involved in apoptotic process; P:peroxisome fission; P:protein complex oligomerization; P:regulation of autophagy of mitochondrion; P:rhythmic process;
XM_040174265.1	chrIV	26891282	26891282	chrIV	26931693	26956846	-	XM_040174265.1	path1	P13505	Caldesmon, smooth muscle		 PF02029;	 GO:0005884;GO:0030016;GO:0051015;GO:0005516;GO:0017022;GO:0006936;GO:1904530;	  C:actin filament; C:myofibril;	  F:actin filament binding; F:calmodulin binding; F:myosin binding;	  P:muscle contraction; P:negative regulation of actin filament binding;
XM_040174022.1	chrIV	27017234	27017234	chrIV	27066682	27080813	+	XM_040174022.1	path1	Q9H3W5 O43377 Q6I9V8 Q8IYQ6	Leucine-rich repeat neuronal protein 3	Neuronal leucine-rich repeat protein 3;	 PF00041;PF07679;PF13855;	 GO:0031012;GO:0005615;GO:0016021;GO:0051965;	  C:extracellular matrix; C:extracellular space; C:integral component of membrane;	 	  P:positive regulation of synapse assembly;
XM_040173119.1	chrIV	27195918	27195918	chrIV	27200613	27286721	-	XM_040173119.1	path1	P59764 B2RUG6	Dedicator of cytokinesis protein 4		 PF06920;PF14429;PF16172;PF07653;	 GO:0005829;GO:0005794;GO:0016020;GO:0005730;GO:0005886;GO:0032420;GO:0032421;GO:0005096;GO:0005085;GO:0030165;GO:0030971;GO:0017124;GO:0031267;GO:0060326;GO:1904694;GO:0043547;GO:1904754;GO:0007264;	  C:cytosol; C:Golgi apparatus; C:membrane; C:nucleolus; C:plasma membrane; C:stereocilium; C:stereocilium bundle;	  F:GTPase activator activity; F:guanyl-nucleotide exchange factor activity; F:PDZ domain binding; F:receptor tyrosine kinase binding; F:SH3 domain binding; F:small GTPase binding;	  P:cell chemotaxis; P:negative regulation of vascular associated smooth muscle contraction; P:positive regulation of GTPase activity; P:positive regulation of vascular associated smooth muscle cell migration; P:small GTPase mediated signal transduction;
XM_040174694.1	chrIV	27236698	27236698	chrIV	27307161	27312829	+	XM_040174694.1	path1	Q5S1U6	Interferon-related developmental regulator 1		 PF05004;PF04836;	 GO:0005634;GO:0030154;GO:0007275;GO:0006357;	  C:nucleus;	 	  P:cell differentiation; P:multicellular organism development; P:regulation of transcription by RNA polymerase II;
XR_005712646.1	chrV	89623	89623	chrV	85230	87298	-	XR_005712646.1	path2	Q63HK3 A1L3B4 Q6ZN77	Zinc finger protein with KRAB and SCAN domains 2	Zinc finger protein 694;	 PF01352;PF02023;PF00096;	 GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:0006357;	  C:nucleus;	  F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;	  P:regulation of transcription by RNA polymerase II;
XM_040177584.1	chrV	89623	89623	chrV	85257	87181	-	XM_040177584.1	path1	Q8IWY8 B3KVB9 Q32M75 Q32M76 Q8NA40	Zinc finger and SCAN domain-containing protein 29	Zinc finger protein 690;	 PF02023;PF00096;	 GO:0005634;GO:0000981;GO:0046872;GO:0000978;GO:1990837;GO:0006357;	  C:nucleus;	  F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;	  P:regulation of transcription by RNA polymerase II;
XM_040176834.1	chrV	302201	302201	chrV	247963	412651	+	XM_040176834.1	path1	A6NFN3 B4DEG6 B4DF29	RNA binding protein fox-1 homolog 3	Fox-1 homolog C;Neuronal nuclei antigen;	 PF12414;PF00076;	 GO:0005737;GO:0005634;GO:0003729;GO:0006397;GO:0007399;GO:0000381;GO:0008380;	  C:cytoplasm; C:nucleus;	  F:mRNA binding;	  P:mRNA processing; P:nervous system development; P:regulation of alternative mRNA splicing, via spliceosome; P:RNA splicing;
XM_040177358.1	chrV	3206635	3206635	chrV	3171419	3196617	-	XM_040177358.1	path1	Q68DX3 B7WNW0 B7ZML5 Q2VY07 Q6GMQ9 Q6ZN38 Q6ZWI2 Q8N5T9	FERM and PDZ domain-containing protein 2	PDZ domain-containing protein 4;PDZ domain-containing protein 5C;	 PF09380;PF00373;PF09379;PF00595;	 GO:0016323;GO:0005923;GO:0005737;GO:0005856;GO:0005545;GO:0070830;	  C:basolateral plasma membrane; C:bicellular tight junction; C:cytoplasm; C:cytoskeleton;	  F:1-phosphatidylinositol binding;	  P:bicellular tight junction assembly;
XM_040176410.1	chrV	3206635	3206635	chrV	3202141	3216977	+	XM_040176410.1	path1	Q9DGD9	Mitogen-activated protein kinase 8	Stress-activated protein kinase JNK1;c-Jun N-terminal kinase 1;	 PF00069;	 GO:0005737;GO:0005634;GO:0045202;GO:0005524;GO:0004705;GO:0004707;GO:0106310;GO:0004674;GO:0106311;GO:0048263;GO:0035556;GO:0007254;GO:0048511;	  C:cytoplasm; C:nucleus; C:synapse;	  F:ATP binding; F:JUN kinase activity; F:MAP kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity;	  P:determination of dorsal identity; P:intracellular signal transduction; P:JNK cascade; P:rhythmic process;
XM_040177177.1	chrV	3206635	3206635	chrV	3218756	3231196	-	XM_040177177.1	path1	Q7Z5H3 A0AVP7 A5YM75 B4DED8 B9EGA0 C9JDM2 O00152 Q6ZSB0	Rho GTPase-activating protein 22	Rho-type GTPase-activating protein 22;	 PF00169;PF00620;	 GO:0005829;GO:0005925;GO:0098978;GO:0005634;GO:0005096;GO:0090630;GO:0001525;GO:0030154;GO:0099175;GO:0051056;GO:0007165;	  C:cytosol; C:focal adhesion; C:glutamatergic synapse; C:nucleus;	  F:GTPase activator activity;	  P:activation of GTPase activity; P:angiogenesis; P:cell differentiation; P:regulation of postsynapse organization; P:regulation of small GTPase mediated signal transduction; P:signal transduction;
XM_040177188.1	chrV	3280959	3280959	chrV	3296334	3311667	+	XM_040177188.1	path1	M0RD54	Cardiac-enriched FHL2-interacting protein {ECO:0000303|PubMed:28717008}		 PF15232;	 GO:0030018;GO:0070886;	  C:Z disc;	 	  P:positive regulation of calcineurin-NFAT signaling cascade;
XM_040177190.1	chrV	3280959	3280959	chrV	3313261	3315498	-	XM_040177190.1	path1	P30884	Bone morphogenetic protein 2-B	BMP-2-II;	 PF00019;PF00688;	 GO:0005615;GO:0005125;GO:0008083;GO:0051216;GO:0030154;GO:0001503;	  C:extracellular space;	  F:cytokine activity; F:growth factor activity;	  P:cartilage development; P:cell differentiation; P:ossification;
XM_040177129.1	chrV	3371342	3371342	chrV	3418496	3424944	-	XM_040177129.1	path1	P10394	Retrovirus-related Pol polyprotein from transposon 412		 PF17921;PF17919;PF00077;PF00078;	 GO:0004190;GO:0004519;GO:0003676;GO:0003964;GO:0015074;	 	  F:aspartic-type endopeptidase activity; F:endonuclease activity; F:nucleic acid binding; F:RNA-directed DNA polymerase activity;	  P:DNA integration;
XM_040176451.1	chrV	3752775	3752775	chrV	3778549	3782135	-	XM_040176451.1	path1	Q9BYW1 E9PH55 Q542Y4 Q6ICJ5 Q8WXF9 Q8WYM4	Solute carrier family 2, facilitated glucose transporter member 11 {ECO:0000305}	Glucose transporter type 11 {ECO:0000303|PubMed:11741323};	 PF00083;	 GO:0030054;GO:0016021;GO:0005654;GO:0005886;GO:0005355;GO:1904659;GO:0008645;	  C:cell junction; C:integral component of membrane; C:nucleoplasm; C:plasma membrane;	  F:glucose transmembrane transporter activity;	  P:glucose transmembrane transport; P:hexose transmembrane transport;
XM_040176454.1	chrV	3752775	3752775	chrV	3782135	3785506	+	XM_040176454.1	path1	Q3KPW1	RNA-binding protein with serine-rich domain 1-B		 PF00076;	 GO:0005737;GO:0016607;GO:0003723;GO:0006397;GO:0008380;	  C:cytoplasm; C:nuclear speck;	  F:RNA binding;	  P:mRNA processing; P:RNA splicing;
XM_040176456.1	chrV	3752775	3752775	chrV	3786667	3787863	-	XM_040176456.1	path1	A8E4L1	Cytochrome c oxidase assembly protein COX19		 PF06747;	 GO:0005829;GO:0005758;GO:0005739;GO:0006878;GO:0033617;	  C:cytosol; C:mitochondrial intermembrane space; C:mitochondrion;	 	  P:cellular copper ion homeostasis; P:mitochondrial cytochrome c oxidase assembly;
XM_040176452.1	chrV	3752775	3752775	chrV	3788483	3810155	+	XM_040176452.1	path1	O75689 A4D2Q2 B3KRZ4 B4DVA6 F6XZ68 H7C2Q4	Arf-GAP with dual PH domain-containing protein 1	Centaurin-alpha-1;Putative MAPK-activating protein PM25;	 PF01412;PF00169;	 GO:0005737;GO:0005829;GO:0043231;GO:0005634;GO:0005886;GO:0005096;GO:0043533;GO:0046872;GO:1902936;GO:0005547;GO:0007166;GO:0043087;	  C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nucleus; C:plasma membrane;	  F:GTPase activator activity; F:inositol 1,3,4,5 tetrakisphosphate binding; F:metal ion binding; F:phosphatidylinositol bisphosphate binding; F:phosphatidylinositol-3,4,5-trisphosphate binding;	  P:cell surface receptor signaling pathway; P:regulation of GTPase activity;
XM_040176429.1	chrV	3888987	3888987	chrV	3832368	3887371	+	XM_040176429.1	path1	Q9ULW5 B2RAA6 Q3L6K5 Q6NXS7	Ras-related protein Rab-26		 PF00071;	 GO:0098993;GO:0005768;GO:0005794;GO:0000139;GO:0031226;GO:0030667;GO:0019002;GO:0005525;GO:0003924;GO:0035272;GO:0043001;GO:0045055;GO:0017157;GO:0099575;	  C:anchored component of synaptic vesicle membrane; C:endosome; C:Golgi apparatus; C:Golgi membrane; C:intrinsic component of plasma membrane; C:secretory granule membrane;	  F:GMP binding; F:GTP binding; F:GTPase activity;	  P:exocrine system development; P:Golgi to plasma membrane protein transport; P:regulated exocytosis; P:regulation of exocytosis; P:regulation of protein catabolic process at presynapse, modulating synaptic transmission;
XM_040177202.1	chrV	3888987	3888987	chrV	3912840	3943198	+	XM_040177202.1	path1	Q7YRH6	Phosphatidylethanolamine N-methyltransferase {ECO:0000255|HAMAP-Rule:MF_03216}	Phospholipid methyltransferase {ECO:0000255|HAMAP-Rule:MF_03216};	 PF04191;	 GO:0005789;GO:0016021;GO:0031966;GO:0080101;GO:0000773;GO:0004608;GO:0032259;GO:0006656;	  C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondrial membrane;	  F:phosphatidyl-N-dimethylethanolamine N-methyltransferase activity; F:phosphatidyl-N-methylethanolamine N-methyltransferase activity; F:phosphatidylethanolamine N-methyltransferase activity;	  P:methylation; P:phosphatidylcholine biosynthetic process;
XM_040177374.1	chrV	3913665	3913665	chrV	3956934	3958699	+	XM_040177374.1	path1	Q9Y272 B2R709 B4DFF4 Q9NYB4	Dexamethasone-induced Ras-related protein 1	Activator of G-protein signaling 1;	 PF00071;	 GO:0005634;GO:0048471;GO:0005886;GO:0016529;GO:0005525;GO:0003924;GO:0007186;GO:0045892;GO:0007263;GO:0007165;	  C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:sarcoplasmic reticulum;	  F:GTP binding; F:GTPase activity;	  P:G protein-coupled receptor signaling pathway; P:negative regulation of transcription, DNA-templated; P:nitric oxide mediated signal transduction; P:signal transduction;
XM_040176332.1	chrV	3915966	3915966	chrV	3982868	3987000	-	XM_040176332.1	path1	Q8VCE6	5'(3')-deoxyribonucleotidase, mitochondrial	Deoxy-5'-nucleotidase 2;	 PF06941;	 GO:0005739;GO:0008253;GO:0046872;GO:0000166;GO:0046079;GO:0009223;	  C:mitochondrion;	  F:5'-nucleotidase activity; F:metal ion binding; F:nucleotide binding;	  P:dUMP catabolic process; P:pyrimidine deoxyribonucleotide catabolic process;
XM_040176330.1	chrV	3924685	3924685	chrV	3987972	3996878	+	XM_040176330.1	path1	Q6P2U9 Q7ZVT8	COP9 signalosome complex subunit 3		 PF01399;	 GO:0008180;GO:0005737;GO:0006511;	  C:COP9 signalosome; C:cytoplasm;	 	  P:ubiquitin-dependent protein catabolic process;
XM_040176334.1	chrV	3983849	3983849	chrV	3997179	4009035	+	XM_040176334.1	path1	A6H8I0 Q1JQ28	Ubiquitin carboxyl-terminal hydrolase 22	Deubiquitinating enzyme 22;Ubiquitin thioesterase 22;Ubiquitin-specific-processing protease 22;	 PF00443;PF02148;	 GO:0005634;GO:0004843;GO:0008270;GO:0007049;GO:0006325;GO:0016579;GO:0006511;	  C:nucleus;	  F:thiol-dependent deubiquitinase; F:zinc ion binding;	  P:cell cycle; P:chromatin organization; P:protein deubiquitination; P:ubiquitin-dependent protein catabolic process;
XM_040176331.1	chrV	3983849	3983849	chrV	4009272	4013388	-	XM_040176331.1	path1	O14836 B2R8B0 B7Z6V8 Q32LX4 Q7Z6F5	Tumor necrosis factor receptor superfamily member 13B	Transmembrane activator and CAML interactor;	 PF09305;	 GO:0005887;GO:0005886;GO:0038023;GO:0002250;GO:0001782;GO:0007166;GO:0002244;GO:0030889;GO:0033209;	  C:integral component of plasma membrane; C:plasma membrane;	  F:signaling receptor activity;	  P:adaptive immune response; P:B cell homeostasis; P:cell surface receptor signaling pathway; P:hematopoietic progenitor cell differentiation; P:negative regulation of B cell proliferation; P:tumor necrosis factor-mediated signaling pathway;
XM_040177124.1	chrV	3983849	3983849	chrV	4015898	4025482	-	XM_040177124.1	path1	P30874 A8K3Y0 B2R9P7 Q4VBP0 Q96GE0 Q96TF2 Q9BWH1	Somatostatin receptor type 2	SRIF-1;	 PF00001;	 GO:0005829;GO:0005887;GO:0043005;GO:0005886;GO:0004930;GO:0042923;GO:0030165;GO:0042277;GO:0004994;GO:0007193;GO:0071392;GO:0071385;GO:0021549;GO:0030900;GO:0007186;GO:0007187;GO:0008285;GO:0007218;GO:0030432;GO:0006937;GO:0042594;GO:0007283;	  C:cytosol; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane;	  F:G protein-coupled receptor activity; F:neuropeptide binding; F:PDZ domain binding; F:peptide binding; F:somatostatin receptor activity;	  P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:cellular response to estradiol stimulus; P:cellular response to glucocorticoid stimulus; P:cerebellum development; P:forebrain development; P:G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:negative regulation of cell population proliferation; P:neuropeptide signaling pathway; P:peristalsis; P:regulation of muscle contraction; P:response to starvation; P:spermatogenesis;
XM_040176771.1	chrV	3983849	3983849	chrV	4046271	4119887	+	XM_040176771.1	path1	Q2YDD4	Zinc transporter ZIP11	Solute carrier family 39 member 11;Zrt- and Irt-like protein 11;	 PF02535;	 GO:0005737;GO:0005794;GO:0016021;GO:0016020;GO:0005634;GO:0005886;GO:0005385;GO:0071577;	  C:cytoplasm; C:Golgi apparatus; C:integral component of membrane; C:membrane; C:nucleus; C:plasma membrane;	  F:zinc ion transmembrane transporter activity;	  P:zinc ion transmembrane transport;
XM_040178552.1	chrVI	166335	166335	chrVI	167054	248534	-	XM_040178552.1	path1	Q9HC58 B1AKV7 Q9BQJ9 Q9BQL7 Q9BQY3 Q9H519	Sodium/potassium/calcium exchanger 3	Na(+)/K(+)/Ca(2+)-exchange protein 3;Solute carrier family 24 member 3;	 PF01699;	 GO:0071944;GO:0005887;GO:0005886;GO:0005262;GO:0008273;GO:0015293;GO:0030282;GO:0070588;GO:0006874;GO:0006811;GO:0010629;GO:0010628;GO:0071805;GO:0035725;GO:0150104;	  C:cell periphery; C:integral component of plasma membrane; C:plasma membrane;	  F:calcium channel activity; F:calcium, potassium:sodium antiporter activity; F:symporter activity;	  P:bone mineralization; P:calcium ion transmembrane transport; P:cellular calcium ion homeostasis; P:ion transport; P:negative regulation of gene expression; P:positive regulation of gene expression; P:potassium ion transmembrane transport; P:sodium ion transmembrane transport; P:transport across blood-brain barrier;
XM_040179465.1	chrVI	286198	286198	chrVI	282940	284959	-	XM_040179465.1	path1	Q9WU63	Heme-binding protein 2	Protein SOUL;	 PF04832;	 GO:0005737;GO:0005739;GO:0020037;GO:0010917;GO:0035794;GO:0010940;	  C:cytoplasm; C:mitochondrion;	  F:heme binding;	  P:negative regulation of mitochondrial membrane potential; P:positive regulation of mitochondrial membrane permeability; P:positive regulation of necrotic cell death;
XM_040179533.1	chrVI	362723	362723	chrVI	366544	375879	+	XM_040179533.1	path1	B3TP03 B3TP04 B3TP05	Cationic amino acid transporter 2	Low affinity cationic amino acid transporter 2;Solute carrier family 7 member 2;	 PF13520;PF13906;	 GO:0005737;GO:0031410;GO:0005794;GO:0016021;GO:0005886;GO:0015171;GO:0015181;GO:0061459;GO:0015189;GO:0000064;GO:0006865;GO:0097638;GO:0097639;GO:1903352;	  C:cytoplasm; C:cytoplasmic vesicle; C:Golgi apparatus; C:integral component of membrane; C:plasma membrane;	  F:amino acid transmembrane transporter activity; F:arginine transmembrane transporter activity; F:L-arginine transmembrane transporter activity; F:L-lysine transmembrane transporter activity; F:L-ornithine transmembrane transporter activity;	  P:amino acid transport; P:L-arginine import across plasma membrane; P:L-lysine import across plasma membrane; P:L-ornithine transmembrane transport;
XM_040177996.1	chrVI	8307613	8307613	chrVI	8171509	8367299	-	XM_040177996.1	path1	A1XQX0	Neurexin-1a	Neurexin Ia-alpha;Neurexin-1a-alpha;	 PF00008;PF02210;PF01034;	 GO:0016021;GO:0046872;GO:0007155;GO:0002040;	  C:integral component of membrane;	  F:metal ion binding;	  P:cell adhesion; P:sprouting angiogenesis;
XM_040177901.1	chrVI	8454811	8454811	chrVI	8471721	8476180	+	XM_040177901.1	path1	Q8VEH8 Q3UZF3 Q8BVN6	Endoplasmic reticulum lectin 1	ER lectin;	 PF07915;	 GO:0005788;GO:0051082;GO:1904153;GO:0030433;	  C:endoplasmic reticulum lumen;	  F:unfolded protein binding;	  P:negative regulation of retrograde protein transport, ER to cytosol; P:ubiquitin-dependent ERAD pathway;
XM_040177897.1	chrVI	8454811	8454811	chrVI	8477022	8480120	-	XM_040177897.1	path1	O95800 B2RC02 Q6NWR2	Probable G-protein coupled receptor 75		 PF00001;	 GO:0005887;GO:0005886;GO:0016493;GO:0004930;GO:0070098;GO:0007186;GO:1901214;	  C:integral component of plasma membrane; C:plasma membrane;	  F:C-C chemokine receptor activity; F:G protein-coupled receptor activity;	  P:chemokine-mediated signaling pathway; P:G protein-coupled receptor signaling pathway; P:regulation of neuron death;
XM_040177891.1	chrVI	8465561	8465561	chrVI	8480572	8502247	-	XM_040177891.1	path1	F1QFR9 E7F2L9	Proteasome activator complex subunit 4A	Proteasome activator PA200-A;	 PF16507;PF11919;	 GO:0005829;GO:0016607;GO:0005634;GO:1990111;GO:0070577;GO:0016504;GO:0070628;GO:0006974;GO:0006281;GO:0010499;GO:0035093;	  C:cytosol; C:nuclear speck; C:nucleus; C:spermatoproteasome complex;	  F:lysine-acetylated histone binding; F:peptidase activator activity; F:proteasome binding;	  P:cellular response to DNA damage stimulus; P:DNA repair; P:proteasomal ubiquitin-independent protein catabolic process; P:spermatogenesis, exchange of chromosomal proteins;
XM_040178138.1	chrVI	8558756	8558756	chrVI	8544717	8561407	+	XM_040178138.1	path1	P35440	Thrombospondin-2		 PF12947;PF00090;PF02412;PF05735;PF00093;	 GO:0062023;GO:0005576;GO:0005509;GO:0008201;GO:0007155;GO:0016525;	  C:collagen-containing extracellular matrix; C:extracellular region;	  F:calcium ion binding; F:heparin binding;	  P:cell adhesion; P:negative regulation of angiogenesis;
XM_040178142.1	chrVI	8558756	8558756	chrVI	8570225	8574990	+	XM_040178142.1	path1	Q5E9R2 Q5EA78	1-acyl-sn-glycerol-3-phosphate acyltransferase delta	1-acylglycerol-3-phosphate O-acyltransferase 4;Lysophosphatidic acid acyltransferase delta;	 PF16076;PF01553;	 GO:0012505;GO:0005783;GO:0005789;GO:0016021;GO:0005741;GO:0003841;GO:0016746;GO:0016024;	  C:endomembrane system; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:integral component of membrane; C:mitochondrial outer membrane;	  F:1-acylglycerol-3-phosphate O-acyltransferase activity; F:transferase activity, transferring acyl groups;	  P:CDP-diacylglycerol biosynthetic process;
XM_040178137.1	chrVI	8558756	8558756	chrVI	8576382	8593045	-	XM_040178137.1	path1	Q9Y6R4 A6H8W0 B7ZLD3 B9EG75 Q5VTT8 Q5VTT9 Q92612 Q9H408	Mitogen-activated protein kinase kinase kinase 4	MAP three kinase 1;MAPK/ERK kinase kinase 4;	 PF00069;	 GO:0005737;GO:0048471;GO:0005524;GO:0004709;GO:0046872;GO:0106310;GO:0106311;GO:0000186;GO:0035556;GO:0043507;GO:1900745;GO:0051973;GO:1904355;GO:0032212;GO:0010225;	  C:cytoplasm; C:perinuclear region of cytoplasm;	  F:ATP binding; F:MAP kinase kinase kinase activity; F:metal ion binding; F:protein serine kinase activity; F:protein threonine kinase activity;	  P:activation of MAPKK activity; P:intracellular signal transduction; P:positive regulation of JUN kinase activity; P:positive regulation of p38MAPK cascade; P:positive regulation of telomerase activity; P:positive regulation of telomere capping; P:positive regulation of telomere maintenance via telomerase; P:response to UV-C;
XM_040178848.1	chrVI	8558782	8558782	chrVI	8596949	8603637	+	XM_040178848.1	path1	O00180 Q13307 Q5T5E8	Potassium channel subfamily K member 1	Inward rectifying potassium channel protein TWIK-1 {ECO:0000303|PubMed:8605869};Potassium channel K2P1 {ECO:0000303|PubMed:15820677};Potassium channel KCNO1;	 PF07885;	 GO:0016324;GO:0031526;GO:0030425;GO:0016021;GO:0005887;GO:0043231;GO:1902937;GO:0043204;GO:0005886;GO:0034705;GO:0055037;GO:0097060;GO:0008076;GO:0042802;GO:0005242;GO:0005267;GO:0022841;GO:0005272;GO:0061337;GO:0071805;GO:0006813;GO:0060075;GO:0035094;GO:0035725;GO:0030322;	  C:apical plasma membrane; C:brush border membrane; C:dendrite; C:integral component of membrane; C:integral component of plasma membrane; C:intracellular membrane-bounded organelle; C:inward rectifier potassium channel complex; C:perikaryon; C:plasma membrane; C:potassium channel complex; C:recycling endosome; C:synaptic membrane; C:voltage-gated potassium channel complex;	  F:identical protein binding; F:inward rectifier potassium channel activity; F:potassium channel activity; F:potassium ion leak channel activity; F:sodium channel activity;	  P:cardiac conduction; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of resting membrane potential; P:response to nicotine; P:sodium ion transmembrane transport; P:stabilization of membrane potential;
XM_040179569.1	chrVI	8573355	8573355	chrVI	8609821	8643746	+	XM_040179569.1	path1	Q8IY50 Q5TDD6 Q8N9C9	Putative thiamine transporter SLC35F3 {ECO:0000305}	Solute carrier family 35 member F3;	 PF00892;	 GO:0016021;GO:0015888;	  C:integral component of membrane;	 	  P:thiamine transport;
XM_040179568.1	chrVI	8575785	8575785	chrVI	8643653	8646552	-	XM_040179568.1	path1	B2RPY5 B0L0L8 J3QN69 Q80T48	G-protein coupled receptor 161		 PF00001;	 GO:0060170;GO:0005929;GO:0016021;GO:0055037;GO:0004930;GO:0007189;GO:0007186;GO:0007275;GO:1901621;	  C:ciliary membrane; C:cilium; C:integral component of membrane; C:recycling endosome;	  F:G protein-coupled receptor activity;	  P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:G protein-coupled receptor signaling pathway; P:multicellular organism development; P:negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning;
XM_040179557.1	chrVI	8694476	8694476	chrVI	8646682	8658680	-	XM_040179557.1	path1	Q13395 Q9H581	Probable methyltransferase TARBP1	TAR RNA-binding protein 1;TAR RNA-binding protein of 185 kDa;	 PF00588;	 GO:0005634;GO:0003723;GO:0016423;GO:0006357;GO:0030488;	  C:nucleus;	  F:RNA binding; F:tRNA (guanine) methyltransferase activity;	  P:regulation of transcription by RNA polymerase II; P:tRNA methylation;
XM_040179572.1	chrVI	8694476	8694476	chrVI	8658797	8666829	-	XM_040179572.1	path1	Q96NE9 D3DSB9 Q5HYF2 Q8N2X1 Q8WUH7	FERM domain-containing protein 6	Willin;	 PF09380;PF00373;PF09379;	 GO:0005737;GO:0005856;GO:0005886;GO:0031032;	  C:cytoplasm; C:cytoskeleton; C:plasma membrane;	 	  P:actomyosin structure organization;
XM_040179561.1	chrVI	8694476	8694476	chrVI	8667316	8681431	-	XM_040179561.1	path1	Q9P2D6 A2RRQ5 Q3C0H3 Q5JXK0 Q5JXK1 Q68DW0 Q6P081 Q9H0F2 Q9NU48 Q9NUQ5 Q9NXL5	Protein FAM135A		 PF12394;PF05057;	 GO:0044255;	 	 	  P:cellular lipid metabolic process;
XM_040178985.1	chrVI	8694476	8694476	chrVI	8684096	8697555	+	XM_040178985.1	path1	Q05722 Q61269 Q61270 Q61433 Q61940	Collagen alpha-1(IX) chain		 PF01391;	 GO:0005604;GO:0005594;GO:0031012;GO:0005615;GO:0005201;GO:0046872;GO:0060349;GO:0051216;GO:0035988;GO:0030198;GO:0003417;GO:0001501;GO:0001894;	  C:basement membrane; C:collagen type IX trimer; C:extracellular matrix; C:extracellular space;	  F:extracellular matrix structural constituent; F:metal ion binding;	  P:bone morphogenesis; P:cartilage development; P:chondrocyte proliferation; P:extracellular matrix organization; P:growth plate cartilage development; P:skeletal system development; P:tissue homeostasis;
XM_040178883.1	chrVI	8694476	8694476	chrVI	8698013	8779782	-	XM_040178883.1	path1	Q14993 Q00559 Q05850 Q12885 Q13676 Q14DH1 Q5JUF0 Q5T424 Q9H572 Q9NPZ2 Q9NQP2	Collagen alpha-1(XIX) chain	Collagen alpha-1(Y) chain;	 PF01391;	 GO:0005581;GO:0062023;GO:0005788;GO:0031012;GO:0005576;GO:0005615;GO:0005201;GO:0030674;GO:0007155;GO:0030154;GO:0098609;GO:0030574;GO:0030199;GO:0030198;GO:0007519;GO:0001501;	  C:collagen trimer; C:collagen-containing extracellular matrix; C:endoplasmic reticulum lumen; C:extracellular matrix; C:extracellular region; C:extracellular space;	  F:extracellular matrix structural constituent; F:protein-macromolecule adaptor activity;	  P:cell adhesion; P:cell differentiation; P:cell-cell adhesion; P:collagen catabolic process; P:collagen fibril organization; P:extracellular matrix organization; P:skeletal muscle tissue development; P:skeletal system development;
XM_040177707.1	chrVI	8716374	8716374	chrVI	8787511	8831121	+	XM_040177707.1	path1	Q5PR61	Lysosomal cobalamin transport escort protein LMBD1 {ECO:0000250|UniProtKB:Q9NUN5}	LMBR1 domain-containing protein 1;	 PF04791;	 GO:0045334;GO:0005789;GO:0016021;GO:0005765;GO:0005886;GO:0005774;GO:0031419;GO:0038016;GO:0061462;GO:0072665;	  C:clathrin-coated endocytic vesicle; C:endoplasmic reticulum membrane; C:integral component of membrane; C:lysosomal membrane; C:plasma membrane; C:vacuolar membrane;	  F:cobalamin binding;	  P:insulin receptor internalization; P:protein localization to lysosome; P:protein localization to vacuole;
XM_040181704.1	chrVII	9502430	9502430	chrVII	9492629	9507373	-	XM_040181704.1	path1	Q9Z2J6 Q54A00	Prostaglandin D2 receptor 2	Chemoattractant receptor-homologous molecule expressed on Th2 cells;G-protein coupled receptor 44;	 PF00001;	 GO:0005887;GO:0043005;GO:0004930;GO:0042923;GO:0042277;GO:0004956;GO:0004958;GO:0001785;GO:0007193;GO:0019722;GO:0006935;GO:0007186;GO:2000255;GO:0007218;GO:0045745;	  C:integral component of plasma membrane; C:neuron projection;	  F:G protein-coupled receptor activity; F:neuropeptide binding; F:peptide binding; F:prostaglandin D receptor activity; F:prostaglandin F receptor activity; F:prostaglandin J receptor activity;	  P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; P:calcium-mediated signaling; P:chemotaxis; P:G protein-coupled receptor signaling pathway; P:negative regulation of male germ cell proliferation; P:neuropeptide signaling pathway; P:positive regulation of G protein-coupled receptor signaling pathway;
XM_040181709.1	chrVII	9509677	9509677	chrVII	9505349	9508116	+	XM_040181709.1	path1	P01688	Ig kappa chain V region K-25		 PF07686;	 GO:0019814;GO:0002250;	  C:immunoglobulin complex;	 	  P:adaptive immune response;
XM_040179747.1	chrVII	9515417	9515417	chrVII	9518180	9520614	+	XM_040179747.1	path1	P01684	Ig kappa chain V region 3374		 PF07686;	 GO:0019814;GO:0002250;	  C:immunoglobulin complex;	 	  P:adaptive immune response;
XM_040182454.1	chrVII	9530313	9530313	chrVII	9531936	9540597	+	XM_040182454.1	path1	P01684	Ig kappa chain V region 3374		 PF07686;	 GO:0019814;GO:0002250;	  C:immunoglobulin complex;	 	  P:adaptive immune response;
XM_040182301.1	chrVII	9540290	9540290	chrVII	9546103	9547520	+	XM_040182301.1	path1	P01696	Ig kappa chain V region K29-213		 PF07686;	 GO:0019814;GO:0002250;	  C:immunoglobulin complex;	 	  P:adaptive immune response;
XM_040182295.1	chrVII	9545020	9545020	chrVII	9553142	9554373	+	XM_040182295.1	path1	P01683	Ig kappa chain V region 3315		 PF07686;	 GO:0019814;GO:0002250;	  C:immunoglobulin complex;	 	  P:adaptive immune response;
XM_040182296.1	chrVII	9545020	9545020	chrVII	9553166	9554373	+	XM_040182296.1	path1	A0A0B4J241	T cell receptor alpha variable 13-1 {ECO:0000303|Ref.2}		 PF07686;	 GO:0042101;GO:0002250;GO:0009617;	  C:T cell receptor complex;	 	  P:adaptive immune response; P:response to bacterium;
XM_040182473.1	chrVII	9559175	9559175	chrVII	9559675	9568295	+	XM_040182473.1	path1	O93209	Pro-Pol polyprotein	Pr125Pol;	 PF17921;PF00075;PF00665;PF00078;PF18103;PF03539;	 GO:0030430;GO:0042025;GO:0019012;GO:0004190;GO:0003887;GO:0046872;GO:0003723;GO:0003964;GO:0004523;GO:0015074;GO:0006310;GO:0075713;GO:0046718;GO:0044826;GO:0075732;	  C:host cell cytoplasm; C:host cell nucleus; C:virion;	  F:aspartic-type endopeptidase activity; F:DNA-directed DNA polymerase activity; F:metal ion binding; F:RNA binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity;	  P:DNA integration; P:DNA recombination; P:establishment of integrated proviral latency; P:viral entry into host cell; P:viral genome integration into host DNA; P:viral penetration into host nucleus;
XM_040182291.1	chrVII	9559175	9559175	chrVII	9568640	9573044	+	XM_040182291.1	path1	P0DOX7	Immunoglobulin kappa light chain {ECO:0000305}	Immunoglobulin kappa light chain EU {ECO:0000305|PubMed:5489770};	 PF07654;PF07686;	 GO:0005576;GO:0019814;GO:0005886;GO:0002250;	  C:extracellular region; C:immunoglobulin complex; C:plasma membrane;	 	  P:adaptive immune response;
XM_040182287.1	chrVII	9594991	9594991	chrVII	9590158	9592269	+	XM_040182287.1	path1	P0DOX2	Immunoglobulin alpha-2 heavy chain {ECO:0000305}	Immunoglobulin alpha-2 heavy chain BUT {ECO:0000305|PubMed:416441};	 PF07654;PF00047;PF07686;	 GO:0005576;GO:0019814;GO:0005886;GO:0002250;	  C:extracellular region; C:immunoglobulin complex; C:plasma membrane;	 	  P:adaptive immune response;
XM_040182288.1	chrVII	9594991	9594991	chrVII	9590181	9592269	+	XM_040182288.1	path1	A0A0B4J241	T cell receptor alpha variable 13-1 {ECO:0000303|Ref.2}		 PF07686;	 GO:0042101;GO:0002250;GO:0009617;	  C:T cell receptor complex;	 	  P:adaptive immune response; P:response to bacterium;
XM_040182293.1	chrVII	9594991	9594991	chrVII	9596493	9599219	+	XM_040182293.1	path1	P0DOX7	Immunoglobulin kappa light chain {ECO:0000305}	Immunoglobulin kappa light chain EU {ECO:0000305|PubMed:5489770};	 PF07654;PF07686;	 GO:0005576;GO:0019814;GO:0005886;GO:0002250;	  C:extracellular region; C:immunoglobulin complex; C:plasma membrane;	 	  P:adaptive immune response;
XM_040182297.1	chrVII	9594991	9594991	chrVII	9606654	9608633	+	XM_040182297.1	path1	P0DOX2	Immunoglobulin alpha-2 heavy chain {ECO:0000305}	Immunoglobulin alpha-2 heavy chain BUT {ECO:0000305|PubMed:416441};	 PF07654;PF00047;PF07686;	 GO:0005576;GO:0019814;GO:0005886;GO:0002250;	  C:extracellular region; C:immunoglobulin complex; C:plasma membrane;	 	  P:adaptive immune response;
XM_040182298.1	chrVII	9594991	9594991	chrVII	9606654	9608633	+	XM_040182298.1	path1	P01696	Ig kappa chain V region K29-213		 PF07686;	 GO:0019814;GO:0002250;	  C:immunoglobulin complex;	 	  P:adaptive immune response;
XM_040182299.1	chrVII	9610195	9610195	chrVII	9629104	9631463	+	XM_040182299.1	path1	P0DOX7	Immunoglobulin kappa light chain {ECO:0000305}	Immunoglobulin kappa light chain EU {ECO:0000305|PubMed:5489770};	 PF07654;PF07686;	 GO:0005576;GO:0019814;GO:0005886;GO:0002250;	  C:extracellular region; C:immunoglobulin complex; C:plasma membrane;	 	  P:adaptive immune response;
XM_040182300.1	chrVII	9619331	9619331	chrVII	9635471	9637482	+	XM_040182300.1	path1	P06323	T-cell receptor alpha chain V region CTL-F3		 PF07686;	 GO:0042101;GO:0002250;	  C:T cell receptor complex;	 	  P:adaptive immune response;
XM_040182292.1	chrVII	9675402	9675402	chrVII	9657933	9659833	+	XM_040182292.1	path1	P0DOX2	Immunoglobulin alpha-2 heavy chain {ECO:0000305}	Immunoglobulin alpha-2 heavy chain BUT {ECO:0000305|PubMed:416441};	 PF07654;PF00047;PF07686;	 GO:0005576;GO:0019814;GO:0005886;GO:0002250;	  C:extracellular region; C:immunoglobulin complex; C:plasma membrane;	 	  P:adaptive immune response;
XM_040182494.1	chrVII	9675402	9675402	chrVII	9660837	9662012	+	XM_040182494.1	path1	A0A0B4J241	T cell receptor alpha variable 13-1 {ECO:0000303|Ref.2}		 PF07686;	 GO:0042101;GO:0002250;GO:0009617;	  C:T cell receptor complex;	 	  P:adaptive immune response; P:response to bacterium;
XM_040179837.1	chrVII	9675402	9675402	chrVII	9667249	9669266	+	XM_040179837.1	path1	A0A075B6I0	Immunoglobulin lambda variable 8-61 {ECO:0000303|PubMed:11872955, ECO:0000303|Ref.3}		 PF07686;	 GO:0005615;GO:0019814;GO:0005886;GO:0002250;GO:0006955;	  C:extracellular space; C:immunoglobulin complex; C:plasma membrane;	 	  P:adaptive immune response; P:immune response;
XM_040183125.1	chrVII	9675402	9675402	chrVII	9682869	9685017	+	XM_040183125.1	path1	A0A0B4J241	T cell receptor alpha variable 13-1 {ECO:0000303|Ref.2}		 PF07686;	 GO:0042101;GO:0002250;GO:0009617;	  C:T cell receptor complex;	 	  P:adaptive immune response; P:response to bacterium;
XM_040183122.1	chrVII	9675402	9675402	chrVII	9687659	9690040	+	XM_040183122.1	path1	Q9Y624 B7Z941	Junctional adhesion molecule A	Junctional adhesion molecule 1;Platelet F11 receptor;Platelet adhesion molecule 1;	 PF07686;	 GO:0005923;GO:0030054;GO:0005911;GO:0031410;GO:0070062;GO:0016021;GO:0005886;GO:0032991;GO:0036057;GO:0070160;GO:0045296;GO:0005178;GO:0030165;GO:0042803;GO:0001618;GO:0031032;GO:0070830;GO:0098609;GO:0071260;GO:0090557;GO:0030198;GO:0006954;GO:0050892;GO:0007159;GO:0050900;GO:0035633;GO:0035683;GO:0034260;GO:0051497;GO:0045777;GO:1903142;GO:0043547;GO:1901731;GO:0035025;GO:1902396;GO:0072659;GO:0032956;GO:2000249;GO:2000810;GO:0008360;GO:0001817;GO:0051493;GO:0090559;GO:0009314;GO:0007179;	  C:bicellular tight junction; C:cell junction; C:cell-cell junction; C:cytoplasmic vesicle; C:extracellular exosome; C:integral component of membrane; C:plasma membrane; C:protein-containing complex; C:slit diaphragm; C:tight junction;	  F:cadherin binding; F:integrin binding; F:PDZ domain binding; F:protein homodimerization activity; F:virus receptor activity;	  P:actomyosin structure organization; P:bicellular tight junction assembly; P:cell-cell adhesion; P:cellular response to mechanical stimulus; P:establishment of endothelial intestinal barrier; P:extracellular matrix organization; P:inflammatory response; P:intestinal absorption; P:leukocyte cell-cell adhesion; P:leukocyte migration; P:maintenance of blood-brain barrier; P:memory T cell extravasation; P:negative regulation of GTPase activity; P:negative regulation of stress fiber assembly; P:positive regulation of blood pressure; P:positive regulation of establishment of endothelial barrier; P:positive regulation of GTPase activity; P:positive regulation of platelet aggregation; P:positive regulation of Rho protein signal transduction; P:protein localization to bicellular tight junction; P:protein localization to plasma membrane; P:regulation of actin cytoskeleton organization; P:regulation of actin cytoskeleton reorganization; P:regulation of bicellular tight junction assembly; P:regulation of cell shape; P:regulation of cytokine production; P:regulation of cytoskeleton organization; P:regulation of membrane permeability; P:response to radiation; P:transforming growth factor beta receptor signaling pathway;
XM_040183127.1	chrVII	9675402	9675402	chrVII	9692052	9695025	+	XM_040183127.1	path1	P0DOX2	Immunoglobulin alpha-2 heavy chain {ECO:0000305}	Immunoglobulin alpha-2 heavy chain BUT {ECO:0000305|PubMed:416441};	 PF07654;PF00047;PF07686;	 GO:0005576;GO:0019814;GO:0005886;GO:0002250;	  C:extracellular region; C:immunoglobulin complex; C:plasma membrane;	 	  P:adaptive immune response;
XM_040183120.1	chrVII	9675402	9675402	chrVII	9697328	9704647	+	XM_040183120.1	path1	A0A0B4J241	T cell receptor alpha variable 13-1 {ECO:0000303|Ref.2}		 PF07686;	 GO:0042101;GO:0002250;GO:0009617;	  C:T cell receptor complex;	 	  P:adaptive immune response; P:response to bacterium;
XM_040183124.1	chrVII	9675809	9675809	chrVII	9706273	9708503	+	XM_040183124.1	path1	A0A0B4J241	T cell receptor alpha variable 13-1 {ECO:0000303|Ref.2}		 PF07686;	 GO:0042101;GO:0002250;GO:0009617;	  C:T cell receptor complex;	 	  P:adaptive immune response; P:response to bacterium;
XM_040183227.1	chrVII	9696181	9696181	chrVII	9714111	9715748	-	XM_040183227.1	path1	A0A1B0GX68	T cell receptor beta variable 2 {ECO:0000303|Ref.2}		 PF07686;	 GO:0005886;GO:0042101;GO:0002250;GO:0007166;	  C:plasma membrane; C:T cell receptor complex;	 	  P:adaptive immune response; P:cell surface receptor signaling pathway;
XM_040183131.1	chrVII	9696181	9696181	chrVII	9726067	9729715	-	XM_040183131.1	path1	Q8VE92	RNA-binding protein 4B	RNA-binding motif protein 30;RNA-binding motif protein 4B;RNA-binding protein 30;	 PF00076;PF00098;	 GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0032991;GO:0003729;GO:0003723;GO:0008270;GO:0032922;GO:0007623;GO:0043153;GO:0000398;GO:0010628;GO:0006417;	  C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:protein-containing complex;	  F:mRNA binding; F:RNA binding; F:zinc ion binding;	  P:circadian regulation of gene expression; P:circadian rhythm; P:entrainment of circadian clock by photoperiod; P:mRNA splicing, via spliceosome; P:positive regulation of gene expression; P:regulation of translation;
XM_040183134.1	chrVII	9720560	9720560	chrVII	9730914	9732044	+	XM_040183134.1	path1	A2VDM0	TRAF-interacting protein with FHA domain-containing protein A {ECO:0000305}		 PF00498;	 GO:0005737;GO:0002753;GO:0007249;GO:0045087;GO:0043123;GO:0051260;	  C:cytoplasm;	 	  P:cytoplasmic pattern recognition receptor signaling pathway; P:I-kappaB kinase/NF-kappaB signaling; P:innate immune response; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:protein homooligomerization;
XM_040183132.1	chrVII	9720560	9720560	chrVII	9733355	9737514	-	XM_040183132.1	path1	Q8C7Q4 O08752 Q8BN66	RNA-binding protein 4	Lark homolog;RNA-binding motif protein 4;RNA-binding motif protein 4a;	 PF00076;PF00098;	 GO:0005737;GO:0010494;GO:0005829;GO:0016607;GO:0005730;GO:0005654;GO:0005634;GO:0048471;GO:0030332;GO:0035198;GO:0003730;GO:0003729;GO:0036002;GO:0097157;GO:0097158;GO:0003723;GO:0008270;GO:0002190;GO:0032922;GO:0097167;GO:0035883;GO:0043153;GO:0042593;GO:0035773;GO:0002192;GO:0035278;GO:0000398;GO:0017148;GO:0032055;GO:0045947;GO:0031016;GO:0051149;GO:0045727;GO:0000381;GO:0010468;GO:0046626;GO:0046822;GO:0046685;	  C:cytoplasm; C:cytoplasmic stress granule; C:cytosol; C:nuclear speck; C:nucleolus; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm;	  F:cyclin binding; F:miRNA binding; F:mRNA 3'-UTR binding; F:mRNA binding; F:pre-mRNA binding; F:pre-mRNA intronic binding; F:pre-mRNA intronic pyrimidine-rich binding; F:RNA binding; F:zinc ion binding;	  P:cap-independent translational initiation; P:circadian regulation of gene expression; P:circadian regulation of translation; P:enteroendocrine cell differentiation; P:entrainment of circadian clock by photoperiod; P:glucose homeostasis; P:insulin secretion involved in cellular response to glucose stimulus; P:IRES-dependent translational initiation of linear mRNA; P:miRNA mediated inhibition of translation; P:mRNA splicing, via spliceosome; P:negative regulation of translation; P:negative regulation of translation in response to stress; P:negative regulation of translational initiation; P:pancreas development; P:positive regulation of muscle cell differentiation; P:positive regulation of translation; P:regulation of alternative mRNA splicing, via spliceosome; P:regulation of gene expression; P:regulation of insulin receptor signaling pathway; P:regulation of nucleocytoplasmic transport; P:response to arsenic-containing substance;
XM_040183130.1	chrVII	9720560	9720560	chrVII	9738674	9752325	-	XM_040183130.1	path1	Q7ZTQ5	Fragile X mental retardation syndrome-related protein 1 homolog B		 PF05641;PF12235;PF16096;PF16097;PF00013;PF17904;PF18336;	 GO:0005737;GO:0005634;GO:0003729;GO:0046982;GO:0042803;GO:0003723;GO:0033592;GO:0030154;GO:0007517;GO:2000637;GO:0006417;	  C:cytoplasm; C:nucleus;	  F:mRNA binding; F:protein heterodimerization activity; F:protein homodimerization activity; F:RNA binding; F:RNA strand annealing activity;	  P:cell differentiation; P:muscle organ development; P:positive regulation of gene silencing by miRNA; P:regulation of translation;
XM_040179901.1	chrVII	9720560	9720560	chrVII	9753998	9757290	+	XM_040179901.1	path1	Q9H6D7 B7WP17 D3DS34 Q86T15 Q86T16 Q86U43 Q9NX59	HAUS augmin-like complex subunit 4		 PF14735;	 GO:0005813;GO:0005829;GO:0070652;GO:1990498;GO:0051011;GO:0051301;GO:0007098;GO:0097711;GO:0000086;GO:0010389;GO:0051225;	  C:centrosome; C:cytosol; C:HAUS complex; C:mitotic spindle microtubule;	  F:microtubule minus-end binding;	  P:cell division; P:centrosome cycle; P:ciliary basal body-plasma membrane docking; P:G2/M transition of mitotic cell cycle; P:regulation of G2/M transition of mitotic cell cycle; P:spindle assembly;
XM_040182504.1	chrVII	9722842	9722842	chrVII	9758108	9804418	+	XM_040182504.1	path1	Q5JSL3 A6NMF0 Q66M66 Q6ZUJ5 Q86VU8 Q96MN3	Dedicator of cytokinesis protein 11 {ECO:0000305}	Activated Cdc42-associated guanine nucleotide exchange factor;Zizimin-2 {ECO:0000305};	 PF06920;PF14429;PF11878;PF00169;	 GO:0005829;GO:0005085;GO:0001782;GO:0007596;GO:0002315;GO:0051491;GO:0043547;GO:0007264;	  C:cytosol;	  F:guanyl-nucleotide exchange factor activity;	  P:B cell homeostasis; P:blood coagulation; P:marginal zone B cell differentiation; P:positive regulation of filopodium assembly; P:positive regulation of GTPase activity; P:small GTPase mediated signal transduction;
XM_040181844.1	chrVII	9784183	9784183	chrVII	9824185	9850541	+	XM_040181844.1	path1	Q80W68 Q8CIJ4 Q8CJ59 Q923L4	Kin of IRRE-like protein 1	Kin of irregular chiasm-like protein 1;Nephrin-like protein 1;	 PF08205;PF07679;	 GO:0031253;GO:0005911;GO:0043198;GO:0005887;GO:0045121;GO:0048471;GO:0005886;GO:0050839;GO:0017022;GO:0098609;GO:0007588;GO:0001933;GO:0030838;	  C:cell projection membrane; C:cell-cell junction; C:dendritic shaft; C:integral component of plasma membrane; C:membrane raft; C:perinuclear region of cytoplasm; C:plasma membrane;	  F:cell adhesion molecule binding; F:myosin binding;	  P:cell-cell adhesion; P:excretion; P:negative regulation of protein phosphorylation; P:positive regulation of actin filament polymerization;
XM_040181176.1	chrVII	9845365	9845365	chrVII	9851487	9859020	+	XM_040181176.1	path1	P17694 Q0P5K5	NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial	Complex I-49kD;NADH-ubiquinone oxidoreductase 49 kDa subunit;	 PF00346;	 GO:0005743;GO:0005747;GO:0005739;GO:0051539;GO:0046872;GO:0051287;GO:0008137;GO:0019826;GO:0048038;GO:0071453;GO:0042063;GO:0006120;GO:0032981;GO:0061351;GO:0022008;GO:0006979;	  C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex I; C:mitochondrion;	  F:4 iron, 4 sulfur cluster binding; F:metal ion binding; F:NAD binding; F:NADH dehydrogenase (ubiquinone) activity; F:oxygen sensor activity; F:quinone binding;	  P:cellular response to oxygen levels; P:gliogenesis; P:mitochondrial electron transport, NADH to ubiquinone; P:mitochondrial respiratory chain complex I assembly; P:neural precursor cell proliferation; P:neurogenesis; P:response to oxidative stress;
XM_040181178.1	chrVII	9845365	9845365	chrVII	9859265	9865971	+	XM_040181178.1	path1	P20491	High affinity immunoglobulin epsilon receptor subunit gamma	Fc receptor gamma-chain;Fc-epsilon RI-gamma;IgE Fc receptor subunit gamma;	 PF02189;PF11628;	 GO:0009986;GO:0009897;GO:0032998;GO:0005887;GO:0045121;GO:0005886;GO:0042802;GO:0019863;GO:0019767;GO:0019864;GO:0046872;GO:0042590;GO:0019886;GO:0007166;GO:0071404;GO:0042742;GO:0002431;GO:0038095;GO:0038094;GO:0016064;GO:0045087;GO:0007229;GO:0038156;GO:0045576;GO:0033026;GO:0002283;GO:0030593;GO:0030316;GO:0006911;GO:0050778;GO:0032733;GO:0032753;GO:0032755;GO:0032765;GO:0043306;GO:0050766;GO:2000010;GO:0032760;GO:0001812;GO:0001798;GO:0001805;GO:0072659;GO:0031623;GO:0050776;GO:0010543;GO:0002554;GO:0007165;GO:0002292;	  C:cell surface; C:external side of plasma membrane; C:Fc-epsilon receptor I complex; C:integral component of plasma membrane; C:membrane raft; C:plasma membrane;	  F:identical protein binding; F:IgE binding; F:IgE receptor activity; F:IgG binding; F:metal ion binding;	  P:antigen processing and presentation of exogenous peptide antigen via MHC class I; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; P:cell surface receptor signaling pathway; P:cellular response to low-density lipoprotein particle stimulus; P:defense response to bacterium; P:Fc receptor mediated stimulatory signaling pathway; P:Fc-epsilon receptor signaling pathway; P:Fc-gamma receptor signaling pathway; P:immunoglobulin mediated immune response; P:innate immune response; P:integrin-mediated signaling pathway; P:interleukin-3-mediated signaling pathway; P:mast cell activation; P:negative regulation of mast cell apoptotic process; P:neutrophil activation involved in immune response; P:neutrophil chemotaxis; P:osteoclast differentiation; P:phagocytosis, engulfment; P:positive regulation of immune response; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-4 production; P:positive regulation of interleukin-6 production; P:positive regulation of mast cell cytokine production; P:positive regulation of mast cell degranulation; P:positive regulation of phagocytosis; P:positive regulation of protein localization to cell surface; P:positive regulation of tumor necrosis factor production; P:positive regulation of type I hypersensitivity; P:positive regulation of type IIa hypersensitivity; P:positive regulation of type III hypersensitivity; P:protein localization to plasma membrane; P:receptor internalization; P:regulation of immune response; P:regulation of platelet activation; P:serotonin secretion by platelet; P:signal transduction; P:T cell differentiation involved in immune response;
XM_040181180.1	chrVII	9845365	9845365	chrVII	9867181	9880261	+	XM_040181180.1	path1	Q5FWR8	Nectin-4	Nectin cell adhesion molecule 4 {ECO:0000250|UniProtKB:Q96NY8};Poliovirus receptor-related protein 4;	 PF08205;PF13895;PF07686;	 GO:0005912;GO:0016021;GO:0005886;GO:0007157;GO:0007156;GO:0046718;	  C:adherens junction; C:integral component of membrane; C:plasma membrane;	 	  P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:viral entry into host cell;
XM_040182244.1	chrVII	9845365	9845365	chrVII	9880875	9884700	+	XM_040182244.1	path1	B2RYG6	Ubiquitin thioesterase OTUB1 {ECO:0000250|UniProtKB:Q7TQI3}	Deubiquitinating enzyme OTUB1 {ECO:0000250|UniProtKB:Q7TQI3};OTU domain-containing ubiquitin aldehyde-binding protein 1 {ECO:0000250|UniProtKB:Q7TQI3};Otubain-1 {ECO:0000250|UniProtKB:Q7TQI3};Ubiquitin-specific-processing protease OTUB1 {ECO:0000250|UniProtKB:Q7TQI3};	 PF10275;	 GO:0005737;GO:0005634;GO:0019784;GO:0004843;GO:0043130;GO:0031625;GO:0002250;GO:0006974;GO:0071347;GO:0006281;GO:2000780;GO:1901315;GO:0071108;	  C:cytoplasm; C:nucleus;	  F:NEDD8-specific protease activity; F:thiol-dependent deubiquitinase; F:ubiquitin binding; F:ubiquitin protein ligase binding;	  P:adaptive immune response; P:cellular response to DNA damage stimulus; P:cellular response to interleukin-1; P:DNA repair; P:negative regulation of double-strand break repair; P:negative regulation of histone H2A K63-linked ubiquitination; P:protein K48-linked deubiquitination;
XM_040182243.1	chrVII	9845365	9845365	chrVII	9884956	9886531	+	XM_040182243.1	path1	Q501S4	Citrate synthase-lysine N-methyltransferase CSKMT, mitochondrial {ECO:0000250|UniProtKB:A8MUP2}	Methyltransferase-like protein 12, mitochondrial {ECO:0000250|UniProtKB:A8MUP2};	 PF13847;	 GO:0005739;GO:0016278;GO:0016279;GO:0018027;GO:0018026;GO:0018023;GO:0006479;	  C:mitochondrion;	  F:lysine N-methyltransferase activity; F:protein-lysine N-methyltransferase activity;	  P:peptidyl-lysine dimethylation; P:peptidyl-lysine monomethylation; P:peptidyl-lysine trimethylation; P:protein methylation;
XM_040182240.1	chrVII	9845365	9845365	chrVII	9886664	9890105	+	XM_040182240.1	path1	Q5IS41	Neurocan core protein	Chondroitin sulfate proteoglycan 3;	 PF00008;PF00059;PF00084;PF07686;PF00193;	 GO:0005576;GO:0005509;GO:0030246;GO:0005540;GO:0007155;	  C:extracellular region;	  F:calcium ion binding; F:carbohydrate binding; F:hyaluronic acid binding;	  P:cell adhesion;
XM_040182242.1	chrVII	9845365	9845365	chrVII	9886664	9890105	+	XM_040182242.1	path1	P16112 B9EK55 E7ENV9 E7EX88 H0YM81 Q13650 Q9UCD3 Q9UCP4 Q9UCP5 Q9UDE0	Aggrecan core protein	Cartilage-specific proteoglycan core protein;Chondroitin sulfate proteoglycan core protein 1;	 PF00059;PF00084;PF07686;PF00193;	 GO:0062023;GO:0031012;GO:0005576;GO:0005796;GO:0043202;GO:0030246;GO:0005201;GO:0005540;GO:0046872;GO:0007155;GO:0007417;GO:0030198;GO:0018146;GO:0042340;GO:0006508;GO:0001501;	  C:collagen-containing extracellular matrix; C:extracellular matrix; C:extracellular region; C:Golgi lumen; C:lysosomal lumen;	  F:carbohydrate binding; F:extracellular matrix structural constituent; F:hyaluronic acid binding; F:metal ion binding;	  P:cell adhesion; P:central nervous system development; P:extracellular matrix organization; P:keratan sulfate biosynthetic process; P:keratan sulfate catabolic process; P:proteolysis; P:skeletal system development;
XM_040181046.1	chrVII	20002375	20002375	chrVII	19959021	19961702	+	XM_040181046.1	path1	P56500 O70178 O88183 Q6GST1	Mitochondrial uncoupling protein 2	Solute carrier family 25 member 8;	 PF00153;	 GO:0005737;GO:0016021;GO:0005743;GO:0005739;GO:0017077;GO:1990845;GO:0007568;GO:0034198;GO:0071333;GO:0032870;GO:0032869;GO:0007565;GO:0097421;GO:1990542;GO:0006839;GO:0043066;GO:0061179;GO:0010942;GO:0120162;GO:0051881;GO:0009409;GO:0070542;GO:0009749;GO:0001666;GO:0000303;	  C:cytoplasm; C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrion;	  F:oxidative phosphorylation uncoupler activity;	  P:adaptive thermogenesis; P:aging; P:cellular response to amino acid starvation; P:cellular response to glucose stimulus; P:cellular response to hormone stimulus; P:cellular response to insulin stimulus; P:female pregnancy; P:liver regeneration; P:mitochondrial transmembrane transport; P:mitochondrial transport; P:negative regulation of apoptotic process; P:negative regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of cell death; P:positive regulation of cold-induced thermogenesis; P:regulation of mitochondrial membrane potential; P:response to cold; P:response to fatty acid; P:response to glucose; P:response to hypoxia; P:response to superoxide;
XM_040181041.1	chrVII	20002375	20002375	chrVII	19962538	19965112	+	XM_040181041.1	path1	Q9W725	Mitochondrial uncoupling protein 2	Solute carrier family 25 member 8;	 PF00153;	 GO:0016021;GO:0005743;GO:0006839;	  C:integral component of membrane; C:mitochondrial inner membrane;	 	  P:mitochondrial transport;
XM_040181040.1	chrVII	20002375	20002375	chrVII	19964626	19967014	-	XM_040181040.1	path1	Q80Y75 Q8CJA2	DnaJ homolog subfamily B member 13	Testis and spermatogenesis cell-related protein 6;Testis spermatocyte apoptosis-related gene 6 protein;Testis spermatogenesis apoptosis-related gene 3 protein;Testis spermatogenesis apoptosis-related gene 6 protein;	 PF00226;PF01556;	 GO:0005930;GO:0005737;GO:0005829;GO:0031514;GO:0097224;GO:0036126;GO:0051087;GO:0051082;GO:1904158;GO:0051085;	  C:axoneme; C:cytoplasm; C:cytosol; C:motile cilium; C:sperm connecting piece; C:sperm flagellum;	  F:chaperone binding; F:unfolded protein binding;	  P:axonemal central apparatus assembly; P:chaperone cofactor-dependent protein refolding;
XM_040181047.1	chrVII	20002375	20002375	chrVII	19967382	19973995	-	XM_040181047.1	path1	Q1KME6	Ras-related protein Rab-6A		 PF00071;	 GO:0005829;GO:0012505;GO:0070381;GO:0005794;GO:0000139;GO:0005802;GO:0005525;GO:0003924;GO:0031489;GO:0019904;GO:0019882;GO:0034498;GO:0006891;GO:0006886;GO:0018125;GO:0034067;GO:0042147;GO:0006890;	  C:cytosol; C:endomembrane system; C:endosome to plasma membrane transport vesicle; C:Golgi apparatus; C:Golgi membrane; C:trans-Golgi network;	  F:GTP binding; F:GTPase activity; F:myosin V binding; F:protein domain specific binding;	  P:antigen processing and presentation; P:early endosome to Golgi transport; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:peptidyl-cysteine methylation; P:protein localization to Golgi apparatus; P:retrograde transport, endosome to Golgi; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;
XM_040182364.1	chrVII	20002375	20002375	chrVII	19978272	19992922	+	XM_040182364.1	path1	Q866T7	Gap junction delta-2 protein	Connexin-36;Gap junction alpha-9 protein;	 PF00029;	 GO:0005922;GO:0016021;GO:0045202;GO:0005243;GO:0001508;GO:0007267;GO:0007268;GO:0007601;	  C:connexin complex; C:integral component of membrane; C:synapse;	  F:gap junction channel activity;	  P:action potential; P:cell-cell signaling; P:chemical synaptic transmission; P:visual perception;
XM_040182381.1	chrVII	20002375	20002375	chrVII	20000284	20004925	+	XM_040182381.1	path1	Q9TS87 Q2KJH8	Transgelin	25 kDa F-actin-binding protein;Smooth muscle protein 22-alpha;	 PF00402;PF00307;	 GO:0005737;GO:0051015;GO:0030855;	  C:cytoplasm;	  F:actin filament binding;	  P:epithelial cell differentiation;
XM_040181926.1	chrVII	20002375	20002375	chrVII	20011600	20016358	-	XM_040181926.1	path1	O35264	Platelet-activating factor acetylhydrolase IB subunit alpha2 {ECO:0000305}	PAF acetylhydrolase 30 kDa subunit;PAF-AH subunit beta;Platelet-activating factor acetylhydrolase alpha 2 subunit;	 PF13472;	 GO:0008247;GO:0005737;GO:0005829;GO:0001650;GO:0005886;GO:0003847;GO:0042802;GO:0047179;GO:0046982;GO:0042803;GO:0044877;GO:0007420;GO:0016042;GO:0016239;GO:0007283;	  C:1-alkyl-2-acetylglycerophosphocholine esterase complex; C:cytoplasm; C:cytosol; C:fibrillar center; C:plasma membrane;	  F:1-alkyl-2-acetylglycerophosphocholine esterase activity; F:identical protein binding; F:platelet-activating factor acetyltransferase activity; F:protein heterodimerization activity; F:protein homodimerization activity; F:protein-containing complex binding;	  P:brain development; P:lipid catabolic process; P:positive regulation of macroautophagy; P:spermatogenesis;
XM_040181927.1	chrVII	20002375	20002375	chrVII	20019346	20024441	+	XM_040181927.1	path1	Q5EAB0	Myelin protein zero-like protein 2	Epithelial V-like antigen 1;	 PF07686;	 GO:0016021;GO:0098609;	  C:integral component of membrane;	 	  P:cell-cell adhesion;
XM_040182713.1	chrVII	20002375	20002375	chrVII	20027756	20035374	+	XM_040182713.1	path1	Q7M729	Sodium channel subunit beta-4		 PF07686;	 GO:0014704;GO:0031226;GO:0005886;GO:0001518;GO:0044325;GO:0017080;GO:0005244;GO:0005248;GO:0086006;GO:0086016;GO:0086002;GO:0060048;GO:0086012;GO:0010765;GO:0086091;GO:2000649;GO:0060307;GO:0035725;GO:0006814;	  C:intercalated disc; C:intrinsic component of plasma membrane; C:plasma membrane; C:voltage-gated sodium channel complex;	  F:ion channel binding; F:sodium channel regulator activity; F:voltage-gated ion channel activity; F:voltage-gated sodium channel activity; F:voltage-gated sodium channel activity involved in cardiac muscle cell action potential;	  P:AV node cell action potential; P:cardiac muscle cell action potential involved in contraction; P:cardiac muscle contraction; P:membrane depolarization during cardiac muscle cell action potential; P:positive regulation of sodium ion transport; P:regulation of heart rate by cardiac conduction; P:regulation of sodium ion transmembrane transporter activity; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:sodium ion transmembrane transport; P:sodium ion transport;
XM_040182707.1	chrVII	20002375	20002375	chrVII	20040132	20069028	+	XM_040182707.1	path1	E1C8P7	Down syndrome cell adhesion molecule-like protein 1 homolog		 PF00041;PF07679;	 GO:0016021;GO:0005886;GO:0045202;GO:0060219;GO:0007417;GO:0007156;GO:0010842;GO:0007416;	  C:integral component of membrane; C:plasma membrane; C:synapse;	 	  P:camera-type eye photoreceptor cell differentiation; P:central nervous system development; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:retina layer formation; P:synapse assembly;
XM_040182711.1	chrVII	20169587	20169587	chrVII	20100762	20116521	+	XM_040182711.1	path1	A5PF48	Unconventional myosin-Ic	Myosin I beta;	 PF00612;PF00063;PF06017;	 GO:0015629;GO:0005737;GO:0031410;GO:0005902;GO:0016459;GO:0005886;GO:0001726;GO:0060171;GO:0031982;GO:0051015;GO:0030898;GO:0005524;GO:0000146;GO:0007015;GO:0032835;GO:0030050;	  C:actin cytoskeleton; C:cytoplasm; C:cytoplasmic vesicle; C:microvillus; C:myosin complex; C:plasma membrane; C:ruffle; C:stereocilium membrane; C:vesicle;	  F:actin filament binding; F:actin-dependent ATPase activity; F:ATP binding; F:microfilament motor activity;	  P:actin filament organization; P:glomerulus development; P:vesicle transport along actin filament;
XM_040182805.1	chrVII	20169587	20169587	chrVII	20121451	20122979	+	XM_040182805.1	path1	P28772	Ependymin-2	Ependymin II;	 PF00811;	 GO:0005576;GO:0005509;GO:0007160;	  C:extracellular region;	  F:calcium ion binding;	  P:cell-matrix adhesion;
XM_040180636.1	chrVII	20169587	20169587	chrVII	20125967	20140480	+	XM_040180636.1	path1	O35638 A2AFF5 Q6NZN7	Cohesin subunit SA-2	SCC3 homolog 2;Stromal antigen 2;	 PF08514;	 GO:0000785;GO:0000775;GO:0008278;GO:0097431;GO:0016363;GO:0005654;GO:0005634;GO:0003682;GO:0051301;GO:0051321;GO:0090307;GO:0007062;GO:0019827;	  C:chromatin; C:chromosome, centromeric region; C:cohesin complex; C:mitotic spindle pole; C:nuclear matrix; C:nucleoplasm; C:nucleus;	  F:chromatin binding;	  P:cell division; P:meiotic cell cycle; P:mitotic spindle assembly; P:sister chromatid cohesion; P:stem cell population maintenance;
XR_005712582.1	chrVII	20169587	20169587	chrVII	20140729	20158790	+	XR_005712582.1	path1	B2KI97	THO complex subunit 2		 PF11262;PF11732;PF16134;	 GO:0016607;GO:0000347;GO:0003723;GO:0048699;GO:0006406;GO:0006397;GO:0048666;GO:0008380;	  C:nuclear speck; C:THO complex;	  F:RNA binding;	  P:generation of neurons; P:mRNA export from nucleus; P:mRNA processing; P:neuron development; P:RNA splicing;
XM_040180637.1	chrVII	20169587	20169587	chrVII	20162821	20215828	-	XM_040180637.1	path1	Q9Z2W9 A2VDF4 Q5DTJ0	Glutamate receptor 3	AMPA-selective glutamate receptor 3;GluR-C;GluR-K3;Glutamate receptor ionotropic, AMPA 3;	 PF01094;PF00060;PF10613;	 GO:0032281;GO:0032279;GO:0030425;GO:0043198;GO:0043197;GO:0098978;GO:0099061;GO:0099055;GO:0099056;GO:0016020;GO:0043025;GO:0098688;GO:0043204;GO:0005886;GO:0014069;GO:0045211;GO:0032991;GO:0043083;GO:0043195;GO:0004971;GO:0001540;GO:0004970;GO:0015276;GO:0030165;GO:0038023;GO:1904315;GO:0001919;	  C:AMPA glutamate receptor complex; C:asymmetric synapse; C:dendrite; C:dendritic shaft; C:dendritic spine; C:glutamatergic synapse; C:integral component of postsynaptic density membrane; C:integral component of postsynaptic membrane; C:integral component of presynaptic membrane; C:membrane; C:neuronal cell body; C:parallel fiber to Purkinje cell synapse; C:perikaryon; C:plasma membrane; C:postsynaptic density; C:postsynaptic membrane; C:protein-containing complex; C:synaptic cleft; C:terminal bouton;	  F:AMPA glutamate receptor activity; F:amyloid-beta binding; F:ionotropic glutamate receptor activity; F:ligand-gated ion channel activity; F:PDZ domain binding; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;	  P:regulation of receptor recycling;
XM_040180501.1	chrVII	20204811	20204811	chrVII	20230849	20238184	-	XM_040180501.1	path1	Q8K2I2 G3UWG0	Coiled-coil alpha-helical rod protein 1	Alpha-helical coiled-coil rod protein;	 PF07111;	 GO:0005814;GO:0005737;GO:0005829;GO:0005634;GO:0042802;GO:0030154;GO:0007275;GO:0006611;	  C:centriole; C:cytoplasm; C:cytosol; C:nucleus;	  F:identical protein binding;	  P:cell differentiation; P:multicellular organism development; P:protein export from nucleus;
XM_040179588.1	chrVII	20204811	20204811	chrVII	20241008	20253082	+	XM_040179588.1	path1	Q8BYM5 A2AGI1 Q8BXR4	Neuroligin-3	Gliotactin homolog;	 PF00135;	 GO:0009986;GO:0030139;GO:0060076;GO:0098982;GO:0098978;GO:0060077;GO:0005887;GO:0099055;GO:0099060;GO:0043025;GO:0098793;GO:0045202;GO:0050839;GO:0042043;GO:0097110;GO:0038023;GO:0030534;GO:0048675;GO:0007268;GO:0060079;GO:0060080;GO:0007612;GO:0060291;GO:0050804;GO:0061002;GO:0090394;GO:0007158;GO:0048709;GO:2000969;GO:0060999;GO:2000463;GO:0097151;GO:1902474;GO:0051965;GO:0051968;GO:2000809;GO:0097104;GO:0098698;GO:0097105;GO:0006898;GO:2000311;GO:0061001;GO:1900271;GO:2000310;GO:0002087;GO:0051966;GO:2000331;GO:0060024;GO:0035176;GO:0007416;GO:0050808;GO:0048488;GO:0008542;GO:0071625;	  C:cell surface; C:endocytic vesicle; C:excitatory synapse; C:GABA-ergic synapse; C:glutamatergic synapse; C:inhibitory synapse; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:integral component of postsynaptic specialization membrane; C:neuronal cell body; C:presynapse; C:synapse;	  F:cell adhesion molecule binding; F:neurexin family protein binding; F:scaffold protein binding; F:signaling receptor activity;	  P:adult behavior; P:axon extension; P:chemical synaptic transmission; P:excitatory postsynaptic potential; P:inhibitory postsynaptic potential; P:learning; P:long-term synaptic potentiation; P:modulation of chemical synaptic transmission; P:negative regulation of dendritic spine morphogenesis; P:negative regulation of excitatory postsynaptic potential; P:neuron cell-cell adhesion; P:oligodendrocyte differentiation; P:positive regulation of AMPA receptor activity; P:positive regulation of dendritic spine development; P:positive regulation of excitatory postsynaptic potential; P:positive regulation of inhibitory postsynaptic potential; P:positive regulation of protein localization to synapse; P:positive regulation of synapse assembly; P:positive regulation of synaptic transmission, glutamatergic; P:positive regulation of synaptic vesicle clustering; P:postsynaptic membrane assembly; P:postsynaptic specialization assembly; P:presynaptic membrane assembly; P:receptor-mediated endocytosis; P:regulation of AMPA receptor activity; P:regulation of dendritic spine morphogenesis; P:regulation of long-term synaptic potentiation; P:regulation of NMDA receptor activity; P:regulation of respiratory gaseous exchange by nervous system process; P:regulation of synaptic transmission, glutamatergic; P:regulation of terminal button organization; P:rhythmic synaptic transmission; P:social behavior; P:synapse assembly; P:synapse organization; P:synaptic vesicle endocytosis; P:visual learning; P:vocalization behavior;
XM_040181897.1	chrVII	20239940	20239940	chrVII	20271901	20274230	+	XM_040181897.1	path1	Q6IQU4	Protein CWC15 homolog		 PF04889;	 GO:0071013;GO:0005634;GO:0071007;GO:0003723;GO:0045292;GO:0000398;	  C:catalytic step 2 spliceosome; C:nucleus; C:U2-type catalytic step 2 spliceosome;	  F:RNA binding;	  P:mRNA cis splicing, via spliceosome; P:mRNA splicing, via spliceosome;
XM_040181892.1	chrVII	20239940	20239940	chrVII	20274827	20280362	+	XM_040181892.1	path1	A6QLT2	Myotubularin-related protein 2	Phosphatidylinositol-3,5-bisphosphate 3-phosphatase;Phosphatidylinositol-3-phosphate phosphatase;	 PF02893;PF06602;	 GO:0030424;GO:0005829;GO:0031901;GO:0005634;GO:0048471;GO:0005774;GO:0042802;GO:0052629;GO:0004438;GO:0004725;GO:0046855;GO:0032288;GO:0031642;GO:0048666;GO:0046856;GO:0060304;	  C:axon; C:cytosol; C:early endosome membrane; C:nucleus; C:perinuclear region of cytoplasm; C:vacuolar membrane;	  F:identical protein binding; F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; F:phosphatidylinositol-3-phosphatase activity; F:protein tyrosine phosphatase activity;	  P:inositol phosphate dephosphorylation; P:myelin assembly; P:negative regulation of myelination; P:neuron development; P:phosphatidylinositol dephosphorylation; P:regulation of phosphatidylinositol dephosphorylation;
XM_040180658.1	chrVII	20239940	20239940	chrVII	20288293	20300200	+	XM_040180658.1	path1	Q80UV9 A2AM32 A2AM33 O35361 Q3UPF3 Q3V223 Q505F9 Q8BQH8 Q8BQQ7 Q8BR59 Q8C7N8 Q9WTW9 Q9WTX0 Q9WTX1	Transcription initiation factor TFIID subunit 1	Cell cycle gene 1 protein;TBP-associated factor 250 kDa;Transcription initiation factor TFIID 250 kDa subunit;	 PF00439;PF12157;PF09247;PF15288;	 GO:0000785;GO:0071339;GO:0005654;GO:0005634;GO:0045120;GO:0005669;GO:0005667;GO:0005524;GO:0003677;GO:0004402;GO:0016301;GO:0070577;GO:0035257;GO:0002039;GO:1990841;GO:0046982;GO:0004672;GO:0106310;GO:0004674;GO:0106311;GO:0001181;GO:0000979;GO:0016251;GO:0061629;GO:0017025;GO:0008134;GO:0140416;GO:0061631;GO:0007049;GO:0071318;GO:0006974;GO:0034644;GO:0016573;GO:0030901;GO:0043433;GO:0010629;GO:1905524;GO:1903026;GO:0000122;GO:2000059;GO:0018105;GO:0018107;GO:2000825;GO:0032436;GO:0032092;GO:0046777;GO:0006468;GO:0000209;GO:0050821;GO:0051123;GO:0006366;GO:0036369;GO:0006361;GO:0006367;GO:0006511;	  C:chromatin; C:MLL1 complex; C:nucleoplasm; C:nucleus; C:pronucleus; C:transcription factor TFIID complex; C:transcription regulator complex;	  F:ATP binding; F:DNA binding; F:histone acetyltransferase activity; F:kinase activity; F:lysine-acetylated histone binding; F:nuclear hormone receptor binding; F:p53 binding; F:promoter-specific chromatin binding; F:protein heterodimerization activity; F:protein kinase activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:RNA polymerase I general transcription initiation factor activity; F:RNA polymerase II core promoter sequence-specific DNA binding; F:RNA polymerase II general transcription initiation factor activity; F:RNA polymerase II-specific DNA-binding transcription factor binding; F:TBP-class protein binding; F:transcription factor binding; F:transcription regulator inhibitor activity; F:ubiquitin conjugating enzyme activity;	  P:cell cycle; P:cellular response to ATP; P:cellular response to DNA damage stimulus; P:cellular response to UV; P:histone acetylation; P:midbrain development; P:negative regulation of DNA-binding transcription factor activity; P:negative regulation of gene expression; P:negative regulation of protein autoubiquitination; P:negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of ubiquitin-dependent protein catabolic process; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of androgen receptor activity; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; P:positive regulation of protein binding; P:protein autophosphorylation; P:protein phosphorylation; P:protein polyubiquitination; P:protein stabilization; P:RNA polymerase II preinitiation complex assembly; P:transcription by RNA polymerase II; P:transcription factor catabolic process; P:transcription initiation from RNA polymerase I promoter; P:transcription initiation from RNA polymerase II promoter; P:ubiquitin-dependent protein catabolic process;
XM_040185242.1	chrVIII	11381120	11381120	chrVIII	11317270	11506768	+	XM_040185242.1	path1	Q13332 O75255 O75870 Q15718 Q16341 Q2M3R7	Receptor-type tyrosine-protein phosphatase S	Receptor-type tyrosine-protein phosphatase sigma;	 PF00041;PF07679;PF00102;	 GO:0030424;GO:0005829;GO:0070062;GO:0098978;GO:0030426;GO:0005887;GO:0099061;GO:0099056;GO:0030285;GO:0043204;GO:0005886;GO:0098685;GO:0035374;GO:0043395;GO:0008201;GO:0004721;GO:0004725;GO:0021549;GO:0021987;GO:0022038;GO:0090557;GO:0021766;GO:0050804;GO:0030517;GO:0048681;GO:0048671;GO:0061000;GO:0032687;GO:0032688;GO:0010977;GO:0034164;GO:0035335;GO:0006470;GO:0099151;GO:0021510;GO:0099560;	  C:axon; C:cytosol; C:extracellular exosome; C:glutamatergic synapse; C:growth cone; C:integral component of plasma membrane; C:integral component of postsynaptic density membrane; C:integral component of presynaptic membrane; C:integral component of synaptic vesicle membrane; C:perikaryon; C:plasma membrane; C:Schaffer collateral - CA1 synapse;	  F:chondroitin sulfate binding; F:heparan sulfate proteoglycan binding; F:heparin binding; F:phosphoprotein phosphatase activity; F:protein tyrosine phosphatase activity;	  P:cerebellum development; P:cerebral cortex development; P:corpus callosum development; P:establishment of endothelial intestinal barrier; P:hippocampus development; P:modulation of chemical synaptic transmission; P:negative regulation of axon extension; P:negative regulation of axon regeneration; P:negative regulation of collateral sprouting; P:negative regulation of dendritic spine development; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of neuron projection development; P:negative regulation of toll-like receptor 9 signaling pathway; P:peptidyl-tyrosine dephosphorylation; P:protein dephosphorylation; P:regulation of postsynaptic density assembly; P:spinal cord development; P:synaptic membrane adhesion;
XM_040184116.1	chrVIII	11504941	11504941	chrVIII	11517332	11526797	+	XM_040184116.1	path1	Q95125 Q95124	Thromboxane A2 receptor	Prostanoid TP receptor;	 PF00001;	 GO:0016021;GO:0016607;GO:0005886;GO:0004961;GO:0007189;GO:0006954;GO:0090051;GO:0045777;GO:0007204;GO:0045987;GO:0045907;GO:0032496;GO:0019932;	  C:integral component of membrane; C:nuclear speck; C:plasma membrane;	  F:thromboxane A2 receptor activity;	  P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; P:inflammatory response; P:negative regulation of cell migration involved in sprouting angiogenesis; P:positive regulation of blood pressure; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of smooth muscle contraction; P:positive regulation of vasoconstriction; P:response to lipopolysaccharide; P:second-messenger-mediated signaling;
XM_040193477.1	chrXII	10445225	10445225	chrXII	10435913	10444630	-	XM_040193477.1	path1	Q867C9	ATP-dependent 6-phosphofructokinase, muscle type {ECO:0000255|HAMAP-Rule:MF_03184}	6-phosphofructokinase type A;Phosphofructo-1-kinase isozyme A;Phosphohexokinase {ECO:0000255|HAMAP-Rule:MF_03184};	 PF00365;	 GO:0005945;GO:0016020;GO:0003872;GO:0016208;GO:0005524;GO:0070095;GO:0042802;GO:0046872;GO:0048029;GO:0061621;GO:0030388;GO:0006002;	  C:6-phosphofructokinase complex; C:membrane;	  F:6-phosphofructokinase activity; F:AMP binding; F:ATP binding; F:fructose-6-phosphate binding; F:identical protein binding; F:metal ion binding; F:monosaccharide binding;	  P:canonical glycolysis; P:fructose 1,6-bisphosphate metabolic process; P:fructose 6-phosphate metabolic process;
XM_040193240.1	chrXII	10455112	10455112	chrXII	10453435	10462001	+	XM_040193240.1	path1	Q7SYB5 Q6TNU8	Differentially expressed in FDCP 6 homolog		 PF00169;	 GO:0005737;GO:0005634;GO:0042074;GO:0060026;GO:0060027;	  C:cytoplasm; C:nucleus;	 	  P:cell migration involved in gastrulation; P:convergent extension; P:convergent extension involved in gastrulation;
XM_040193242.1	chrXII	10455820	10455820	chrXII	10463148	10469650	+	XM_040193242.1	path1	Q03181 A8K6J6 B4E3V3 B6ZGS1 B7Z3W1 E9PE18 Q5D1P0 Q7Z5K0 Q9BUD4	Peroxisome proliferator-activated receptor delta	NUCI;Nuclear hormone receptor 1;Nuclear receptor subfamily 1 group C member 2;Peroxisome proliferator-activated receptor beta;	 PF00104;PF00105;	 GO:0000785;GO:0005654;GO:0005634;GO:0003677;GO:0003700;GO:0000981;GO:0001227;GO:0008144;GO:0070539;GO:0008289;GO:0051059;GO:0004879;GO:0000978;GO:0001103;GO:1990837;GO:0003707;GO:0001223;GO:0008134;GO:0008270;GO:0060612;GO:0006915;GO:0097190;GO:0008366;GO:0030154;GO:0008283;GO:0031589;GO:0071456;GO:0071222;GO:0008203;GO:0046697;GO:0007566;GO:0006635;GO:0009062;GO:0006631;GO:0015908;GO:0006091;GO:0006006;GO:1904659;GO:0007507;GO:0009755;GO:0051546;GO:0043616;GO:0006629;GO:0043066;GO:0030308;GO:0010887;GO:0032966;GO:0050680;GO:0050728;GO:0045662;GO:1902894;GO:0014912;GO:0048662;GO:0000122;GO:0045892;GO:0008654;GO:0045684;GO:0045600;GO:0045923;GO:0046321;GO:0010628;GO:0035774;GO:2000288;GO:0014068;GO:0043415;GO:0045944;GO:0045893;GO:0006029;GO:0019216;GO:0014842;GO:0006357;GO:0014823;GO:0009749;GO:0033993;GO:0033189;GO:0006367;GO:0006776;GO:0042060;	  C:chromatin; C:nucleoplasm; C:nucleus;	  F:DNA binding; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; F:drug binding; F:linoleic acid binding; F:lipid binding; F:NF-kappaB binding; F:nuclear receptor activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II repressing transcription factor binding; F:sequence-specific double-stranded DNA binding; F:steroid hormone receptor activity; F:transcription coactivator binding; F:transcription factor binding; F:zinc ion binding;	  P:adipose tissue development; P:apoptotic process; P:apoptotic signaling pathway; P:axon ensheathment; P:cell differentiation; P:cell population proliferation; P:cell-substrate adhesion; P:cellular response to hypoxia; P:cellular response to lipopolysaccharide; P:cholesterol metabolic process; P:decidualization; P:embryo implantation; P:fatty acid beta-oxidation; P:fatty acid catabolic process; P:fatty acid metabolic process; P:fatty acid transport; P:generation of precursor metabolites and energy; P:glucose metabolic process; P:glucose transmembrane transport; P:heart development; P:hormone-mediated signaling pathway; P:keratinocyte migration; P:keratinocyte proliferation; P:lipid metabolic process; P:negative regulation of apoptotic process; P:negative regulation of cell growth; P:negative regulation of cholesterol storage; P:negative regulation of collagen biosynthetic process; P:negative regulation of epithelial cell proliferation; P:negative regulation of inflammatory response; P:negative regulation of myoblast differentiation; P:negative regulation of pri-miRNA transcription by RNA polymerase II; P:negative regulation of smooth muscle cell migration; P:negative regulation of smooth muscle cell proliferation; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:phospholipid biosynthetic process; P:positive regulation of epidermis development; P:positive regulation of fat cell differentiation; P:positive regulation of fatty acid metabolic process; P:positive regulation of fatty acid oxidation; P:positive regulation of gene expression; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; P:positive regulation of myoblast proliferation; P:positive regulation of phosphatidylinositol 3-kinase signaling; P:positive regulation of skeletal muscle tissue regeneration; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:proteoglycan metabolic process; P:regulation of lipid metabolic process; P:regulation of skeletal muscle satellite cell proliferation; P:regulation of transcription by RNA polymerase II; P:response to activity; P:response to glucose; P:response to lipid; P:response to vitamin A; P:transcription initiation from RNA polymerase II promoter; P:vitamin A metabolic process; P:wound healing;
XM_040193244.1	chrXII	10466629	10466629	chrXII	10470042	10473642	+	XM_040193244.1	path1	Q9UHC7 A4D1T7 B3KXB4 Q256Y7 Q59G11 Q6GSF1 Q9H0G0 Q9UEZ7 Q9UHW2	E3 ubiquitin-protein ligase makorin-1	RING finger protein 61;RING-type E3 ubiquitin transferase makorin-1 {ECO:0000305};	 PF15815;PF00097;PF00642;PF18044;	 GO:0005829;GO:0046872;GO:0003723;GO:0061630;GO:0000209;GO:0016567;	  C:cytosol;	  F:metal ion binding; F:RNA binding; F:ubiquitin protein ligase activity;	  P:protein polyubiquitination; P:protein ubiquitination;
XM_040193247.1	chrXII	10466629	10466629	chrXII	10470042	10473642	+	XM_040193247.1	path1	Q5NU14 Q5KSL0	Probable E3 ubiquitin-protein ligase makorin-1	RING-type E3 ubiquitin transferase makorin-1 {ECO:0000305};	 PF15815;PF00097;PF18044;	 GO:0046872;GO:0016740;GO:0016567;	 	  F:metal ion binding; F:transferase activity;	  P:protein ubiquitination;
XM_040193243.1	chrXII	10466629	10466629	chrXII	10470055	10473642	+	XM_040193243.1	path1	Q13434	Putative E3 ubiquitin-protein ligase makorin-4	Makorin RING finger protein pseudogene 4;Makorin RING finger protein pseudogene 5;RING finger protein 64;RING-type E3 ubiquitin transferase makorin-4 {ECO:0000305};Zinc finger protein 127-Xp;Zinc finger protein 127-like 1;	 PF15815;PF00097;PF18044;	 GO:0046872;GO:0061630;GO:0016567;	 	  F:metal ion binding; F:ubiquitin protein ligase activity;	  P:protein ubiquitination;
XM_040193619.1	chrXII	10466629	10466629	chrXII	10473803	10477603	+	XM_040193619.1	path1	Q9HB96 A8K907 Q4ZGH2	Fanconi anemia group E protein		 PF11510;	 GO:0043240;GO:0005654;GO:0005634;GO:0036297;	  C:Fanconi anaemia nuclear complex; C:nucleoplasm; C:nucleus;	 	  P:interstrand cross-link repair;
XM_040193625.1	chrXII	10467632	10467632	chrXII	10477962	10480203	+	XM_040193625.1	path1	Q90YV8	60S ribosomal protein L10a		 PF00687;	 GO:0015934;GO:0003723;GO:0003735;GO:0042541;GO:0006412;	  C:large ribosomal subunit;	  F:RNA binding; F:structural constituent of ribosome;	  P:hemoglobin biosynthetic process; P:translation;
XM_040193622.1	chrXII	10467633	10467633	chrXII	10480340	10484509	+	XM_040193622.1	path1	Q12912 A0AVM2 B4E077 Q8N301	Inositol 1,4,5-triphosphate receptor associated 2 {ECO:0000305}	Lymphoid-restricted membrane protein;Protein Jaw1;	 PF05781;	 GO:0035577;GO:0005694;GO:0005789;GO:0016021;GO:0005887;GO:0016020;GO:0005815;GO:0005635;GO:0005886;GO:0000922;GO:0008017;GO:0043312;GO:0006997;GO:0007338;GO:0006906;GO:0006903;	  C:azurophil granule membrane; C:chromosome; C:endoplasmic reticulum membrane; C:integral component of membrane; C:integral component of plasma membrane; C:membrane; C:microtubule organizing center; C:nuclear envelope; C:plasma membrane; C:spindle pole;	  F:microtubule binding;	  P:neutrophil degranulation; P:nucleus organization; P:single fertilization; P:vesicle fusion; P:vesicle targeting;
XM_040193621.1	chrXII	10468605	10468605	chrXII	10483597	10491222	-	XM_040193621.1	path1	Q3KP66 B4E1K9 E9PFY0 Q9NV65 Q9NVI0	Innate immunity activator protein {ECO:0000312|HGNC:HGNC:25599}		 PF11819;	 GO:0005737;GO:0005634;GO:0000187;GO:0034334;GO:0045087;GO:0060729;GO:0070431;GO:0002221;GO:0002720;GO:0043123;GO:0032731;GO:0032733;GO:0032755;GO:0031398;GO:0032874;GO:1903409;GO:0032495;GO:0032494;	  C:cytoplasm; C:nucleus;	 	  P:activation of MAPK activity; P:adherens junction maintenance; P:innate immune response; P:intestinal epithelial structure maintenance; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; P:pattern recognition receptor signaling pathway; P:positive regulation of cytokine production involved in immune response; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-10 production; P:positive regulation of interleukin-6 production; P:positive regulation of protein ubiquitination; P:positive regulation of stress-activated MAPK cascade; P:reactive oxygen species biosynthetic process; P:response to muramyl dipeptide; P:response to peptidoglycan;
XM_040194497.1	chrXII	10474406	10474406	chrXII	10492265	10495731	-	XM_040194497.1	path1	Q3TGF2 Q9CR82	Protein FAM107B {ECO:0000305}		 PF06625;	 GO:0007605;	 	 	  P:sensory perception of sound;
XM_040193607.1	chrXII	10476642	10476642	chrXII	10496590	10508378	+	XM_040193607.1	path1	Q802R9	Structural maintenance of chromosomes protein 5		 PF02463;	 GO:0000781;GO:0005634;GO:0016605;GO:0030915;GO:0005524;GO:0016887;GO:0051301;GO:0090398;GO:0000724;GO:0034184;GO:0007062;GO:0000722;	  C:chromosome, telomeric region; C:nucleus; C:PML body; C:Smc5-Smc6 complex;	  F:ATP binding; F:ATPase activity;	  P:cell division; P:cellular senescence; P:double-strand break repair via homologous recombination; P:positive regulation of maintenance of mitotic sister chromatid cohesion; P:sister chromatid cohesion; P:telomere maintenance via recombination;
XM_040195422.1	chrXIII	6801124	6801124	chrXIII	6547010	6873560	-	XM_040195422.1	path1	Q68Y21	Glutamate receptor ionotropic, delta-2		 PF01094;PF00060;PF10613;	 GO:0016021;GO:0005886;GO:0045211;GO:0008066;GO:0004970;GO:0015276;GO:0038023;GO:1904315;GO:0050804;GO:0035249;	  C:integral component of membrane; C:plasma membrane; C:postsynaptic membrane;	  F:glutamate receptor activity; F:ionotropic glutamate receptor activity; F:ligand-gated ion channel activity; F:signaling receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;	  P:modulation of chemical synaptic transmission; P:synaptic transmission, glutamatergic;
XM_040195033.1	chrXIII	6981579	6981579	chrXIII	7000452	7022164	-	XM_040195033.1	path1	Q9NQ86 A1L3Z1 A6NDD0 B7Z3V4 B7ZAV7 E9PFI8 Q0P5Z9	E3 ubiquitin-protein ligase TRIM36	RING finger protein 98;RING-type E3 ubiquitin transferase TRIM36 {ECO:0000305};Tripartite motif-containing protein 36;Zinc-binding protein Rbcc728;	 PF18568;PF00041;PF00643;PF13445;	 GO:0001669;GO:0005737;GO:0005856;GO:0005829;GO:0043014;GO:0004842;GO:0008270;GO:0007340;GO:0000281;GO:0000209;GO:0051726;GO:0070507;GO:0007051;	  C:acrosomal vesicle; C:cytoplasm; C:cytoskeleton; C:cytosol;	  F:alpha-tubulin binding; F:ubiquitin-protein transferase activity; F:zinc ion binding;	  P:acrosome reaction; P:mitotic cytokinesis; P:protein polyubiquitination; P:regulation of cell cycle; P:regulation of microtubule cytoskeleton organization; P:spindle organization;
XM_040195932.1	chrXIII	7004033	7004033	chrXIII	7030176	7041066	-	XM_040195932.1	path1	Q5EAD5	Geranylgeranyl transferase type-1 subunit beta	Geranylgeranyl transferase type I subunit beta;Type I protein geranyl-geranyltransferase subunit beta;	 PF00432;	 GO:0005953;GO:0004662;GO:0004661;GO:0008270;GO:0018344;GO:0018342;	  C:CAAX-protein geranylgeranyltransferase complex;	  F:CAAX-protein geranylgeranyltransferase activity; F:protein geranylgeranyltransferase activity; F:zinc ion binding;	  P:protein geranylgeranylation; P:protein prenylation;
XM_040196791.1	chrXIII	7028095	7028095	chrXIII	7055349	7060754	-	XM_040196791.1	path1	Q8CEF1 Q3UGV8 Q8C7S4	Protein fem-1 homolog C	FEM1-gamma;	 PF12796;PF13606;	 GO:0005829;GO:0005654;GO:0000151;GO:0016567;GO:0006511;	  C:cytosol; C:nucleoplasm; C:ubiquitin ligase complex;	 	  P:protein ubiquitination; P:ubiquitin-dependent protein catabolic process;
XM_040196801.1	chrXIII	7031659	7031659	chrXIII	7062015	7064639	-	XM_040196801.1	path1	D3ZTX0	Transmembrane emp24 domain-containing protein 7	p24 family protein gamma-3;p27;	 PF01105;	 GO:0030663;GO:0030134;GO:0005783;GO:0005789;GO:0005793;GO:0033116;GO:0012507;GO:0005794;GO:0016021;GO:0006888;GO:0007030;GO:0006886;	  C:COPI-coated vesicle membrane; C:COPII-coated ER to Golgi transport vesicle; C:endoplasmic reticulum; C:endoplasmic reticulum membrane; C:endoplasmic reticulum-Golgi intermediate compartment; C:endoplasmic reticulum-Golgi intermediate compartment membrane; C:ER to Golgi transport vesicle membrane; C:Golgi apparatus; C:integral component of membrane;	 	  P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:intracellular protein transport;
XM_040196790.1	chrXIII	7038908	7038908	chrXIII	7065815	7074504	+	XM_040196790.1	path1	Q05A36 Q2VPQ2	RNA-binding E3 ubiquitin-protein ligase MEX3C	RING finger and KH domain-containing protein 2;RING-type E3 ubiquitin transferase MEX3C {ECO:0000305};	 PF00013;	 GO:0005737;GO:0005634;GO:0046872;GO:0003723;GO:0061630;GO:0003415;GO:0097009;GO:0045598;	  C:cytoplasm; C:nucleus;	  F:metal ion binding; F:RNA binding; F:ubiquitin protein ligase activity;	  P:chondrocyte hypertrophy; P:energy homeostasis; P:regulation of fat cell differentiation;
XM_040196251.1	chrXIII	9952088	9952088	chrXIII	9917970	9921350	+	XM_040196251.1	path1	Q6TXF1	Arrestin domain-containing protein 3	Liver regeneration-related protein LRRG00048;	 PF02752;PF00339;	 GO:0005737;GO:0005769;GO:0005768;GO:0005764;GO:0005886;GO:0031699;GO:0060613;GO:0071878;GO:0120163;GO:0031651;GO:0090327;GO:0051443;GO:0015031;GO:0043588;GO:0001659;	  C:cytoplasm; C:early endosome; C:endosome; C:lysosome; C:plasma membrane;	  F:beta-3 adrenergic receptor binding;	  P:fat pad development; P:negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway; P:negative regulation of cold-induced thermogenesis; P:negative regulation of heat generation; P:negative regulation of locomotion involved in locomotory behavior; P:positive regulation of ubiquitin-protein transferase activity; P:protein transport; P:skin development; P:temperature homeostasis;
XM_040196250.1	chrXIII	9952088	9952088	chrXIII	9921403	9925843	+	XM_040196250.1	path1	Q6TXF1	Arrestin domain-containing protein 3	Liver regeneration-related protein LRRG00048;	 PF02752;PF00339;	 GO:0005737;GO:0005769;GO:0005768;GO:0005764;GO:0005886;GO:0031699;GO:0060613;GO:0071878;GO:0120163;GO:0031651;GO:0090327;GO:0051443;GO:0015031;GO:0043588;GO:0001659;	  C:cytoplasm; C:early endosome; C:endosome; C:lysosome; C:plasma membrane;	  F:beta-3 adrenergic receptor binding;	  P:fat pad development; P:negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway; P:negative regulation of cold-induced thermogenesis; P:negative regulation of heat generation; P:negative regulation of locomotion involved in locomotory behavior; P:positive regulation of ubiquitin-protein transferase activity; P:protein transport; P:skin development; P:temperature homeostasis;
XM_040195838.1	chrXIII	9952088	9952088	chrXIII	9945879	9948603	-	XM_040195838.1	path1	Q5ZII6	Protein kish-A	Transmembrane protein 167;Transmembrane protein 167A;	 PF06842;	 GO:0000139;GO:0016021;GO:0046907;GO:0009306;	  C:Golgi membrane; C:integral component of membrane;	 	  P:intracellular transport; P:protein secretion;
XR_005713964.1	chrXIII	9952088	9952088	chrXIII	9948610	9966361	+	XR_005713964.1	path1	Q924T3 Q8BKC9 Q8BU02 Q9D6U6	DNA repair protein XRCC4	X-ray repair cross-complementing protein 4;	 PF06632;	 GO:0000781;GO:0005829;GO:0032807;GO:0005958;GO:0070522;GO:0070419;GO:0005654;GO:0005634;GO:0035861;GO:0003677;GO:0042802;GO:0008022;GO:0007417;GO:0006266;GO:0051103;GO:0006302;GO:0006303;GO:0033152;GO:0001701;GO:0045190;GO:0043524;GO:1905765;GO:0048146;GO:0051351;GO:0050769;GO:0002328;GO:1990166;GO:0010332;GO:0010212;GO:0010165;GO:0033077;GO:0061819;GO:0033151;	  C:chromosome, telomeric region; C:cytosol; C:DNA ligase IV complex; C:DNA-dependent protein kinase-DNA ligase 4 complex; C:ERCC4-ERCC1 complex; C:nonhomologous end joining complex; C:nucleoplasm; C:nucleus; C:site of double-strand break;	  F:DNA binding; F:identical protein binding; F:protein C-terminus binding;	  P:central nervous system development; P:DNA ligation; P:DNA ligation involved in DNA repair; P:double-strand break repair; P:double-strand break repair via nonhomologous end joining; P:immunoglobulin V(D)J recombination; P:in utero embryonic development; P:isotype switching; P:negative regulation of neuron apoptotic process; P:negative regulation of protection from non-homologous end joining at telomere; P:positive regulation of fibroblast proliferation; P:positive regulation of ligase activity; P:positive regulation of neurogenesis; P:pro-B cell differentiation; P:protein localization to site of double-strand break; P:response to gamma radiation; P:response to ionizing radiation; P:response to X-ray; P:T cell differentiation in thymus; P:telomeric DNA-containing double minutes formation; P:V(D)J recombination;
XM_040195418.1	chrXIII	9952088	9952088	chrXIII	9974787	10015161	+	XM_040195418.1	path1	Q90953 Q90945	Versican core protein	Chondroitin sulfate proteoglycan core protein 2;Large fibroblast proteoglycan;PG-M;	 PF00008;PF00059;PF00084;PF07686;PF00193;	 GO:0031012;GO:0005576;GO:0033165;GO:0001750;GO:0005509;GO:0030246;GO:0005540;GO:0007155;GO:0007417;GO:0001501;	  C:extracellular matrix; C:extracellular region; C:interphotoreceptor matrix; C:photoreceptor outer segment;	  F:calcium ion binding; F:carbohydrate binding; F:hyaluronic acid binding;	  P:cell adhesion; P:central nervous system development; P:skeletal system development;
XM_040196619.1	chrXIII	9983245	9983245	chrXIII	10016628	10023776	-	XM_040196619.1	path1	P03994	Hyaluronan and proteoglycan link protein 1	Cartilage-linking protein 1;Proteoglycan link protein;	 PF07686;PF00193;	 GO:0031012;GO:0005576;GO:0045202;GO:0005540;GO:0005198;GO:0007155;GO:0007417;GO:0001501;	  C:extracellular matrix; C:extracellular region; C:synapse;	  F:hyaluronic acid binding; F:structural molecule activity;	  P:cell adhesion; P:central nervous system development; P:skeletal system development;
XM_040195851.1	chrXIII	10131765	10131765	chrXIII	10061654	10134142	-	XM_040195851.1	path1	O43854 B2R763 O43855 Q5D094 Q8N610	EGF-like repeat and discoidin I-like domain-containing protein 3	Developmentally-regulated endothelial cell locus 1 protein;Integrin-binding protein DEL1;	 PF00008;PF00754;PF12661;	 GO:0062023;GO:0070062;GO:1903561;GO:0005509;GO:0005178;GO:0007155;GO:0007275;GO:0010811;	  C:collagen-containing extracellular matrix; C:extracellular exosome; C:extracellular vesicle;	  F:calcium ion binding; F:integrin binding;	  P:cell adhesion; P:multicellular organism development; P:positive regulation of cell-substrate adhesion;
XM_040196362.1	chrXIII	10239466	10239466	chrXIII	10233825	10235840	+	XM_040196362.1	path1	P17665 Q3U5S7	Cytochrome c oxidase subunit 7C, mitochondrial	Cytochrome c oxidase polypeptide VIIc;	 PF02935;	 GO:0016021;GO:0005743;GO:0005751;GO:0005739;GO:0004129;GO:0006123;	  C:integral component of membrane; C:mitochondrial inner membrane; C:mitochondrial respiratory chain complex IV; C:mitochondrion;	  F:cytochrome-c oxidase activity;	  P:mitochondrial electron transport, cytochrome c to oxygen;
XM_040195640.1	chrXIII	10239466	10239466	chrXIII	10257401	10278831	+	XM_040195640.1	path1	P20936 B2R6W3 B4DTL2 Q68CU6 Q9UDI1	Ras GTPase-activating protein 1	Ras p21 protein activator;p120GAP;	 PF00168;PF00169;PF00616;PF00017;PF00018;	 GO:0005737;GO:0005829;GO:0005886;GO:0001726;GO:0005096;GO:0051020;GO:0001784;GO:0019870;GO:0005102;GO:0048514;GO:0048013;GO:0035556;GO:0000165;GO:0000281;GO:0043066;GO:0007162;GO:0001953;GO:0043524;GO:0046580;GO:0030833;GO:0008360;GO:0051252;GO:0007165;GO:0001570;	  C:cytoplasm; C:cytosol; C:plasma membrane; C:ruffle;	  F:GTPase activator activity; F:GTPase binding; F:phosphotyrosine residue binding; F:potassium channel inhibitor activity; F:signaling receptor binding;	  P:blood vessel morphogenesis; P:ephrin receptor signaling pathway; P:intracellular signal transduction; P:MAPK cascade; P:mitotic cytokinesis; P:negative regulation of apoptotic process; P:negative regulation of cell adhesion; P:negative regulation of cell-matrix adhesion; P:negative regulation of neuron apoptotic process; P:negative regulation of Ras protein signal transduction; P:regulation of actin filament polymerization; P:regulation of cell shape; P:regulation of RNA metabolic process; P:signal transduction; P:vasculogenesis;
XM_040195644.1	chrXIII	10239466	10239466	chrXIII	10278128	10282242	-	XM_040195644.1	path1	P51947	Cyclin-H	MO15-associated protein;p36;	 PF16899;PF00134;	 GO:0070985;GO:0016538;GO:0007049;GO:0006357;GO:0006351;	  C:transcription factor TFIIK complex;	  F:cyclin-dependent protein serine/threonine kinase regulator activity;	  P:cell cycle; P:regulation of transcription by RNA polymerase II; P:transcription, DNA-templated;
XM_040196449.1	chrXIII	10329711	10329711	chrXIII	10382330	10439040	-	XM_040196449.1	path1	Q06413 C9JMZ0 D7F7N5 F8W7V7	Myocyte-specific enhancer factor 2C {ECO:0000305}	Myocyte enhancer factor 2C {ECO:0000312|HGNC:HGNC:6996};	 PF12347;PF00319;	 GO:0000785;GO:0005737;GO:0005829;GO:0043231;GO:0016607;GO:0005654;GO:0005634;GO:0098794;GO:0032991;GO:0016528;GO:0033613;GO:0003677;GO:0001228;GO:0003700;GO:0000981;GO:0042826;GO:0003680;GO:0046982;GO:0000978;GO:0000977;GO:1990837;GO:0000976;GO:0006915;GO:0001782;GO:0042100;GO:0050853;GO:0001568;GO:0001974;GO:0003211;GO:0030154;GO:0048667;GO:0071277;GO:0035690;GO:0071498;GO:0071222;GO:0071374;GO:0071560;GO:0035984;GO:0002062;GO:0001958;GO:2001013;GO:0060079;GO:0002467;GO:0072102;GO:0007507;GO:0001947;GO:0006959;GO:0007611;GO:0000165;GO:0030318;GO:0007521;GO:0007517;GO:0014902;GO:0043537;GO:0010629;GO:0043524;GO:0030279;GO:0000122;GO:1904753;GO:1904706;GO:1905563;GO:0072160;GO:0007399;GO:0014033;GO:0048666;GO:0030182;GO:0001764;GO:0001649;GO:0003151;GO:0030220;GO:0010694;GO:0030890;GO:2000987;GO:0030501;GO:2000727;GO:0060045;GO:0010628;GO:2000111;GO:0043406;GO:0051149;GO:0045663;GO:0045666;GO:0045669;GO:2001016;GO:0048643;GO:0045944;GO:0045893;GO:0003138;GO:2000311;GO:0060998;GO:0002634;GO:0045652;GO:0043523;GO:0046928;GO:2000310;GO:0051963;GO:0060025;GO:0048167;GO:0051966;GO:0006357;GO:0006355;GO:0061333;GO:0002931;GO:0003139;GO:0003185;GO:0007519;GO:0051145;GO:0055012;	  C:chromatin; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:nuclear speck; C:nucleoplasm; C:nucleus; C:postsynapse; C:protein-containing complex; C:sarcoplasm;	  F:activating transcription factor binding; F:DNA binding; F:DNA-binding transcription activator activity, RNA polymerase II-specific; F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:histone deacetylase binding; F:minor groove of adenine-thymine-rich DNA binding; F:protein heterodimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding; F:transcription regulatory region sequence-specific DNA binding;	  P:apoptotic process; P:B cell homeostasis; P:B cell proliferation; P:B cell receptor signaling pathway; P:blood vessel development; P:blood vessel remodeling; P:cardiac ventricle formation; P:cell differentiation; P:cell morphogenesis involved in neuron differentiation; P:cellular response to calcium ion; P:cellular response to drug; P:cellular response to fluid shear stress; P:cellular response to lipopolysaccharide; P:cellular response to parathyroid hormone stimulus; P:cellular response to transforming growth factor beta stimulus; P:cellular response to trichostatin A; P:chondrocyte differentiation; P:endochondral ossification; P:epithelial cell proliferation involved in renal tubule morphogenesis; P:excitatory postsynaptic potential; P:germinal center formation; P:glomerulus morphogenesis; P:heart development; P:heart looping; P:humoral immune response; P:learning or memory; P:MAPK cascade; P:melanocyte differentiation; P:muscle cell fate determination; P:muscle organ development; P:myotube differentiation; P:negative regulation of blood vessel endothelial cell migration; P:negative regulation of gene expression; P:negative regulation of neuron apoptotic process; P:negative regulation of ossification; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of vascular associated smooth muscle cell migration; P:negative regulation of vascular associated smooth muscle cell proliferation; P:negative regulation of vascular endothelial cell proliferation; P:nephron tubule epithelial cell differentiation; P:nervous system development; P:neural crest cell differentiation; P:neuron development; P:neuron differentiation; P:neuron migration; P:osteoblast differentiation; P:outflow tract morphogenesis; P:platelet formation; P:positive regulation of alkaline phosphatase activity; P:positive regulation of B cell proliferation; P:positive regulation of behavioral fear response; P:positive regulation of bone mineralization; P:positive regulation of cardiac muscle cell differentiation; P:positive regulation of cardiac muscle cell proliferation; P:positive regulation of gene expression; P:positive regulation of macrophage apoptotic process; P:positive regulation of MAP kinase activity; P:positive regulation of muscle cell differentiation; P:positive regulation of myoblast differentiation; P:positive regulation of neuron differentiation; P:positive regulation of osteoblast differentiation; P:positive regulation of skeletal muscle cell differentiation; P:positive regulation of skeletal muscle tissue development; P:positive regulation of transcription by RNA polymerase II; P:positive regulation of transcription, DNA-templated; P:primary heart field specification; P:regulation of AMPA receptor activity; P:regulation of dendritic spine development; P:regulation of germinal center formation; P:regulation of megakaryocyte differentiation; P:regulation of neuron apoptotic process; P:regulation of neurotransmitter secretion; P:regulation of NMDA receptor activity; P:regulation of synapse assembly; P:regulation of synaptic activity; P:regulation of synaptic plasticity; P:regulation of synaptic transmission, glutamatergic; P:regulation of transcription by RNA polymerase II; P:regulation of transcription, DNA-templated; P:renal tubule morphogenesis; P:response to ischemia; P:secondary heart field specification; P:sinoatrial valve morphogenesis; P:skeletal muscle tissue development; P:smooth muscle cell differentiation; P:ventricular cardiac muscle cell differentiation;
XM_040194956.1	chrXIII	17261913	17261913	chrXIII	17223819	17235138	+	XM_040194956.1	path1	O19064	Tyrosine-protein kinase JAK2 {ECO:0000250|UniProtKB:O60674}	Janus kinase 2;	 PF18379;PF18377;PF17887;PF07714;PF00017;	 GO:0005737;GO:0005856;GO:0012505;GO:0005925;GO:0005654;GO:0005634;GO:0005886;GO:0005524;GO:0005131;GO:0020037;GO:0042393;GO:0035401;GO:0042802;GO:0046872;GO:0019901;GO:0004713;GO:0042169;GO:0004714;GO:0042976;GO:0002250;GO:0019221;GO:0030218;GO:0060397;GO:0035409;GO:0045087;GO:0035722;GO:0035556;GO:0010811;GO:0060391;GO:0042531;GO:0046777;GO:0042981;GO:0050727;GO:0046677;GO:0007165;GO:0033209;GO:0007260;	  C:cytoplasm; C:cytoskeleton; C:endomembrane system; C:focal adhesion; C:nucleoplasm; C:nucleus; C:plasma membrane;	  F:ATP binding; F:growth hormone receptor binding; F:heme binding; F:histone binding; F:histone kinase activity (H3-Y41 specific); F:identical protein binding; F:metal ion binding; F:protein kinase binding; F:protein tyrosine kinase activity; F:SH2 domain binding; F:transmembrane receptor protein tyrosine kinase activity;	  P:activation of Janus kinase activity; P:adaptive immune response; P:cytokine-mediated signaling pathway; P:erythrocyte differentiation; P:growth hormone receptor signaling pathway via JAK-STAT; P:histone H3-Y41 phosphorylation; P:innate immune response; P:interleukin-12-mediated signaling pathway; P:intracellular signal transduction; P:positive regulation of cell-substrate adhesion; P:positive regulation of SMAD protein signal transduction; P:positive regulation of tyrosine phosphorylation of STAT protein; P:protein autophosphorylation; P:regulation of apoptotic process; P:regulation of inflammatory response; P:response to antibiotic; P:signal transduction; P:tumor necrosis factor-mediated signaling pathway; P:tyrosine phosphorylation of STAT protein;
XM_040194958.1	chrXIII	17261913	17261913	chrXIII	17237691	17241464	+	XM_040194958.1	path1	Q6P2X9 Q28D48	Monocarboxylate transporter 12 {ECO:0000305}	Solute carrier family 16 member 12;	 PF07690;	 GO:0016021;GO:0005887;GO:0005308;GO:0008028;GO:0015293;GO:0015881;GO:0015718;	  C:integral component of membrane; C:integral component of plasma membrane;	  F:creatine transmembrane transporter activity; F:monocarboxylic acid transmembrane transporter activity; F:symporter activity;	  P:creatine transmembrane transport; P:monocarboxylic acid transport;
XM_040194957.1	chrXIII	17261913	17261913	chrXIII	17241569	17254556	-	XM_040194957.1	path1	P15505	Glycine dehydrogenase (decarboxylating), mitochondrial {ECO:0000305}	Glycine cleavage system P protein;Glycine decarboxylase {ECO:0000303|PubMed:1993704};Glycine dehydrogenase (aminomethyl-transferring);	 PF01212;PF02347;	 GO:0005739;GO:0004375;GO:0047960;GO:0016829;GO:0042803;GO:0070280;GO:0006546;GO:1903442;GO:0036255;	  C:mitochondrion;	  F:glycine dehydrogenase (decarboxylating) activity; F:glycine dehydrogenase activity; F:lyase activity; F:protein homodimerization activity; F:pyridoxal binding;	  P:glycine catabolic process; P:response to lipoic acid; P:response to methylamine;
XM_040194961.1	chrXIII	17261913	17261913	chrXIII	17256498	17258320	+	XM_040194961.1	path1	B1Q006	Ghrelin O-acyltransferase {ECO:0000303|PubMed:18443287}	Membrane-bound O-acyltransferase domain-containing protein 4 {ECO:0000250|UniProtKB:Q96T53};	 PF03062;	 GO:0030176;GO:0016020;GO:0016412;GO:0016746;GO:0030258;GO:0018191;GO:0032094;	  C:integral component of endoplasmic reticulum membrane; C:membrane;	  F:serine O-acyltransferase activity; F:transferase activity, transferring acyl groups;	  P:lipid modification; P:peptidyl-serine octanoylation; P:response to food;
XM_040194960.1	chrXIII	17261913	17261913	chrXIII	17256666	17262732	-	XM_040194960.1	path1	Q96H96 O95331 Q1JQ78 Q684R2	4-hydroxybenzoate polyprenyltransferase, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03189}	4-hydroxybenzoate decaprenyltransferase {ECO:0000255|HAMAP-Rule:MF_03189};COQ2 homolog;Para-hydroxybenzoate--polyprenyltransferase {ECO:0000255|HAMAP-Rule:MF_03189};	 PF01040;	 GO:0031305;GO:0005743;GO:0002083;GO:0047293;GO:0004659;GO:0016765;GO:0006071;GO:0008299;GO:0006744;	  C:integral component of mitochondrial inner membrane; C:mitochondrial inner membrane;	  F:4-hydroxybenzoate decaprenyltransferase activity; F:4-hydroxybenzoate nonaprenyltransferase activity; F:prenyltransferase activity; F:transferase activity, transferring alkyl or aryl (other than methyl) groups;	  P:glycerol metabolic process; P:isoprenoid biosynthetic process; P:ubiquinone biosynthetic process;
XM_040195153.1	chrXIII	17261913	17261913	chrXIII	17263440	17267824	-	XM_040195153.1	path1	Q0P5M9	Major facilitator superfamily domain-containing protein 10	Tetracycline transporter-like protein;	 PF07690;	 GO:0031526;GO:0016021;GO:0005637;GO:0022857;GO:0006915;	  C:brush border membrane; C:integral component of membrane; C:nuclear inner membrane;	  F:transmembrane transporter activity;	  P:apoptotic process;
XM_040195149.1	chrXIII	17261913	17261913	chrXIII	17268325	17278215	-	XM_040195149.1	path1	Q96JM2 Q5T0T4 Q8N408	Zinc finger protein 462 {ECO:0000305}	Zinc finger PBX1-interacting protein {ECO:0000250|UniProtKB:B1AWL2};	 	 GO:0005634;GO:0003677;GO:0046872;GO:0006325;GO:0043392;GO:0045944;GO:0010468;	  C:nucleus;	  F:DNA binding; F:metal ion binding;	  P:chromatin organization; P:negative regulation of DNA binding; P:positive regulation of transcription by RNA polymerase II; P:regulation of gene expression;
XM_040195150.1	chrXIII	17261913	17261913	chrXIII	17278323	17285604	+	XM_040195150.1	path1	Q9QX72	Selenocysteine insertion sequence-binding protein 2		 PF01248;	 GO:0005829;GO:0005634;GO:1990904;GO:0003730;GO:0043021;GO:0003723;GO:0035368;GO:0008135;GO:2000623;GO:0048666;GO:1904571;GO:0001514;GO:0021756;	  C:cytosol; C:nucleus; C:ribonucleoprotein complex;	  F:mRNA 3'-UTR binding; F:ribonucleoprotein complex binding; F:RNA binding; F:selenocysteine insertion sequence binding; F:translation factor activity, RNA binding;	  P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; P:neuron development; P:positive regulation of selenocysteine incorporation; P:selenocysteine incorporation; P:striatum development;
XM_040195233.1	chrXIII	17261913	17261913	chrXIII	17286513	17292147	-	XM_040195233.1	path1	Q6JTA8 O46679 Q6JTA9 Q6JTB0	Prolactin receptor		 PF09067;	 GO:0009897;GO:0016021;GO:0043235;GO:0005127;GO:0019955;GO:0004896;GO:0004923;GO:0046872;GO:0017046;GO:0004925;GO:0019221;GO:0038165;GO:0008284;	  C:external side of plasma membrane; C:integral component of membrane; C:receptor complex;	  F:ciliary neurotrophic factor receptor binding; F:cytokine binding; F:cytokine receptor activity; F:leukemia inhibitory factor receptor activity; F:metal ion binding; F:peptide hormone binding; F:prolactin receptor activity;	  P:cytokine-mediated signaling pathway; P:oncostatin-M-mediated signaling pathway; P:positive regulation of cell population proliferation;
XM_040195228.1	chrXIII	17261913	17261913	chrXIII	17292227	17301261	+	XM_040195228.1	path1	Q9UDY8 Q9NTB7 Q9ULX4	Mucosa-associated lymphoid tissue lymphoma translocation protein 1 {ECO:0000305}	MALT lymphoma-associated translocation {ECO:0000303|PubMed:10339464};Paracaspase {ECO:0000303|PubMed:11090634};	 PF13895;PF18703;	 GO:0032449;GO:0005737;GO:0005829;GO:0001650;GO:0005634;GO:0048471;GO:0002096;GO:0032991;GO:0004197;GO:0004175;GO:0042802;GO:0008233;GO:0002020;GO:0043621;GO:0004842;GO:0007250;GO:0042113;GO:0001923;GO:0006952;GO:0038095;GO:0045087;GO:0031663;GO:0043066;GO:0051168;GO:0043280;GO:0043123;GO:0032731;GO:0032743;GO:0051092;GO:0031398;GO:0002726;GO:2000321;GO:0006508;GO:0051603;GO:0042981;GO:0050856;GO:0009620;GO:0002223;GO:0042098;GO:0050852;	  C:CBM complex; C:cytoplasm; C:cytosol; C:fibrillar center; C:nucleus; C:perinuclear region of cytoplasm; C:polkadots; C:protein-containing complex;	  F:cysteine-type endopeptidase activity; F:endopeptidase activity; F:identical protein binding; F:peptidase activity; F:protease binding; F:protein self-association; F:ubiquitin-protein transferase activity;	  P:activation of NF-kappaB-inducing kinase activity; P:B cell activation; P:B-1 B cell differentiation; P:defense response; P:Fc-epsilon receptor signaling pathway; P:innate immune response; P:lipopolysaccharide-mediated signaling pathway; P:negative regulation of apoptotic process; P:nuclear export; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; P:positive regulation of interleukin-1 beta production; P:positive regulation of interleukin-2 production; P:positive regulation of NF-kappaB transcription factor activity; P:positive regulation of protein ubiquitination; P:positive regulation of T cell cytokine production; P:positive regulation of T-helper 17 cell differentiation; P:proteolysis; P:proteolysis involved in cellular protein catabolic process; P:regulation of apoptotic process; P:regulation of T cell receptor signaling pathway; P:response to fungus; P:stimulatory C-type lectin receptor signaling pathway; P:T cell proliferation; P:T cell receptor signaling pathway;
XM_040195237.1	chrXIII	17261913	17261913	chrXIII	17301581	17304779	+	XM_040195237.1	path1	Q6PCB8 B7Z6S3 B7Z902	Embigin		 PF07679;PF00047;	 GO:0030424;GO:0005887;GO:0005886;GO:0045202;GO:0098632;GO:0007411;GO:0070593;GO:0007156;GO:0035879;	  C:axon; C:integral component of plasma membrane; C:plasma membrane; C:synapse;	  F:cell-cell adhesion mediator activity;	  P:axon guidance; P:dendrite self-avoidance; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:plasma membrane lactate transport;
XM_040195236.1	chrXIII	17261913	17261913	chrXIII	17304954	17308185	-	XM_040195236.1	path1	P82924 Q05B75	28S ribosomal protein S30, mitochondrial		 PF07147;	 GO:0005743;GO:0005762;GO:0003735;GO:0006412;	  C:mitochondrial inner membrane; C:mitochondrial large ribosomal subunit;	  F:structural constituent of ribosome;	  P:translation;
XM_040196668.1	chrXIII	17261913	17261913	chrXIII	17309225	17310361	+	XM_040196668.1	path1	Q9BX68 Q5TCW3	Histidine triad nucleotide-binding protein 2, mitochondrial {ECO:0000305}	HINT-3 {ECO:0000303|Ref.4};HIT-17kDa {ECO:0000303|Ref.1};PKCI-1-related HIT protein {ECO:0000303|Ref.2};	 PF01230;	 GO:0005737;GO:0005739;GO:0016787;GO:0000166;GO:0006915;GO:0016042;GO:2000757;GO:0006694;	  C:cytoplasm; C:mitochondrion;	  F:hydrolase activity; F:nucleotide binding;	  P:apoptotic process; P:lipid catabolic process; P:negative regulation of peptidyl-lysine acetylation; P:steroid biosynthetic process;
XM_040195698.1	chrXIII	17284104	17284104	chrXIII	17330447	17333199	-	XM_040195698.1	path1	P52556 Q3T0T4	Flavin reductase (NADPH)	Biliverdin reductase B;Biliverdin-IX beta-reductase;Green heme-binding protein;NADPH-dependent diaphorase;NADPH-flavin reductase;	 PF13460;	 GO:0005829;GO:0106276;GO:0004074;GO:0106277;GO:0042602;GO:0042167;	  C:cytosol;	  F:biliberdin reductase NAD+ activity; F:biliverdin reductase (NAD(P)+) activity; F:biliverdin reductase (NADP+) activity; F:riboflavin reductase (NADPH) activity;	  P:heme catabolic process;
XM_040195695.1	chrXIII	17284104	17284104	chrXIII	17333993	17344062	+	XM_040195695.1	path1	O14830 O14831	Serine/threonine-protein phosphatase with EF-hands 2		 PF13499;PF00149;PF08321;	 GO:0005829;GO:0005634;GO:0001917;GO:0001750;GO:0005509;GO:0030544;GO:0051879;GO:0005506;GO:0030145;GO:0031435;GO:0106306;GO:0004722;GO:0106307;GO:0050906;GO:0043409;GO:0010801;GO:0006470;GO:0043506;GO:0043405;GO:0007601;	  C:cytosol; C:nucleus; C:photoreceptor inner segment; C:photoreceptor outer segment;	  F:calcium ion binding; F:Hsp70 protein binding; F:Hsp90 protein binding; F:iron ion binding; F:manganese ion binding; F:mitogen-activated protein kinase kinase kinase binding; F:protein serine phosphatase activity; F:protein serine/threonine phosphatase activity; F:protein threonine phosphatase activity;	  P:detection of stimulus involved in sensory perception; P:negative regulation of MAPK cascade; P:negative regulation of peptidyl-threonine phosphorylation; P:protein dephosphorylation; P:regulation of JUN kinase activity; P:regulation of MAP kinase activity; P:visual perception;
XM_040195055.1	chrXIII	17285384	17285384	chrXIII	17347346	17361205	-	XM_040195055.1	path1	P27615	Lysosome membrane protein 2	85 kDa lysosomal membrane sialoglycoprotein;CD36 antigen-like 2;Lysosome membrane protein II;Scavenger receptor class B member 2;	 PF01130;	 GO:0005737;GO:0030666;GO:0016021;GO:0043202;GO:0005765;GO:0005886;GO:0038024;GO:0051087;GO:0015485;GO:0019899;GO:0031210;GO:0001786;GO:0042803;GO:0005044;GO:0015917;GO:0010976;GO:0006622;GO:0006898;GO:0043471;GO:1905123;	  C:cytoplasm; C:endocytic vesicle membrane; C:integral component of membrane; C:lysosomal lumen; C:lysosomal membrane; C:plasma membrane;	  F:cargo receptor activity; F:chaperone binding; F:cholesterol binding; F:enzyme binding; F:phosphatidylcholine binding; F:phosphatidylserine binding; F:protein homodimerization activity; F:scavenger receptor activity;	  P:aminophospholipid transport; P:positive regulation of neuron projection development; P:protein targeting to lysosome; P:receptor-mediated endocytosis; P:regulation of cellular carbohydrate catabolic process; P:regulation of glucosylceramidase activity;
XM_040195206.1	chrXIII	17357570	17357570	chrXIII	17380724	17384871	+	XM_040195206.1	path1	O08918 O35612	Cyclin-G2		 PF00134;	 GO:0000307;GO:0005737;GO:0005829;GO:0005634;GO:0016538;GO:0051301;GO:0044772;GO:0051726;GO:0000079;	  C:cyclin-dependent protein kinase holoenzyme complex; C:cytoplasm; C:cytosol; C:nucleus;	  F:cyclin-dependent protein serine/threonine kinase regulator activity;	  P:cell division; P:mitotic cell cycle phase transition; P:regulation of cell cycle; P:regulation of cyclin-dependent protein serine/threonine kinase activity;
NM_001267636.1	chrXIII	17357570	17357570	chrXIII	17385746	17389217	+	NM_001267636.1	path1	O43173 A8K0F2 Q6B085 Q9NS41	Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase	Alpha-2,8-sialyltransferase 8C;Alpha-2,8-sialyltransferase III;ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3;Sialyltransferase 8C;Sialyltransferase St8Sia III {ECO:0000303|PubMed:9826427};	 PF00777;	 GO:0000139;GO:0016021;GO:0003828;GO:0042802;GO:0033691;GO:0008373;GO:0001574;GO:0009100;GO:0006688;GO:0006491;GO:0009311;GO:0006486;GO:1990743;	  C:Golgi membrane; C:integral component of membrane;	  F:alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity; F:identical protein binding; F:sialic acid binding; F:sialyltransferase activity;	  P:ganglioside biosynthetic process; P:glycoprotein metabolic process; P:glycosphingolipid biosynthetic process; P:N-glycan processing; P:oligosaccharide metabolic process; P:protein glycosylation; P:protein sialylation;
XM_040194974.1	chrXIII	17357570	17357570	chrXIII	17392524	17395970	-	XM_040194974.1	path1	Q99P74	Ras-related protein Rab-27B		 PF00071;	 GO:0098993;GO:0016324;GO:1904115;GO:0005794;GO:0005795;GO:0005770;GO:0042470;GO:0032585;GO:0030141;GO:0030667;GO:0030140;GO:0042589;GO:0003925;GO:0019003;GO:0005525;GO:0003924;GO:0031489;GO:0019904;GO:0099641;GO:0032402;GO:0071985;GO:0045921;GO:0017157;GO:0048488;	  C:anchored component of synaptic vesicle membrane; C:apical plasma membrane; C:axon cytoplasm; C:Golgi apparatus; C:Golgi stack; C:late endosome; C:melanosome; C:multivesicular body membrane; C:secretory granule; C:secretory granule membrane; C:trans-Golgi network transport vesicle; C:zymogen granule membrane;	  F:G protein activity; F:GDP binding; F:GTP binding; F:GTPase activity; F:myosin V binding; F:protein domain specific binding;	  P:anterograde axonal protein transport; P:melanosome transport; P:multivesicular body sorting pathway; P:positive regulation of exocytosis; P:regulation of exocytosis; P:synaptic vesicle endocytosis;
XM_040194965.1	chrXIII	17357570	17357570	chrXIII	17396246	17400580	-	XM_040194965.1	path1	Q6R3M4 Q641P1 Q6R3M3 Q9R1A6	DNA polymerase iota	Rad30 homolog B;	 PF00817;PF11799;PF11798;	 GO:0036464;GO:0016607;GO:0003684;GO:0003887;GO:0046872;GO:0071494;GO:0006260;GO:0019985;	  C:cytoplasmic ribonucleoprotein granule; C:nuclear speck;	  F:damaged DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding;	  P:cellular response to UV-C; P:DNA replication; P:translesion synthesis;
XM_040194973.1	chrXIII	17357570	17357570	chrXIII	17408661	17416892	-	XM_040194973.1	path1	P0DTE4 B4E2F4 D3GER1 D3GER2 E9PDM7 J3KNA3 Q9Y4X1	UDP-glucuronosyltransferase 2A1 {ECO:0000303|PubMed:18719240}		 PF00201;	 GO:0005789;GO:0016021;GO:0015020;GO:0008206;GO:0052695;GO:0050896;GO:0007608;	  C:endoplasmic reticulum membrane; C:integral component of membrane;	  F:glucuronosyltransferase activity;	  P:bile acid metabolic process; P:cellular glucuronidation; P:response to stimulus; P:sensory perception of smell;
XM_040194967.1	chrXIII	17357570	17357570	chrXIII	17419472	17428507	-	XM_040194967.1	path1	Q6PDD0	UDP-glucuronosyltransferase 2A2 {ECO:0000305}		 PF00201;	 GO:0016021;GO:0043231;GO:0015020;GO:0008206;GO:0052695;	  C:integral component of membrane; C:intracellular membrane-bounded organelle;	  F:glucuronosyltransferase activity;	  P:bile acid metabolic process; P:cellular glucuronidation;
XM_040196267.1	chrXIII	17392330	17392330	chrXIII	17437873	17440325	-	XM_040196267.1	path1	Q16559 A0AVI7	T-cell acute lymphocytic leukemia protein 2	Class A basic helix-loop-helix protein 19;	 PF00010;	 GO:0000785;GO:0003677;GO:0000981;GO:0046983;GO:0000978;GO:0030901;GO:0035264;GO:0009791;GO:0006357;GO:0021794;	  C:chromatin;	  F:DNA binding; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:protein dimerization activity; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;	  P:midbrain development; P:multicellular organism growth; P:post-embryonic development; P:regulation of transcription by RNA polymerase II; P:thalamus development;
XR_005714011.1	chrXIII	17392330	17392330	chrXIII	17440620	17446255	+	XR_005714011.1	path1	Q5VXU9 A2A2V3 Q2M1H8 Q96M73	Protein shortage in chiasmata 1 ortholog {ECO:0000305}	Protein ZIP2 homolog {ECO:0000250|UniProtKB:A2ALV5};	 PF17825;	 GO:0005694;GO:0000794;GO:0016887;GO:0003697;GO:0007131;GO:0000712;	  C:chromosome; C:condensed nuclear chromosome;	  F:ATPase activity; F:single-stranded DNA binding;	  P:reciprocal meiotic recombination; P:resolution of meiotic recombination intermediates;
XM_040196671.1	chrXIII	17392330	17392330	chrXIII	17453233	17461950	-	XM_040196671.1	path1	Q7RTR2 Q5EY36 Q8NF48 Q8NI01 Q8NI02 Q8TEL3	NLR family CARD domain-containing protein 3	CARD15-like protein;Caterpiller protein 16.2 {ECO:0000303|PubMed:15705585};NACHT, LRR and CARD domains-containing protein 3;Nucleotide-binding oligomerization domain protein 3;	 PF13516;PF05729;PF17776;PF17779;	 GO:0034451;GO:0005737;GO:0005829;GO:0043231;GO:0048471;GO:0005524;GO:0036312;GO:0007249;GO:0035556;GO:1900016;GO:0050680;GO:0048147;GO:0043124;GO:0050728;GO:0045824;GO:0032687;GO:0032688;GO:0032715;GO:0032088;GO:1901223;GO:1900226;GO:0014067;GO:0032720;GO:0042110;	  C:centriolar satellite; C:cytoplasm; C:cytosol; C:intracellular membrane-bounded organelle; C:perinuclear region of cytoplasm;	  F:ATP binding; F:phosphatidylinositol 3-kinase regulatory subunit binding;	  P:I-kappaB kinase/NF-kappaB signaling; P:intracellular signal transduction; P:negative regulation of cytokine production involved in inflammatory response; P:negative regulation of epithelial cell proliferation; P:negative regulation of fibroblast proliferation; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; P:negative regulation of inflammatory response; P:negative regulation of innate immune response; P:negative regulation of interferon-alpha production; P:negative regulation of interferon-beta production; P:negative regulation of interleukin-6 production; P:negative regulation of NF-kappaB transcription factor activity; P:negative regulation of NIK/NF-kappaB signaling; P:negative regulation of NLRP3 inflammasome complex assembly; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of tumor necrosis factor production; P:T cell activation;
XM_040196622.1	chrXIII	17430028	17430028	chrXIII	17479518	17484965	-	XM_040196622.1	path1	Q9R1R0 O88706 Q6P1H2 Q9R1R1	LIM/homeobox protein Lhx6	LIM/homeobox protein Lhx6.1;	 PF00046;PF00412;	 GO:0005634;GO:0003700;GO:0000981;GO:0046872;GO:0000977;GO:1990837;GO:0048469;GO:0021853;GO:0021895;GO:0021799;GO:0021800;GO:0021884;GO:0021877;GO:0030182;GO:0006357;	  C:nucleus;	  F:DNA-binding transcription factor activity; F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; F:sequence-specific double-stranded DNA binding;	  P:cell maturation; P:cerebral cortex GABAergic interneuron migration; P:cerebral cortex neuron differentiation; P:cerebral cortex radially oriented cell migration; P:cerebral cortex tangential migration; P:forebrain neuron development; P:forebrain neuron fate commitment; P:neuron differentiation; P:regulation of transcription by RNA polymerase II;
XM_040196285.1	chrXIII	17430028	17430028	chrXIII	17495802	17502159	+	XM_040196285.1	path1	O97554	Prostaglandin G/H synthase 1	Cyclooxygenase-1;Prostaglandin H2 synthase 1;Prostaglandin-endoperoxide synthase 1;	 PF03098;PF00008;	 GO:0005789;GO:0051213;GO:0020037;GO:0046872;GO:0004601;GO:0004666;GO:0019371;GO:0006954;GO:0008217;GO:0006979;	  C:endoplasmic reticulum membrane;	  F:dioxygenase activity; F:heme binding; F:metal ion binding; F:peroxidase activity; F:prostaglandin-endoperoxide synthase activity;	  P:cyclooxygenase pathway; P:inflammatory response; P:regulation of blood pressure; P:response to oxidative stress;
XM_040196282.1	chrXIII	17430028	17430028	chrXIII	17502782	17513421	-	XM_040196282.1	path1	D3YXG0 D3Z2Q7	Hemicentin-1 {ECO:0000312|MGI:MGI:2685047}	Fibulin-6 {ECO:0000303|PubMed:24951538};	 PF12662;PF07645;PF07474;PF07679;PF00090;	 GO:0005912;GO:0005604;GO:0005938;GO:0030054;GO:0032154;GO:0062023;GO:0005576;GO:0005509;GO:0007049;GO:0051301;GO:0007157;GO:0007156;GO:0009617;	  C:adherens junction; C:basement membrane; C:cell cortex; C:cell junction; C:cleavage furrow; C:collagen-containing extracellular matrix; C:extracellular region;	  F:calcium ion binding;	  P:cell cycle; P:cell division; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; P:homophilic cell adhesion via plasma membrane adhesion molecules; P:response to bacterium;
XM_040195754.1	chrXIII	17456684	17456684	chrXIII	17515144	17520268	+	XM_040195754.1	path1	Q10713 B4DKL3 E7ET61 Q16639 Q5SXM9 Q8N513	Mitochondrial-processing peptidase subunit alpha	Alpha-MPP;Inactive zinc metalloprotease alpha {ECO:0000305};P-55;	 PF00675;PF05193;	 GO:0005615;GO:0005743;GO:0005759;GO:0005739;GO:0046872;GO:0006851;GO:0006627;	  C:extracellular space; C:mitochondrial inner membrane; C:mitochondrial matrix; C:mitochondrion;	  F:metal ion binding;	  P:mitochondrial calcium ion transmembrane transport; P:protein processing involved in protein targeting to mitochondrion;
XM_040195752.1	chrXIII	17456684	17456684	chrXIII	17520299	17524700	-	XM_040195752.1	path1	Q9WVR1 A0A0G2K6T4	Phosphatidylinositol polyphosphate 5-phosphatase type IV	5-phosphatase that induces arborization {ECO:0000303|PubMed:10405344};72 kDa inositol polyphosphate 5-phosphatase;Inositol polyphosphate-5-phosphatase E;Phosphatidylinositol 4,5-bisphosphate 5-phosphatase;Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase;	 PF03372;	 GO:0005930;GO:0005929;GO:0005737;GO:0005925;GO:0032580;GO:0000139;GO:0005654;GO:0005634;GO:0005886;GO:0001726;GO:0004445;GO:0016314;GO:0034485;GO:0004439;GO:0106019;GO:0046855;GO:0014067;GO:1903565;GO:0017148;GO:0046856;GO:0046488;	  C:axoneme; C:cilium; C:cytoplasm; C:focal adhesion; C:Golgi cisterna membrane; C:Golgi membrane; C:nucleoplasm; C:nucleus; C:plasma membrane; C:ruffle;	  F:inositol-polyphosphate 5-phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity; F:phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity; F:phosphatidylinositol-4,5-bisphosphate phosphatase activity;	  P:inositol phosphate dephosphorylation; P:negative regulation of phosphatidylinositol 3-kinase signaling; P:negative regulation of protein localization to cilium; P:negative regulation of translation; P:phosphatidylinositol dephosphorylation; P:phosphatidylinositol metabolic process;
XM_040195350.1	chrXIII	17462302	17462302	chrXIII	17553464	17586728	+	XM_040195350.1	path1	A2RUV0 F7CY31	Neurogenic locus notch homolog protein 1		 PF12796;PF11936;PF00008;PF07645;PF12661;PF06816;PF07684;PF00066;	 GO:0016021;GO:0005634;GO:0005886;GO:0005509;GO:0005112;GO:0038023;GO:0001525;GO:0030154;GO:0060271;GO:0061314;GO:0007219;GO:0050793;GO:0006355;	  C:integral component of membrane; C:nucleus; C:plasma membrane;	  F:calcium ion binding; F:Notch binding; F:signaling receptor activity;	  P:angiogenesis; P:cell differentiation; P:cilium assembly; P:Notch signaling involved in heart development; P:Notch signaling pathway; P:regulation of developmental process; P:regulation of transcription, DNA-templated;
XM_040198661.1	chrXV	7141237	7141237	chrXV	7103769	7117038	-	XM_040198661.1	path1	Q5DU00 Q5SZU0 Q80Y99	Doublecortin domain-containing protein 2		 PF03607;	 GO:0005930;GO:0034451;GO:0005929;GO:0005737;GO:0005856;GO:0005829;GO:0060091;GO:0005874;GO:0015630;GO:0005815;GO:0072686;GO:0005654;GO:0045202;GO:0019894;GO:0060271;GO:0048813;GO:0035556;GO:0001764;GO:0019228;GO:0045880;GO:1902017;GO:0030111;GO:0007605;GO:0035249;GO:0008542;	  C:axoneme; C:centriolar satellite; C:cilium; C:cytoplasm; C:cytoskeleton; C:cytosol; C:kinocilium; C:microtubule; C:microtubule cytoskeleton; C:microtubule organizing center; C:mitotic spindle; C:nucleoplasm; C:synapse;	  F:kinesin binding;	  P:cilium assembly; P:dendrite morphogenesis; P:intracellular signal transduction; P:neuron migration; P:neuronal action potential; P:positive regulation of smoothened signaling pathway; P:regulation of cilium assembly; P:regulation of Wnt signaling pathway; P:sensory perception of sound; P:synaptic transmission, glutamatergic; P:visual learning;
XM_040198659.1	chrXV	7141237	7141237	chrXV	7118348	7121345	-	XM_040198659.1	path1	Q5U3G1	Collectin-11		 PF01391;PF00059;	 GO:0005581;GO:0005615;GO:0005509;GO:0120153;GO:0003677;GO:0042806;GO:0005537;GO:0070492;GO:0019730;GO:0001867;GO:0032502;GO:0001755;	  C:collagen trimer; C:extracellular space;	  F:calcium ion binding; F:calcium-dependent carbohydrate binding; F:DNA binding; F:fucose binding; F:mannose binding; F:oligosaccharide binding;	  P:antimicrobial humoral response; P:complement activation, lectin pathway; P:developmental process; P:neural crest cell migration;
XM_040200003.1	chrXV	7141237	7141237	chrXV	7122633	7152660	+	XM_040200003.1	path1	Q9UM54 A6H8V4 E1P540 Q5TEM5 Q5TEM6 Q5TEM7 Q9BZZ7 Q9UEG2	Unconventional myosin-VI	Unconventional myosin-6;	 PF16521;PF00063;	 GO:0015629;GO:0005884;GO:0005938;GO:0005905;GO:0030665;GO:0005737;GO:0031410;GO:0005829;GO:0030139;GO:0070062;GO:0031941;GO:0030175;GO:0005794;GO:0005765;GO:0016020;GO:0005902;GO:0031965;GO:0005654;GO:0005634;GO:0048471;GO:0005886;GO:0016591;GO:0001726;GO:0032587;GO:0016461;GO:0031982;GO:0003779;GO:0051015;GO:0030898;GO:0043531;GO:0005524;GO:0005516;GO:0042802;GO:0000146;GO:0060001;GO:0003774;GO:0007015;GO:0030048;GO:0030330;GO:0006897;GO:0042491;GO:0042472;GO:0006886;GO:0045944;GO:0051046;GO:0007605;GO:0030050;	  C:actin cytoskeleton; C:actin filament; C:cell cortex; C:clathrin-coated pit; C:clathrin-coated vesicle membrane; C:cytoplasm; C:cytoplasmic vesicle; C:cytosol; C:endocytic vesicle; C:extracellular exosome; C:filamentous actin; C:filopodium; C:Golgi apparatus; C:lysosomal membrane; C:membrane; C:microvillus; C:nuclear membrane; C:nucleoplasm; C:nucleus; C:perinuclear region of cytoplasm; C:plasma membrane; C:RNA polymerase II, holoenzyme; C:ruffle; C:ruffle membrane; C:unconventional myosin complex; C:vesicle;	  F:actin binding; F:actin filament binding; F:actin-dependent ATPase activity; F:ADP binding; F:ATP binding; F:calmodulin binding; F:identical protein binding; F:microfilament motor activity; F:minus-end directed microfilament motor activity; F:motor activity;	  P:actin filament organization; P:actin filament-based movement; P:DNA damage response, signal transduction by p53 class mediator; P:endocytosis; P:inner ear auditory receptor cell differentiation; P:inner ear morphogenesis; P:intracellular protein transport; P:positive regulation of transcription by RNA polymerase II; P:regulation of secretion; P:sensory perception of sound; P:vesicle transport along actin filament;
XM_040200009.1	chrXV	7141237	7141237	chrXV	7154128	7170923	-	XM_040200009.1	path1	Q8JIR8	Interphotoreceptor matrix proteoglycan 1	Sialoprotein associated with cones and rods;	 PF01390;	 GO:0005576;GO:0033165;GO:0001917;GO:0001750;GO:0035374;GO:0008201;GO:0005540;GO:0007601;	  C:extracellular region; C:interphotoreceptor matrix; C:photoreceptor inner segment; C:photoreceptor outer segment;	  F:chondroitin sulfate binding; F:heparin binding; F:hyaluronic acid binding;	  P:visual perception;
XM_040200382.1	chrXV	7179766	7179766	chrXV	7182060	7186219	-	XM_040200382.1	path1	Q9N2B7	5-hydroxytryptamine receptor 1B	Serotonin receptor 1B;	 PF00001;	 GO:0030425;GO:0005887;GO:0045202;GO:0004993;GO:0030594;GO:0051378;GO:0007198;GO:0007610;GO:0046849;GO:0071312;GO:0035690;GO:0007268;GO:0007187;GO:0014063;GO:0050795;GO:0042310;	  C:dendrite; C:integral component of plasma membrane; C:synapse;	  F:G protein-coupled serotonin receptor activity; F:neurotransmitter receptor activity; F:serotonin binding;	  P:adenylate cyclase-inhibiting serotonin receptor signaling pathway; P:behavior; P:bone remodeling; P:cellular response to alkaloid; P:cellular response to drug; P:chemical synaptic transmission; P:G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger; P:negative regulation of serotonin secretion; P:regulation of behavior; P:vasoconstriction;
XM_040198716.1	chrXV	7179766	7179766	chrXV	7207859	7220834	-	XM_040198716.1	path1	Q9Y5W7 B4DI55 Q4VBR3 Q5TCF9 Q5TCG0 Q6NUI7 Q6PI37 Q9BSD1	Sorting nexin-14		 PF08628;PF00787;PF02194;PF00615;	 GO:0005829;GO:0030425;GO:0016021;GO:0043231;GO:0005770;GO:0031902;GO:0005765;GO:0005764;GO:0080025;GO:0097352;GO:0015031;	  C:cytosol; C:dendrite; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:late endosome; C:late endosome membrane; C:lysosomal membrane; C:lysosome;	  F:phosphatidylinositol-3,5-bisphosphate binding;	  P:autophagosome maturation; P:protein transport;
XR_005714215.1	chrXV	15927067	15927067	chrXV	15934124	15937052	+	XR_005714215.1	path1	Q7L622 Q9BVR2 Q9H9E9 Q9NXC0 Q9P2L3	G2/M phase-specific E3 ubiquitin-protein ligase	G2/M phase-specific HECT-type E3 ubiquitin transferase;	 PF00632;	 GO:0005829;GO:0005794;GO:0043231;GO:0005730;GO:0005634;GO:0046872;GO:0004842;GO:0006915;GO:0007275;	  C:cytosol; C:Golgi apparatus; C:intracellular membrane-bounded organelle; C:nucleolus; C:nucleus;	  F:metal ion binding; F:ubiquitin-protein transferase activity;	  P:apoptotic process; P:multicellular organism development;
XM_040200502.1	chrXV	17075806	17075806	chrXV	16974254	17087669	+	XM_040200502.1	path1	A1XQX8 A1XQX9	Neurexin-3a	Neurexin IIIa-alpha;Neurexin-3a-alpha;	 PF02210;PF01034;	 GO:0016021;GO:0046872;GO:0001525;GO:0007155;	  C:integral component of membrane;	  F:metal ion binding;	  P:angiogenesis; P:cell adhesion;
XM_040200322.1	chrXV	17075806	17075806	chrXV	17103656	17107480	-	XM_040200322.1	path1	P79747 Q8QFX5	Type II iodothyronine deiodinase	5DII;DIOII;Type 2 DI;Type-II 5'-deiodinase;	 PF00837;	 GO:0016021;GO:0004800;GO:0042446;GO:0042403;	  C:integral component of membrane;	  F:thyroxine 5'-deiodinase activity;	  P:hormone biosynthetic process; P:thyroid hormone metabolic process;
XM_040199401.1	chrXV	17075806	17075806	chrXV	17114713	17131050	-	XM_040199401.1	path1	Q8N1C3 Q5H9T8	Gamma-aminobutyric acid receptor subunit gamma-1	GABA(A) receptor subunit gamma-1;	 PF02931;PF02932;	 GO:0034707;GO:0032590;GO:1902711;GO:0005887;GO:0043005;GO:0005886;GO:0098794;GO:0045211;GO:0045202;GO:0050811;GO:0004890;GO:0022851;GO:0005237;GO:0030594;GO:1904315;GO:0007268;GO:1902476;GO:0007214;GO:0034220;GO:0050877;GO:0042391;GO:0060078;GO:0007165;GO:0051932;	  C:chloride channel complex; C:dendrite membrane; C:GABA-A receptor complex; C:integral component of plasma membrane; C:neuron projection; C:plasma membrane; C:postsynapse; C:postsynaptic membrane; C:synapse;	  F:GABA receptor binding; F:GABA-A receptor activity; F:GABA-gated chloride ion channel activity; F:inhibitory extracellular ligand-gated ion channel activity; F:neurotransmitter receptor activity; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential;	  P:chemical synaptic transmission; P:chloride transmembrane transport; P:gamma-aminobutyric acid signaling pathway; P:ion transmembrane transport; P:nervous system process; P:regulation of membrane potential; P:regulation of postsynaptic membrane potential; P:signal transduction; P:synaptic transmission, GABAergic;
XM_040200344.1	chrXV	17124985	17124985	chrXV	17183869	17189149	+	XM_040200344.1	path1	Q5XJQ7	Protein odd-skipped-related 1 {ECO:0000312|EMBL:AAH83241.1}		 PF00096;	 GO:0005634;GO:0000981;GO:0046872;GO:0000977;GO:0035779;GO:0072112;GO:0048389;GO:0001822;GO:0048382;GO:0000122;GO:0045892;GO:0033339;GO:0035777;GO:0035775;GO:0035778;GO:0035776;GO:0048793;GO:1903224;GO:1900107;GO:0006357;GO:0001655;	  C:nucleus;	  F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:metal ion binding; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding;	  P:angioblast cell differentiation; P:glomerular visceral epithelial cell differentiation; P:intermediate mesoderm development; P:kidney development; P:mesendoderm development; P:negative regulation of transcription by RNA polymerase II; P:negative regulation of transcription, DNA-templated; P:pectoral fin development; P:pronephric distal tubule development; P:pronephric glomerulus morphogenesis; P:pronephric nephron tubule epithelial cell differentiation; P:pronephric proximal tubule development; P:pronephros development; P:regulation of endodermal cell differentiation; P:regulation of nodal signaling pathway; P:regulation of transcription by RNA polymerase II; P:urogenital system development;
XM_040199961.1	chrXV	17241787	17241787	chrXV	17298604	17302939	-	XM_040199961.1	path1	Q6Y228	Ragulator complex protein LAMTOR3	Late endosomal/lysosomal adaptor and MAPK and MTOR activator 3;	 PF08923;	 GO:0071986;GO:0034613;GO:0071230;GO:0032008;GO:0050790;	  C:Ragulator complex;	 	  P:cellular protein localization; P:cellular response to amino acid stimulus; P:positive regulation of TOR signaling; P:regulation of catalytic activity;
XM_040203335.1	chrXVII	9212205	9212205	chrXVII	9210314	9213138	-	XM_040203335.1	path1	Q80ZF7	Retinol dehydrogenase 10		 PF00106;	 GO:0005737;GO:0005789;GO:0016021;GO:0043231;GO:0005811;GO:0016020;GO:0052650;GO:0016616;GO:0004745;GO:0009887;GO:0060449;GO:0043583;GO:0031076;GO:0035115;GO:0048568;GO:0048703;GO:0008406;GO:0001701;GO:0001656;GO:0014032;GO:0043584;GO:1900054;GO:0060431;GO:0042574;GO:0002138;GO:0042572;GO:0007601;	  C:cytoplasm; C:endoplasmic reticulum membrane; C:integral component of membrane; C:intracellular membrane-bounded organelle; C:lipid droplet; C:membrane;	  F:NADP-retinol dehydrogenase activity; F:oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; F:retinol dehydrogenase activity;	  P:animal organ morphogenesis; P:bud elongation involved in lung branching; P:ear development; P:embryonic camera-type eye development; P:embryonic forelimb morphogenesis; P:embryonic organ development; P:embryonic viscerocranium morphogenesis; P:gonad development; P:in utero embryonic development; P:metanephros development; P:neural crest cell development; P:nose development; P:positive regulation of retinoic acid biosynthetic process; P:primary lung bud formation; P:retinal metabolic process; P:retinoic acid biosynthetic process; P:retinol metabolic process; P:visual perception;
XM_040204698.1	chrXVII	9234304	9234304	chrXVII	9217866	9243100	-	XM_040204698.1	path1	Q9MZ19	Potassium voltage-gated channel subfamily B member 1 {ECO:0000250|UniProtKB:Q14721}	Voltage-gated potassium channel subunit Kv2.1;	 PF02214;PF00520;PF03521;	 GO:0030424;GO:0030425;GO:0016328;GO:0032809;GO:0043204;GO:0005886;GO:0045211;GO:0042383;GO:0008076;GO:0005251;GO:0046982;GO:0001508;GO:0071333;GO:0031669;GO:0042593;GO:0007215;GO:0046676;GO:0045956;GO:0033605;GO:1900454;GO:0010701;GO:0090314;GO:0071805;GO:0006813;GO:0051260;GO:0072659;GO:0098900;GO:0034765;GO:2000671;GO:0006904;	  C:axon; C:dendrite; C:lateral plasma membrane; C:neuronal cell body membrane; C:perikaryon; C:plasma membrane; C:postsynaptic membrane; C:sarcolemma; C:voltage-gated potassium channel complex;	  F:delayed rectifier potassium channel activity; F:protein heterodimerization activity;	  P:action potential; P:cellular response to glucose stimulus; P:cellular response to nutrient levels; P:glucose homeostasis; P:glutamate receptor signaling pathway; P:negative regulation of insulin secretion; P:positive regulation of calcium ion-dependent exocytosis; P:positive regulation of catecholamine secretion; P:positive regulation of long-term synaptic depression; P:positive regulation of norepinephrine secretion; P:positive regulation of protein targeting to membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:protein homooligomerization; P:protein localization to plasma membrane; P:regulation of action potential; P:regulation of ion transmembrane transport; P:regulation of motor neuron apoptotic process; P:vesicle docking involved in exocytosis;
XM_040205138.1	chrXVII	9257795	9257795	chrXVII	9254852	9261389	-	XM_040205138.1	path1	F1RE08 A1XBQ5 A9LLA5	Prostacyclin synthase {ECO:0000303|PubMed:18032380}	Hydroperoxy icosatetraenoate dehydratase;Prostaglandin I2 synthase {ECO:0000303|PubMed:18032380};	 PF00067;	 GO:0005789;GO:0016021;GO:0020037;GO:0106256;GO:0005506;GO:0004497;GO:0016705;GO:0008116;GO:0001516;	  C:endoplasmic reticulum membrane; C:integral component of membrane;	  F:heme binding; F:hydroperoxy icosatetraenoate dehydratase activity; F:iron ion binding; F:monooxygenase activity; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen; F:prostaglandin-I synthase activity;	  P:prostaglandin biosynthetic process;
XM_040204631.1	chrXVII	9257795	9257795	chrXVII	9262269	9269281	-	XM_040204631.1	path1	Q2T9W2 Q1JPF6	THUMP domain-containing protein 3		 PF02926;PF01170;	 GO:0008168;GO:0003723;GO:0032259;	 	  F:methyltransferase activity; F:RNA binding;	  P:methylation;
XM_040159966.1	chrXVII	9283852	9283852	chrXVII	9284816	9287192	+	XM_040159966.1	path3	P41542	General vesicular transport factor p115 {ECO:0000303|PubMed:7831323}	Protein USO1 homolog;Transcytosis-associated protein {ECO:0000303|PubMed:7831324};Vesicle-docking protein;	 PF18770;PF04871;PF04869;	 GO:0005829;GO:0005783;GO:0012507;GO:0001650;GO:0000139;GO:0005795;GO:0048471;GO:0006888;GO:0007030;GO:0048211;GO:0006891;GO:0006886;GO:0061025;GO:1900076;GO:0032252;GO:0007264;GO:0045056;GO:0048280;	  C:cytosol; C:endoplasmic reticulum; C:ER to Golgi transport vesicle membrane; C:fibrillar center; C:Golgi membrane; C:Golgi stack; C:perinuclear region of cytoplasm;	 	  P:endoplasmic reticulum to Golgi vesicle-mediated transport; P:Golgi organization; P:Golgi vesicle docking; P:intra-Golgi vesicle-mediated transport; P:intracellular protein transport; P:membrane fusion; P:regulation of cellular response to insulin stimulus; P:secretory granule localization; P:small GTPase mediated signal transduction; P:transcytosis; P:vesicle fusion with Golgi apparatus;
XM_040203559.1	chrXVII	9283852	9283852	chrXVII	9289012	9329997	+	XM_040203559.1	path1	O43295 Q8IX13 Q8IZV8	SLIT-ROBO Rho GTPase-activating protein 3	Mental disorder-associated GAP;Rho GTPase-activating protein 14;WAVE-associated Rac GTPase-activating protein;	 PF00611;PF00620;PF00018;	 GO:0005737;GO:0005829;GO:0005096;GO:0030336;GO:0043547;GO:0051056;GO:0007165;	  C:cytoplasm; C:cytosol;	  F:GTPase activator activity;	  P:negative regulation of cell migration; P:positive regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:signal transduction;
XM_040204787.1	chrXVII	9315195	9315195	chrXVII	9334434	9338440	-	XM_040204787.1	path1	Q7LHG5 D6VVK4 Q04717 Q04722 Q05350	Transposon Ty3-I Gag-Pol polyprotein	Gag3-Pol3;Transposon Ty3-2 TYA-TYB polyprotein;	 PF17921;PF12384;PF17919;PF00665;PF00078;	 GO:0005737;GO:0005634;GO:0000943;GO:0004190;GO:0005524;GO:0003677;GO:0003887;GO:0008233;GO:0004540;GO:0003723;GO:0003964;GO:0004523;GO:0008270;GO:0015074;GO:0006310;GO:0032197;	  C:cytoplasm; C:nucleus; C:retrotransposon nucleocapsid;	  F:aspartic-type endopeptidase activity; F:ATP binding; F:DNA binding; F:DNA-directed DNA polymerase activity; F:peptidase activity; F:ribonuclease activity; F:RNA binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity; F:zinc ion binding;	  P:DNA integration; P:DNA recombination; P:transposition, RNA-mediated;
XM_040204786.1	chrXVII	9315195	9315195	chrXVII	9334982	9338435	-	XM_040204786.1	path1	P04323	Retrovirus-related Pol polyprotein from transposon 17.6		 PF17921;PF17917;PF00078;	 GO:0004190;GO:0004519;GO:0003676;GO:0003964;GO:0015074;	 	  F:aspartic-type endopeptidase activity; F:endonuclease activity; F:nucleic acid binding; F:RNA-directed DNA polymerase activity;	  P:DNA integration;
XM_040204788.1	chrXVII	9320735	9320735	chrXVII	9339268	9340904	-	XM_040204788.1	path1	P03360 Q2Q1R2	Gag-Pol polyprotein		 PF18697;PF00075;PF17919;PF00665;PF00078;PF09337;	 GO:0004190;GO:0003677;GO:0003887;GO:0046872;GO:0003723;GO:0003964;GO:0004523;GO:0015074;GO:0006310;GO:0075713;GO:0046718;GO:0044826;	 	  F:aspartic-type endopeptidase activity; F:DNA binding; F:DNA-directed DNA polymerase activity; F:metal ion binding; F:RNA binding; F:RNA-directed DNA polymerase activity; F:RNA-DNA hybrid ribonuclease activity;	  P:DNA integration; P:DNA recombination; P:establishment of integrated proviral latency; P:viral entry into host cell; P:viral genome integration into host DNA;
XM_040203999.1	chrXVII	9366816	9366816	chrXVII	9347893	9368460	+	XM_040203999.1	path1	Q9NS91 Q58F55 Q9NRT6	E3 ubiquitin-protein ligase RAD18	Postreplication repair protein RAD18;RING finger protein 73;RING-type E3 ubiquitin transferase RAD18 {ECO:0000305};	 PF02037;	 GO:0005813;GO:0005737;GO:0016604;GO:0042405;GO:0005654;GO:0005634;GO:0097505;GO:0005657;GO:0035861;GO:0003684;GO:0042802;GO:0046872;GO:0031593;GO:0044877;GO:0003697;GO:0061630;GO:0031625;GO:0000403;GO:0006974;GO:0042769;GO:0006281;GO:0060548;GO:0051984;GO:0006301;GO:0051865;GO:0006513;GO:0016567;GO:0009411;	  C:centrosome; C:cytoplasm; C:nuclear body; C:nuclear inclusion body; C:nucleoplasm; C:nucleus; C:Rad6-Rad18 complex; C:replication fork; C:site of double-strand break;	  F:damaged DNA binding; F:identical protein binding; F:metal ion binding; F:polyubiquitin modification-dependent protein binding; F:protein-containing complex binding; F:single-stranded DNA binding; F:ubiquitin protein ligase activity; F:ubiquitin protein ligase binding; F:Y-form DNA binding;	  P:cellular response to DNA damage stimulus; P:DNA damage response, detection of DNA damage; P:DNA repair; P:negative regulation of cell death; P:positive regulation of chromosome segregation; P:postreplication repair; P:protein autoubiquitination; P:protein monoubiquitination; P:protein ubiquitination; P:response to UV;
XM_040203400.1	chrXVII	9366816	9366816	chrXVII	9390094	9393019	-	XM_040203400.1	path1	P56539 A8K777 Q3T1A4	Caveolin-3	M-caveolin;	 PF01146;	 GO:0005901;GO:0009986;GO:0016010;GO:0005783;GO:0000139;GO:0005887;GO:0014704;GO:0043231;GO:0045121;GO:0031594;GO:0005886;GO:0042383;GO:0030315;GO:0031982;GO:0030018;GO:0043014;GO:0005246;GO:0071253;GO:0044325;GO:0060090;GO:0050998;GO:0019870;GO:0008022;GO:0044877;GO:0017080;GO:0007015;GO:0055013;GO:0070836;GO:0030154;GO:0071417;GO:0042632;GO:0031122;GO:0035995;GO:0006897;GO:0042593;GO:0060347;GO:0031579;GO:0046716;GO:0006936;GO:0007517;GO:0007520;GO:0051926;GO:0010614;GO:0061052;GO:0045792;GO:0043407;GO:0043409;GO:1900826;GO:0051001;GO:1901380;GO:1901017;GO:0006469;GO:2000009;GO:0060299;GO:0051647;GO:0007009;GO:0001778;GO:2001288;GO:0008284;GO:0007204;GO:0031116;GO:0010831;GO:2000060;GO:0008104;GO:0072659;GO:0060762;GO:0090279;GO:1901019;GO:0098909;GO:0055117;GO:0051480;GO:0008016;GO:0002027;GO:1900825;GO:0042391;GO:0051394;GO:1900744;GO:0051896;GO:0038009;GO:0014819;GO:2000649;GO:0017015;GO:0060373;GO:0060307;GO:0033292;GO:0006641;GO:0086005;	  C:caveola; C:cell surface; C:dystrophin-associated glycoprotein complex; C:endoplasmic reticulum; C:Golgi membrane; C:integral component of plasma membrane; C:intercalated disc; C:intracellular membrane-bounded organelle; C:membrane raft; C:neuromuscular junction; C:plasma membrane; C:sarcolemma; C:T-tubule; C:vesicle; C:Z disc;	  F:alpha-tubulin binding; F:calcium channel regulator activity; F:connexin binding; F:ion channel binding; F:molecular adaptor activity; F:nitric-oxide synthase binding; F:potassium channel inhibitor activity; F:protein C-terminus binding; F:protein-containing complex binding; F:sodium channel regulator activity;	  P:actin filament organization; P:cardiac muscle cell development; P:caveola assembly; P:cell differentiation; P:cellular response to organonitrogen compound; P:cholesterol homeostasis; P:cytoplasmic microtubule organization; P:detection of muscle stretch; P:endocytosis; P:glucose homeostasis; P:heart trabecula formation; P:membrane raft organization; P:muscle cell cellular homeostasis; P:muscle contraction; P:muscle organ development; P:myoblast fusion; P:negative regulation of calcium ion transport; P:negative regulation of cardiac muscle hypertrophy; P:negative regulation of cell growth involved in cardiac muscle cell development; P:negative regulation of cell size; P:negative regulation of MAP kinase activity; P:negative regulation of MAPK cascade; P:negative regulation of membrane depolarization during cardiac muscle cell action potential; P:negative regulation of nitric-oxide synthase activity; P:negative regulation of potassium ion transmembrane transport; P:negative regulation of potassium ion transmembrane transporter activity; P:negative regulation of protein kinase activity; P:negative regulation of protein localization to cell surface; P:negative regulation of sarcomere organization; P:nucleus localization; P:plasma membrane organization; P:plasma membrane repair; P:positive regulation of caveolin-mediated endocytosis; P:positive regulation of cell population proliferation; P:positive regulation of cytosolic calcium ion concentration; P:positive regulation of microtubule polymerization; P:positive regulation of myotube differentiation; P:positive regulation of ubiquitin-dependent protein catabolic process; P:protein localization; P:protein localization to plasma membrane; P:regulation of branching involved in mammary gland duct morphogenesis; P:regulation of calcium ion import; P:regulation of calcium ion transmembrane transporter activity; P:regulation of cardiac muscle cell action potential involved in regulation of contraction; P:regulation of cardiac muscle contraction; P:regulation of cytosolic calcium ion concentration; P:regulation of heart contraction; P:regulation of heart rate; P:regulation of membrane depolarization during cardiac muscle cell action potential; P:regulation of membrane potential; P:regulation of nerve growth factor receptor activity; P:regulation of p38MAPK cascade; P:regulation of protein kinase B signaling; P:regulation of signal transduction by receptor internalization; P:regulation of skeletal muscle contraction; P:regulation of sodium ion transmembrane transporter activity; P:regulation of transforming growth factor beta receptor signaling pathway; P:regulation of ventricular cardiac muscle cell membrane depolarization; P:regulation of ventricular cardiac muscle cell membrane repolarization; P:T-tubule organization; P:triglyceride metabolic process; P:ventricular cardiac muscle cell action potential;
XM_040203401.1	chrXVII	9369178	9369178	chrXVII	9394150	9397684	-	XM_040203401.1	path1	A0M8S6	Caveolin-2		 PF01146;	 GO:0005901;GO:0031410;GO:0031234;GO:0005794;GO:0000139;GO:0005887;GO:0005634;GO:0048471;GO:0031748;GO:0060090;GO:0019901;GO:0070836;GO:0030154;GO:0007029;GO:0008286;GO:0007005;GO:0001937;GO:0060161;GO:0043410;GO:0051480;GO:0048741;GO:0048278;GO:0006906;	  C:caveola; C:cytoplasmic vesicle; C:extrinsic component of cytoplasmic side of plasma membrane; C:Golgi apparatus; C:Golgi membrane; C:integral component of plasma membrane; C:nucleus; C:perinuclear region of cytoplasm;	  F:D1 dopamine receptor binding; F:molecular adaptor activity; F:protein kinase binding;	  P:caveola assembly; P:cell differentiation; P:endoplasmic reticulum organization; P:insulin receptor signaling pathway; P:mitochondrion organization; P:negative regulation of endothelial cell proliferation; P:positive regulation of dopamine receptor signaling pathway; P:positive regulation of MAPK cascade; P:regulation of cytosolic calcium ion concentration; P:skeletal muscle fiber development; P:vesicle docking; P:vesicle fusion;
XM_040203390.1	chrXVII	9435280	9435280	chrXVII	9403901	9414786	-	XM_040203390.1	path1	Q9Y6F1 Q8NER9 Q96CG2 Q9UG81	Protein mono-ADP-ribosyltransferase PARP3 {ECO:0000305}	ADP-ribosyltransferase diphtheria toxin-like 3 {ECO:0000303|PubMed:20106667};DNA ADP-ribosyltransferase PARP3 {ECO:0000305};IRT1;NAD(+) ADP-ribosyltransferase 3 {ECO:0000303|PubMed:20106667};Poly [ADP-ribose] polymerase 3 {ECO:0000303|PubMed:12640039, ECO:0000303|PubMed:20106667};Poly[ADP-ribose] synthase 3 {ECO:0000303|PubMed:20106667};	 PF00644;PF02877;PF05406;	 GO:0005814;GO:0005737;GO:0045171;GO:0016604;GO:0005730;GO:0005654;GO:0035861;GO:0003824;GO:0140294;GO:0003950;GO:1990404;GO:0030592;GO:0006281;GO:0006302;GO:0045829;GO:1905662;GO:0051106;GO:2001034;GO:0006471;GO:0070213;GO:1990166;GO:0140289;GO:0070212;GO:0060236;GO:0000723;	  C:centriole; C:cytoplasm; C:intercellular bridge; C:nuclear body; C:nucleolus; C:nucleoplasm; C:site of double-strand break;	  F:catalytic activity; F:NAD DNA ADP-ribosyltransferase activity; F:NAD+ ADP-ribosyltransferase activity; F:protein ADP-ribosylase activity;	  P:DNA ADP-ribosylation; P:DNA repair; P:double-strand break repair; P:negative regulation of isotype switching; P:negative regulation of telomerase RNA reverse transcriptase activity; P:positive regulation of DNA ligation; P:positive regulation of double-strand break repair via nonhomologous end joining; P:protein ADP-ribosylation; P:protein auto-ADP-ribosylation; P:protein localization to site of double-strand break; P:protein mono-ADP-ribosylation; P:protein poly-ADP-ribosylation; P:regulation of mitotic spindle organization; P:telomere maintenance;
XM_040203385.1	chrXVII	9435280	9435280	chrXVII	9416038	9441455	-	XM_040203385.1	path1	Q14BI2	Metabotropic glutamate receptor 2		 PF00003;PF01094;PF07562;	 GO:0097449;GO:0030424;GO:0030425;GO:0005887;GO:0099055;GO:0043005;GO:0042734;GO:0001640;GO:0005246;GO:0001641;GO:0097110;GO:0035095;GO:0007268;GO:0007216;GO:0010467;GO:0090461;GO:0014047;GO:0014059;GO:0014048;GO:0051896;GO:2001023;GO:0051966;GO:0042220;	  C:astrocyte projection; C:axon; C:dendrite; C:integral component of plasma membrane; C:integral component of postsynaptic membrane; C:neuron projection; C:presynaptic membrane;	  F:adenylate cyclase inhibiting G protein-coupled glutamate receptor activity; F:calcium channel regulator activity; F:group II metabotropic glutamate receptor activity; F:scaffold protein binding;	  P:behavioral response to nicotine; P:chemical synaptic transmission; P:G protein-coupled glutamate receptor signaling pathway; P:gene expression; P:glutamate homeostasis; P:glutamate secretion; P:regulation of dopamine secretion; P:regulation of glutamate secretion; P:regulation of protein kinase B signaling; P:regulation of response to drug; P:regulation of synaptic transmission, glutamatergic; P:response to cocaine;
XM_040203396.1	chrXVII	9435280	9435280	chrXVII	9442862	9490373	-	XM_040203396.1	path1	Q9Y6I9 B3KN87 Q9UKD7	Testis-expressed protein 264 {ECO:0000305}	Putative secreted protein Zsig11 {ECO:0000303|Ref.1};	 	 GO:0000421;GO:0005829;GO:0005789;GO:0005576;GO:0016021;GO:0005634;GO:0031093;GO:0005657;GO:0038023;GO:0002576;GO:0106300;GO:0061709;	  C:autophagosome membrane; C:cytosol; C:endoplasmic reticulum membrane; C:extracellular region; C:integral component of membrane; C:nucleus; C:platelet alpha granule lumen; C:replication fork;	  F:signaling receptor activity;	  P:platelet degranulation; P:protein-DNA covalent cross-linking repair; P:reticulophagy;
XM_040203380.1	chrXVII	9467756	9467756	chrXVII	9491592	9503485	-	XM_040203380.1	path1	Q9BXW9 Q2LA86 Q69YP9 Q6PJN7 Q9BQ06 Q9H9T9	Fanconi anemia group D2 protein		 PF14631;	 GO:0000793;GO:0005829;GO:0016604;GO:0005730;GO:0005654;GO:0005634;GO:0070182;GO:0048854;GO:0034599;GO:1990918;GO:0007276;GO:0007129;GO:0036297;GO:0031573;GO:0097150;GO:2000348;GO:0051090;GO:0050727;GO:0045589;GO:0010332;	  C:condensed chromosome; C:cytosol; C:nuclear body; C:nucleolus; C:nucleoplasm; C:nucleus;	  F:DNA polymerase binding;	  P:brain morphogenesis; P:cellular response to oxidative stress; P:double-strand break repair involved in meiotic recombination; P:gamete generation; P:homologous chromosome pairing at meiosis; P:interstrand cross-link repair; P:intra-S DNA damage checkpoint; P:neuronal stem cell population maintenance; P:regulation of CD40 signaling pathway; P:regulation of DNA-binding transcription factor activity; P:regulation of inflammatory response; P:regulation of regulatory T cell differentiation; P:response to gamma radiation;
XM_040203399.1	chrXVII	9485952	9485952	chrXVII	9504605	9506438	+	XM_040203399.1	path1	P00435 A6QPG3	Glutathione peroxidase 1 {ECO:0000305}	Cellular glutathione peroxidase;	 PF00255;	 GO:0005829;GO:0097413;GO:0005739;GO:0004602;GO:0004601;GO:0047066;GO:0017124;GO:0060055;GO:0019369;GO:0051702;GO:0043534;GO:0045454;GO:0001885;GO:0045444;GO:0006749;GO:0060047;GO:0042744;GO:0019372;GO:0051450;GO:0043154;GO:1902042;GO:0002862;GO:1902176;GO:0090201;GO:0051897;GO:1902905;GO:0018158;GO:0040029;GO:0033599;GO:0061136;GO:0010332;GO:0042542;GO:0033194;GO:0010269;GO:0009609;GO:0009410;GO:0007605;GO:0048741;GO:0043403;GO:0001659;GO:0006641;GO:0009650;GO:0042311;	  C:cytosol; C:Lewy body; C:mitochondrion;	  F:glutathione peroxidase activity; F:peroxidase activity; F:phospholipid-hydroperoxide glutathione peroxidase activity; F:SH3 domain binding;	  P:angiogenesis involved in wound healing; P:arachidonic acid metabolic process; P:biological process involved in interaction with symbiont; P:blood vessel endothelial cell migration; P:cell redox homeostasis; P:endothelial cell development; P:fat cell differentiation; P:glutathione metabolic process; P:heart contraction; P:hydrogen peroxide catabolic process; P:lipoxygenase pathway; P:myoblast proliferation; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; P:negative regulation of inflammatory response to antigenic stimulus; P:negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; P:negative regulation of release of cytochrome c from mitochondria; P:positive regulation of protein kinase B signaling; P:positive regulation of supramolecular fiber organization; P:protein oxidation; P:regulation of gene expression, epigenetic; P:regulation of mammary gland epithelial cell proliferation; P:regulation of proteasomal protein catabolic process; P:response to gamma radiation; P:response to hydrogen peroxide; P:response to hydroperoxide; P:response to selenium ion; P:response to symbiotic bacterium; P:response to xenobiotic stimulus; P:sensory perception of sound; P:skeletal muscle fiber development; P:skeletal muscle tissue regeneration; P:temperature homeostasis; P:triglyceride metabolic process; P:UV protection; P:vasodilation;
XM_040203384.1	chrXVII	9485952	9485952	chrXVII	9506810	9518872	-	XM_040203384.1	path1	A6QR55	Ubiquitin carboxyl-terminal hydrolase 4	Deubiquitinating enzyme 4;Ubiquitin thioesterase 4;Ubiquitin-specific-processing protease 4;	 PF06337;PF14836;PF00443;	 GO:0005737;GO:0005829;GO:0005634;GO:0005886;GO:0031685;GO:0042802;GO:0046872;GO:0004843;GO:0031397;GO:0016579;GO:0034394;GO:0031647;GO:0000244;GO:0006511;	  C:cytoplasm; C:cytosol; C:nucleus; C:plasma membrane;	  F:adenosine receptor binding; F:identical protein binding; F:metal ion binding; F:thiol-dependent deubiquitinase;	  P:negative regulation of protein ubiquitination; P:protein deubiquitination; P:protein localization to cell surface; P:regulation of protein stability; P:spliceosomal tri-snRNP complex assembly; P:ubiquitin-dependent protein catabolic process;
XM_040160694.1	chrXVIII	5367982	5367982	chrXVIII	5362990	5414764	-	XM_040160694.1	path1	Q5RHR6	Protein broad-minded	TBC1 domain family member 32;	 PF14961;	 GO:0005929;GO:0005737;GO:0035082;GO:0060271;GO:0007275;GO:1905515;	  C:cilium; C:cytoplasm;	 	  P:axoneme assembly; P:cilium assembly; P:multicellular organism development; P:non-motile cilium assembly;
XM_040160077.1	chrXVIII	5469082	5469082	chrXVIII	5466514	5472852	+	XM_040160077.1	path1	Q3SZW3	Protein ARV1		 PF04161;	 GO:0005789;GO:0016021;GO:0008203;GO:0032366;GO:0090181;GO:0032383;	  C:endoplasmic reticulum membrane; C:integral component of membrane;	 	  P:cholesterol metabolic process; P:intracellular sterol transport; P:regulation of cholesterol metabolic process; P:regulation of intracellular cholesterol transport;
XM_040160445.1	chrXVIII	5567306	5567306	chrXVIII	5563106	5738795	-	XM_040160445.1	path1	Q5IGR7	Exostosin-1b	Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase 1b;Multiple exostoses protein 1 homolog b;	 PF03016;PF09258;	 GO:0005794;GO:0030176;GO:0008375;GO:0050508;GO:0015020;GO:0046872;GO:0050509;GO:0016757;GO:0015012;GO:0006486;	  C:Golgi apparatus; C:integral component of endoplasmic reticulum membrane;	  F:acetylglucosaminyltransferase activity; F:glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; F:glucuronosyltransferase activity; F:metal ion binding; F:N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity; F:transferase activity, transferring glycosyl groups;	  P:heparan sulfate proteoglycan biosynthetic process; P:protein glycosylation;
XM_040161332.1	chrXVIII	6949222	6949222	chrXVIII	6866600	6941305	-	XM_040161332.1	path1	Q15413 O15175 Q15412	Ryanodine receptor 3	Brain ryanodine receptor-calcium release channel;Brain-type ryanodine receptor;Type 3 ryanodine receptor;	 PF08709;PF00520;PF02815;PF08454;PF06459;PF01365;PF02026;PF00622;	 GO:0034704;GO:0030659;GO:0016021;GO:0005886;GO:0042383;GO:0016529;GO:0033017;GO:0005790;GO:0030018;GO:0005509;GO:0048763;GO:0015278;GO:0005516;GO:0005219;GO:0070588;GO:0006816;GO:0071318;GO:0071313;GO:0071277;GO:0071286;GO:0034220;GO:0051289;GO:1903779;GO:0051209;	  C:calcium channel complex; C:cytoplasmic vesicle membrane; C:integral component of membrane; C:plasma membrane; C:sarcolemma; C:sarcoplasmic reticulum; C:sarcoplasmic reticulum membrane; C:smooth endoplasmic reticulum; C:Z disc;	  F:calcium ion binding; F:calcium-induced calcium release activity; F:calcium-release channel activity; F:calmodulin binding; F:ryanodine-sensitive calcium-release channel activity;	  P:calcium ion transmembrane transport; P:calcium ion transport; P:cellular response to ATP; P:cellular response to caffeine; P:cellular response to calcium ion; P:cellular response to magnesium ion; P:ion transmembrane transport; P:protein homotetramerization; P:regulation of cardiac conduction; P:release of sequestered calcium ion into cytosol;
XM_040160328.1	chrXVIII	6949222	6949222	chrXVIII	6967844	6968621	-	XM_040160328.1	path2	Q9BPU6 Q8TCL6 Q9NQC4 Q9NRY9	Dihydropyrimidinase-related protein 5	CRMP3-associated molecule;Collapsin response mediator protein 5;UNC33-like phosphoprotein 6;	 PF01979;	 GO:0005829;GO:0030425;GO:0043025;GO:0016810;GO:0008017;GO:0007411;GO:0007399;GO:0007165;	  C:cytosol; C:dendrite; C:neuronal cell body;	  F:hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds; F:microtubule binding;	  P:axon guidance; P:nervous system development; P:signal transduction;
XM_040160286.1	chrXVIII	6980343	6980343	chrXVIII	6989640	7045217	+	XM_040160286.1	path1	O43166 J3KP19 O95321 Q9UDU4 Q9UNU4	Signal-induced proliferation-associated 1-like protein 1	High-risk human papilloma viruses E6 oncoproteins targeted protein 1;	 PF02145;PF11881;	 GO:0015629;GO:0005737;GO:0043197;GO:0005886;GO:0014069;GO:0046875;GO:0005096;GO:0031532;GO:0090630;GO:0048013;GO:0050770;GO:0048814;GO:0061001;GO:0043087;GO:0051056;GO:0048167;	  C:actin cytoskeleton; C:cytoplasm; C:dendritic spine; C:plasma membrane; C:postsynaptic density;	  F:ephrin receptor binding; F:GTPase activator activity;	  P:actin cytoskeleton reorganization; P:activation of GTPase activity; P:ephrin receptor signaling pathway; P:regulation of axonogenesis; P:regulation of dendrite morphogenesis; P:regulation of dendritic spine morphogenesis; P:regulation of GTPase activity; P:regulation of small GTPase mediated signal transduction; P:regulation of synaptic plasticity;
XM_040160312.1	chrXVIII	7070855	7070855	chrXVIII	7050759	7093018	+	XM_040160312.1	path1	Q9Z2H2 Q08AT5 Q8BGI8	Regulator of G-protein signaling 6		 PF00610;PF00631;PF00615;PF18148;	 GO:0005737;GO:0005829;GO:0019898;GO:0005794;GO:0005634;GO:0005886;GO:0032991;GO:0005096;GO:0019904;GO:0007186;GO:0035556;GO:0009968;GO:0043547;GO:0045666;	  C:cytoplasm; C:cytosol; C:extrinsic component of membrane; C:Golgi apparatus; C:nucleus; C:plasma membrane; C:protein-containing complex;	  F:GTPase activator activity; F:protein domain specific binding;	  P:G protein-coupled receptor signaling pathway; P:intracellular signal transduction; P:negative regulation of signal transduction; P:positive regulation of GTPase activity; P:positive regulation of neuron differentiation;
XM_040160307.1	chrXVIII	7070855	7070855	chrXVIII	7094917	7221007	-	XM_040160307.1	path1	Q60675 F8VQ43 Q05003 Q64061	Laminin subunit alpha-2	Laminin M chain;Laminin-12 subunit alpha;Laminin-2 subunit alpha;Laminin-4 subunit alpha;Merosin heavy chain;	 PF00052;PF00053;PF00054;PF02210;PF06008;PF06009;PF00055;	 GO:0005604;GO:0062023;GO:0043197;GO:0005576;GO:0031594;GO:0042383;GO:0043083;GO:0005201;GO:0005102;GO:0009887;GO:0007411;GO:0007155;GO:0032224;GO:0030155;GO:0030334;GO:0045995;GO:0014037;GO:0009888;	  C:basement membrane; C:collagen-containing extracellular matrix; C:dendritic spine; C:extracellular region; C:neuromuscular junction; C:sarcolemma; C:synaptic cleft;	  F:extracellular matrix structural constituent; F:signaling receptor binding;	  P:animal organ morphogenesis; P:axon guidance; P:cell adhesion; P:positive regulation of synaptic transmission, cholinergic; P:regulation of cell adhesion; P:regulation of cell migration; P:regulation of embryonic development; P:Schwann cell differentiation; P:tissue development;
XM_040166202.1	chrXX	10019655	10019655	chrXX	10016919	10019649	-	XM_040166202.1	path1	Q6P0J3 Q6ED30	Transcription factor Sp8		 PF00096;	 GO:0005634;GO:0000981;GO:0003690;GO:0046872;GO:0000978;GO:0030326;GO:0035118;GO:0045743;GO:0006357;	  C:nucleus;	  F:DNA-binding transcription factor activity, RNA polymerase II-specific; F:double-stranded DNA binding; F:metal ion binding; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding;	  P:embryonic limb morphogenesis; P:embryonic pectoral fin morphogenesis; P:positive regulation of fibroblast growth factor receptor signaling pathway; P:regulation of transcription by RNA polymerase II;
XM_040166432.1	chrXX	10145050	10145050	chrXX	10129068	10195827	+	XM_040166432.1	path1	Q76LL6 B2RQR3 Q5DTV7 Q76HP7 Q76LL5	FH1/FH2 domain-containing protein 3	Formin homolog overexpressed in spleen 2;	 PF02181;PF18382;	 GO:0005737;GO:0005856;GO:0030017;GO:0005865;GO:0030018;GO:0051015;GO:0051639;GO:0055003;GO:0030866;GO:0030837;GO:0045214;	  C:cytoplasm; C:cytoskeleton; C:sarcomere; C:striated muscle thin filament; C:Z disc;	  F:actin filament binding;	  P:actin filament network formation; P:cardiac myofibril assembly; P:cortical actin cytoskeleton organization; P:negative regulation of actin filament polymerization; P:sarcomere organization;
XM_040165316.1	chrXX	10244598	10244598	chrXX	10209928	10224466	+	XM_040165316.1	path1	P0C0L5 A2BHY4 P01028 P78445 Q13160 Q13906 Q14033 Q14835 Q6U2E9 Q6U2G1 Q6U2I5 Q6U2L1 Q6U2L7 Q6U2L9 Q6U2M5 Q6VCV8 Q96SA7 Q9NPK5 Q9UIP5	Complement C4-B	Basic complement C4;C3 and PZP-like alpha-2-macroglobulin domain-containing protein 3;	 PF00207;PF07703;PF07677;PF01821;PF01835;PF17791;PF17789;PF01759;PF07678;	 GO:0030424;GO:0072562;GO:0030425;GO:0070062;GO:0005576;GO:0005615;GO:0044216;GO:0005886;GO:0045202;GO:0030246;GO:0001848;GO:0004866;GO:0006956;GO:0006958;GO:0032490;GO:0006954;GO:0045087;GO:0008228;GO:2000427;GO:0030449;	  C:axon; C:blood microparticle; C:dendrite; C:extracellular exosome; C:extracellular region; C:extracellular space; C:other organism cell; C:plasma membrane; C:synapse;	  F:carbohydrate binding; F:complement binding; F:endopeptidase inhibitor activity;	  P:complement activation; P:complement activation, classical pathway; P:detection of molecule of bacterial origin; P:inflammatory response; P:innate immune response; P:opsonization; P:positive regulation of apoptotic cell clearance; P:regulation of complement activation;
XM_040166373.1	chrXX	10242563	10242563	chrXX	10227618	10234296	+	XM_040166373.1	path1	P10039 O73584 O73585 P13132	Tenascin	Cytotactin;GMEM;GP 150-225;Glioma-associated-extracellular matrix antigen;Hexabrachion;JI;Myotendinous antigen;Neuronectin;Tenascin-C;	 PF07974;PF18720;PF00147;PF00041;	 GO:0062023;GO:0005615;GO:0005102;GO:0007155;GO:0042127;	  C:collagen-containing extracellular matrix; C:extracellular space;	  F:signaling receptor binding;	  P:cell adhesion; P:regulation of cell population proliferation;
XM_040166091.1	chrXX	10242429	10242429	chrXX	10234536	10237797	+	XM_040166091.1	path1	P08686 A2BHY6 P04033 Q01204 Q08AG8 Q16749 Q16806 Q5ST44 Q96NU8	Steroid 21-hydroxylase {ECO:0000303|PubMed:25855791}	21-OHase;Cytochrome P-450c21;Cytochrome P450 21;Cytochrome P450 XXI;Cytochrome P450-C21;Cytochrome P450-C21B;	 PF00067;	 GO:0005789;GO:0103069;GO:0020037;GO:0005506;GO:0106309;GO:0004509;GO:0005496;GO:0008395;GO:0006704;GO:0006705;GO:0006694;GO:0008202;GO:0016125;	  C:endoplasmic reticulum membrane;	  F:17-hydroxyprogesterone 21-hydroxylase activity; F:heme binding; F:iron ion binding; F:progesterone 21-hydroxylase activity; F:steroid 21-monooxygenase activity; F:steroid binding; F:steroid hydroxylase activity;	  P:glucocorticoid biosynthetic process; P:mineralocorticoid biosynthetic process; P:steroid biosynthetic process; P:steroid metabolic process; P:sterol metabolic process;
XM_040165609.1	chrXX	10242429	10242429	chrXX	10243848	10245316	+	XM_040165609.1	path1	Q9BQI0 B2RBC4 Q6ZR40 Q8NAX7 Q8WU47 Q9H9G0	Allograft inflammatory factor 1-like	Ionized calcium-binding adapter molecule 2;	 	 GO:0015629;GO:0005737;GO:0070062;GO:0005925;GO:0032991;GO:0032587;GO:0051015;GO:0005509;GO:0051017;GO:0097178;	  C:actin cytoskeleton; C:cytoplasm; C:extracellular exosome; C:focal adhesion; C:protein-containing complex; C:ruffle membrane;	  F:actin filament binding; F:calcium ion binding;	  P:actin filament bundle assembly; P:ruffle assembly;
XR_005710264.1	chrXX	10242429	10242429	chrXX	10244982	10267375	-	XR_005710264.1	path1	Q9N179	Protein 4.1	4.1R;Band 4.1;Erythrocyte membrane protein band 4.1 {ECO:0000250|UniProtKB:P11171};	 PF05902;PF08736;PF09380;PF00373;PF09379;PF04382;	 GO:0016323;GO:0099738;GO:0005856;GO:0005634;GO:0005886;GO:0003779;GO:0005516;GO:0005198;GO:0031032;GO:0007049;GO:0051301;GO:0030866;GO:1904778;GO:0051924;GO:1904478;	  C:basolateral plasma membrane; C:cell cortex region; C:cytoskeleton; C:nucleus; C:plasma membrane;	  F:actin binding; F:calmodulin binding; F:structural molecule activity;	  P:actomyosin structure organization; P:cell cycle; P:cell division; P:cortical actin cytoskeleton organization; P:positive regulation of protein localization to cell cortex; P:regulation of calcium ion transport; P:regulation of intestinal absorption;
XM_040165608.1	chrXX	10242429	10242429	chrXX	10245423	10248902	+	XM_040165608.1	path1	P67868 P07312 P13862 Q2YDL2	Casein kinase II subunit beta	Phosvitin;	 PF01214;	 GO:0005737;GO:0005956;GO:0046872;GO:0019887;GO:0046719;GO:0042325;GO:0050792;GO:0016055;	  C:cytoplasm; C:protein kinase CK2 complex;	  F:metal ion binding; F:protein kinase regulator activity;	  P:regulation by virus of viral protein levels in host cell; P:regulation of phosphorylation; P:regulation of viral process; P:Wnt signaling pathway;
XR_005710265.1	chrXX	10246627	10246627	chrXX	10279721	10280652	-	XR_005710265.1	path1	O95279 B2RAQ6 B5TJL2 Q5VV76	Potassium channel subfamily K member 5	Acid-sensitive potassium channel protein TASK-2;TWIK-related acid-sensitive K(+) channel 2;	 PF07885;	 GO:0005887;GO:0005267;GO:0022841;GO:0005244;GO:0007588;GO:0097623;GO:0071805;GO:0006813;GO:0034765;GO:0060075;GO:0030322;	  C:integral component of plasma membrane;	  F:potassium channel activity; F:potassium ion leak channel activity; F:voltage-gated ion channel activity;	  P:excretion; P:potassium ion export across plasma membrane; P:potassium ion transmembrane transport; P:potassium ion transport; P:regulation of ion transmembrane transport; P:regulation of resting membrane potential; P:stabilization of membrane potential;
XM_040165303.1	chrXX	10252440	10252440	chrXX	10292765	10297287	-	XM_040165303.1	path1	P19139 Q5BKC1	Casein kinase II subunit alpha		 PF00069;	 GO:0000785;GO:0005737;GO:0005829;GO:0005634;GO:0016581;GO:0005886;GO:0005956;GO:0016580;GO:0005524;GO:0008013;GO:0042802;GO:0016301;GO:0047485;GO:0019888;GO:0106310;GO:0004674;GO:0106311;GO:0043021;GO:0006915;GO:0007049;GO:0021987;GO:0097421;GO:0043154;GO:2000059;GO:0018105;GO:0018107;GO:0030307;GO:0008284;GO:0045732;GO:0030177;GO:0046777;GO:0006468;GO:0051726;GO:1905818;GO:1903076;GO:0033574;GO:0048511;GO:0016055;	  C:chromatin; C:cytoplasm; C:cytosol; C:nucleus; C:NuRD complex; C:plasma membrane; C:protein kinase CK2 complex; C:Sin3 complex;	  F:ATP binding; F:beta-catenin binding; F:identical protein binding; F:kinase activity; F:protein N-terminus binding; F:protein phosphatase regulator activity; F:protein serine kinase activity; F:protein serine/threonine kinase activity; F:protein threonine kinase activity; F:ribonucleoprotein complex binding;	  P:apoptotic process; P:cell cycle; P:cerebral cortex development; P:liver regeneration; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; P:negative regulation of ubiquitin-dependent protein catabolic process; P:peptidyl-serine phosphorylation; P:peptidyl-threonine phosphorylation; P:positive regulation of cell growth; P:positive regulation of cell population proliferation; P:positive regulation of protein catabolic process; P:positive regulation of Wnt signaling pathway; P:protein autophosphorylation; P:protein phosphorylation; P:regulation of cell cycle; P:regulation of chromosome separation; P:regulation of protein localization to plasma membrane; P:response to testosterone; P:rhythmic process; P:Wnt signaling pathway;
XM_040164753.1	chrXX	10381259	10381259	chrXX	10365700	10369166	-	XM_040164753.1	path1	P59647 Q6P9W0	FXYD domain-containing ion transport regulator 5		 PF02038;	 GO:0016021;GO:0003779;GO:0045296;GO:0099106;GO:0017080;GO:0006811;GO:2000649;	  C:integral component of membrane;	  F:actin binding; F:cadherin binding; F:ion channel regulator activity; F:sodium channel regulator activity;	  P:ion transport; P:regulation of sodium ion transmembrane transporter activity;
XM_040164761.1	chrXX	10381259	10381259	chrXX	10372591	10422343	-	XM_040164761.1	path1	O60500 A6NDH2 C3RX61	Nephrin	Renal glomerulus-specific cell adhesion receptor;	 PF08205;PF00041;PF07679;	 GO:0042995;GO:0005911;GO:0070062;GO:0005925;GO:0005887;GO:0005886;GO:0036057;GO:0050839;GO:0017022;GO:0007155;GO:0098609;GO:0007588;GO:0032836;GO:0072015;GO:0007254;GO:0007520;GO:0030838;GO:0035418;GO:0044062;GO:0007519;	  C:cell projection; C:cell-cell junction; C:extracellular exosome; C:focal adhesion; C:integral component of plasma membrane; C:plasma membrane; C:slit diaphragm;	  F:cell adhesion molecule binding; F:myosin binding;	  P:cell adhesion; P:cell-cell adhesion; P:excretion; P:glomerular basement membrane development; P:glomerular visceral epithelial cell development; P:JNK cascade; P:myoblast fusion; P:positive regulation of actin filament polymerization; P:protein localization to synapse; P:regulation of excretion; P:skeletal muscle tissue development;
